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MeOH  Methanol 
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mL   10-3 litre 
mM   10-3 Mol 
m. p.   melting point 
MS   Mass Spectrometry 
nm   10-9 metre 
NMR   Nuclear Magnetic Resonance 
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ppm   parts per million 
q   quartet 
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RP   Reversed Phase 
RT  Room Temperature 
RT  Reverse Transcriptase (in connection with HIV-1) 
s   singlet 
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1 Introduction 
 
1.1  Marine microorganisms 
 
Marine microorganisms, particularly fungi and bacteria, have provided new incentives for 
marine natural products research over the past 15 years, and also continue to be the subject of 
vigorous chemical investigation (Liberra & Lindequist, 1995; Faulkner, 2001; Blunt et al., 
2003). The diversity of secondary metabolites reported during the recent decade is 
fascinating. This highlights the importance of marine microorganisms as a source of natural 
products (König & Wright, 1996; Pietra, 1997; Faulkner, 2000 a and b). 
 
The marine environment comprises nearly three quarters of the earth’s surface, and can be 
considered a soup of essentially all imaginable types of microbes (König & Wright, 1999). 
They may occur suspended, on living or inanimate surfaces as epibionts, or as symbionts. 
Microorganisms play important roles in all the major elemental cycles in the oceans 
(Hawksworth, 1991), and are intimately involved in ecological phenomena, e.g. biofouling, 
settlement, and metamorphosis. The marine environment is unique in terms of its specific 
composition in both organic and inorganic substances, as well as temperature ranges, and 
pressure conditions. Ecological niches e.g. deep-sea hydrothermal vents, mangrove forests, 
algae, sponge, and fish provide habitats for the evaluation of specific microorganisms 
(Kohlmeyer, 1979). 
 
The difficulties associated with the collection of marine macroorganisms as well as the 
inadequate amount of the bioactive substance isolated (Proksch et al., 2002), motivated many 
research groups to investigate the microbes associated with them, or those found directly in 
the water column and/or marine sediments (König & Wright, 1996). There are some 
advantages obvious when investigating microbes as compared to macroorganisms. These 
include; e.g. biotechnological fermentations with different parameters are possible without 
ecological exploitation, reisolation of the compounds is possible after large scale cultivation 
of the microorganism, and microorganisms are easier manipulated genetically. On this basis, 
marine microbes become a central topic for many groups investigating natural products with 
the aim of finding pharmaceutical drugs or compounds useful for agriculture (Osterhage, 
2001).  
 
An endophyte (Tan and Zou, 2001) is a bacterium (including actinomycetes) or fungal micro-
organism, which spends the whole or part of its life cycle colonizing inter- and/or intra-
cellular space inside the healthy tissues of the host plants, typically causing no apparent 
symptoms of disease. Often endophytes remain asymptomatic for many years and only 
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become parasitic when their hosts are stressed. For the isolation of endophytes it is important 
that collected algal material looks healthy, it must not have any visual symptoms of disease 
(Osterhage Dissertation, 2001).  
 
1.2  Marine fungi 
 
Marine microbes, particularly fungi, have recently been utilized as a new source of novel 
bioactive secondary metabolites (Biabani & Laatsch, 1998; König & Wright, 1999). This 
study is thus devoted to the investigation of some marine fungal strains, derived from algae or 
sponges, and aims at finding new natural products with biological activity and/or novel 
chemical structures. 
 
The kingdom of fungi is the second largest group after insects, and widely distributed in 
nature. Fungi occur in Antarctic ice, tropical, and temperate regions. They inhabit soils, the 
surface of mountain rocks, and seawater (Feofilova, 2001). Fungi parasitize plants, protozoa, 
fishes, insects, and mammals. The generally accepted estimate of the number of the fungal 
species on Earth is a conservative 1.5 million (Hawksworth & Rossman, 1997). Although it is 
uncertain exactly how many fungal species are already known, one can be reasonably sure 
that it is in the range of 72,000 to 100,000. This implies that the fungi known today do not 
exceed 5% of all existing species. Evidently, the majority of fungi inhabiting the world have 
not yet been described. This implies that fungi represent an enormous source for natural 
products with diverse chemical structures and activities (Hawksworth, 1991, 1997).  
 
Fungi from marine habitats are separated into obligate and facultative marine species, the 
former being restricted to the marine environment and the latter occurring also in freshwater 
or terrestrial localities, or both (Kohlmeyer, 1974). In 1991 Kohlmeyer & Volkmann-
Kohlmeyer listed 321 filamentous higher marine fungi. Their key included 255 Ascomycetes, 
60 mitosporic fungi, and only six Basidiomycetes. The isolation of a fungal strain from a 
marine sample does not prove that this fungus is actively living in the marine environment. It 
is always possible to isolate a terrestrial fungus being a contaminant in the marine habitat. 
Possibly such a fungal isolate was dormant in the form of spores or hyphen fragments until 
the surrounding conditions in the laboratory became favorable for germination and growth. 
Most fungi isolated from marine samples are not proven to be obligate or facultative marine. 
Thus, the more general expression marine-derived fungi is used (Kohlmeyer & Kohlmeyer, 
1979).  
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1.2.1 Secondary metabolites of algae-derived fungi 
 
Special ecological niches in the marine environment have been observed as interesting for 
many natural products chemists. Such niches are marine microorganisms associated with 
macroorganisms e.g. algae, sponges. Most kinds of macroorganisms e.g. algae, sponges, 
corals, tunicates, and fish have extensively been investigated for their natural products content 
(Faulkner, 2001). These macroorganisms also serve as hosts for microorganisms and were 
recently considered as an important source of natural products. The current project focused on 
fungi associated with marine algae and sponges. Natural products in these association may 
have an ecological purpose. In many cases the natural function of secondary metabolites is, 
however unknown (König & Wright, 1996).  
 
There are several reviews dealing with marine fungal metabolites (Faulkner, 2001; Pietra, 
1997). They covered the isolated metabolites till 2000. In addition to this reviews, Dr. Claudia 
Osterhage, a prior Ph. D. student in our group, listed the metabolites isolated from algicolous 
fungi for the period from 1993 till May 2000. For these reasons only the metabolites isolated 
from algicolous fungi after May 2000 up to May 2003 are listed in Table 1. In Figure 1 the 
chemical structures of the compounds are shown (drawn in an alphabetical order). 
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Table 1. Metabolites reported from algae-derived fungi (May 2000-May 2003). 
 
Algal species 
investigated 
Fungus isolated 
& investigated 
Metabolite (s) isolated Literature 
Ceratodictyon 
spongiosum 
KO63 Dictyonamides A and B Komatsu et al. 
(2001) 
Enteromorpha 
intestinalis 
Penicillium sp.  
 
Penochalasins D-H 
 
Iwamoto et  
al. (2001) 
Rosenvingea sp.  Pestalotia sp. Pestalone Cueto et al. (2001) 
Sargassum tortile Leptosphaeria 
sp. 
Leptosins M, M1, N, and N1 Yamada et 
 al. (2002) 
Fucus spiralis Phoma tropica 5-Hydroxyramulosin Osterhage et al. 
(2002) 
Liagora viscida Drechslera 
dematioidea 
Isosativenetriol, Drechslerines A and 
B, 9-Hydroxyhelminthosporol, 
Drechslerines C-G, Sativene epoxide 
Osterhage et al. 
(2002) 
Carpopeltis cornea Aspergillus  
parasiticus  
Parasitenone Son et al. (2002) 
Codium fragile Fusarium sp. Tetrapeptide JM47 Jiang et al. (2002) 
Gracilaria 
verrucosa 
Unidentified Nb-Acetyltryptamine Li et al. (2003) 
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 Figure 1: Metabolites from algae-derived fungi. 
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                     Figure 1 (continued): Metabolites from algae-derived fungi. 
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Figure 1 (continued): Metabolites from algae-derived fungi. 
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1.2.2 Secondary metabolites from sponge-derived fungi 
 
As some marine microorganisms survive under extreme environmental conditions, it can be 
expected that they may have evolved to biosynthesize biologically active chemical 
compounds (Brauers et al., 2000). They often live in symbiosis with soft bodied filter feeding 
invertebrates such as sponges, and their bioactive metabolites may be interpreted as chemical 
mediated defense mechanisms for protecting their host organism from environmental dangers 
such as predation (Proksch et al., 2002). The association between sponge and microorganisms 
probably dates back to 500 million years ago (Friedrich et al., 1999). The relationship 
between marine invertebrate (sponge) and marine microorganisms (fungi or bacteria) may be 
manifold, it can serve as food or just live inside it. Thus, this relation is complex and far from 
being understood (Proksch et al., 2002, Steinert et al., 2000). The relationship between host 
sponges and fungi is still unknown; only marine Ascomycetes of the genus Koralionastes 
have been reported to be in some way associated with crustaceous sponges (Kohlmeyer & 
Volkmann-Kohlmeyer, 1991).  
 
As sponges are filter-feeding organisms, which take up the spores and mycelium fragments 
from seawater, the development of these fungi under laboratory conditions does not mean that 
they are active inside the sponge (Höller et al., 2000; Biabani et al., 1998). The isolation of a 
fungus from a marine organism also does not indicate whether the fungus is obligate or 
facultative marine (Proksch et al., 2002). 
 
As mentioned before, there are valuable reviews dealing with marine fungi (Liberra & 
Lindequist, 1995; Pietra, 1997; Faulkner, 2001; Blunt et al., 2003). In addition to these 
reviews, Dr. Ulrich Höller, a former Ph. D. student in our group, listed the metabolites 
isolated from sponges-derived fungi in the time between 1993 and 1998. For these reasones 
only the metabolites which were isolated after this date are listed in Table 2 (1998-May 
2003). In Figure 2 the chemical structures of the compounds are shown (drawn in an 
alphabetical order). 
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Table 2. Metabolites reported from sponge-derived fungi (2000-2002). 
 
Sponge species 
investigated 
Fungus isolated 
& Investigated 
Metabolite (s) isolated Literature 
Drechslera 
hawaiiensis 
Speciferol A; Butoxyl-spiciferin Edrada et al. 
(2000) 
Pandangolide 3 and 4; Acetyl sumiki’s 
acid  
Jadulco et al. 
(2001) 
Callyspongia 
aerizusa 
Cladosporium 
herbarum 
Herbarin A and B Jadulco et al 
(2002) 
Unidentified 
 
Unidentified  Iso-cladospolide B; seco-Patulolide C; 
Pandangolide 1and 2 
Smith et al. 
(2000) 
Hyrtios proteus Aspergillus niger Asperic acid Varoglu et al. 
(2000) 
Microsphaeropsis 
sp. 
10-Hydroxy-18-methoxyl betaenone; 10-
Hydroxy-18-N-2-naphthyl-N-phenylamino 
betaenone; three 1,3,6,8-Tetra- hydroxyl- 
anthroquinone congeneres 
Brauers et al. 
(2000) 
Hortaea 
werneckii 
Hortein Brauers et al. 
(2001) 
Aplysina 
aerophoba 
Microsphaeropsis 
sp. 
Microsphaerones A and B Wang et al. 
(2002) 
Porifera sp. Emericella 
variecolor 
Varitriol; Varioxirane, Dihydroterrein; 
Varixanthone 
Malmstrøm et 
al. (2002) 
Xestospongia 
exigua 
Penicillium cf. 
montanense 
Xestodecalactones A-C Edrada et al. 
(2002) 
 Aspergillus 
versicolor 
Aspergiones A-F Lin et al. 
(2003) 
Niphates olemda Curvularia lunata Lunatin Jadulco et al. 
(2002) 
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Figure 2: Metabolites from sponge-derived fungi. 
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Figure 2 (continued): Metabolites from sponge-derived fungi. 
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Figure 2 (continued): Metabolites from sponge-derived fungi. 
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2 Scope of the present study 
 
The main objective of the present study was the isolation of new and preferably biologically 
active secondary metabolites from marine microorganisms, especially marine-derived fungi. 
Marine fungi were obtained from macroalgae and to a lesser extent from sponges. 
 
2.1 Biological and chemical screening of fungal extracts 
 
After taxonomical identification of fungal strains, isolates belonging to typical marine genera 
were selected for further investigation. Small scale cultivation and extraction enabled 
biological activity testing. These tests mainly consisted of agar diffusion assays for 
antibacterial, antifungal and antialgal activity. An additional investigation by 1H NMR was 
used for chemical characterisation of the fungal extract. The results obtained with these 
methods were used for the selection of strains for detailed chemical investigation. 
 
2.2 Chemical investigation of fungal strains 
 
Large-scale cultivation, extraction and separation using diverse chromatographic methods, 
mainly HPLC, was to be employed, in order to isolate pure compounds. Structure elucidation 
was performed using mainly 1D NMR and 2D NMR techniques, and by physical 
characterisation of the isolated metabolites. 
 
2.3 Pharmacological potential of isolated pure compounds 
 
Each pure compound obtained during this study was to be tested in as many different 
bioassays as possible. Especially antimicrobial, antioxidant and enzyme inhibitory activities 
were to be evaluated with the help of collaborating scientists. 
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3 Materials and methods  
 
The special materials and methods used during this study are described in detail in the 
"Description of partial projects" chapter as they are of specific interest for the respective 
study. This chapter describes the general materials and methods, which were used in many or 
all partial projects in order to avoid repetitions.  
 
3.1 Chromatography 
 
3.1.1 Thin layer chromatography (TLC) 
 
TLC was carried out using either TLC aluminium sheets silica gel 60 F254 (Merck 5554) or 
pre-coated TLC plates SIL RP-18W / UV 254 (Macherey-Nagel). Standard chromatograms of 
fungal extracts were prepared by applying 20 µL solution (5 mg/mL) to a silica gel TLC plate 
and developing it with DCM/MeOH (95/5 v/v) under saturated conditions. Chromatograms 
were detected under UV light (254 and 366 nm), and with vanillin-H2SO4 reagent (1g vanillin 
dissolved in 100 ml H2SO4, heated at 100 °C after spraying). 
 
3.1.2 Vacuum-liquid chromatography (VLC) 
 
Sorbents for VLC were either silica gel 60 (0.063-0.200 mm, Merck 7734; Merck 7739; 
normal-phase) or Polyprep 60-50 C18 (Machery-Nagel 71150; reversed-phase). Columns 
were filled with the appropriate sorbent soaked with petroleum ether or MeOH. Before 
applying the sample, the column was equilibrated with the first designated eluent. 
 
3.1.3 High performance liquid chromatography (HPLC) and detectors 
 
HPLC was carried out either using a Merck-Hitachi system equipped with an L-6200A 
Intelligent Pump, a L-4500A diode array detector, a D-6000A interface with D-7000 HSM 
software, a Rheodyne 7725i injection system, or a system equipped with a Waters associates 
chromatography pump, a Knauer Differential refractometer, a Rheodyne 7725i injection 
system and a Linseis L 200 E recorder. If not stated otherwise, the system with differential 
refractometer as detector was used. Columns used were either a Knauer Spherisorb S ODS 2 
(5 µm, 250 x 8 mm), a Merck LiChrospher Si 60 (5 µm, 250 x 7 mm), or similar columns. 
Typical flow rates were 2.0 - 3.0 mL/min, or 1.0 mL/min in special cases (see partial project 
chapter). All solvents were distilled prior to use. The eluents were degassed under reduced 
pressure. If not stated otherwise, samples were diluted in the eluent to yield solutions of 20-40  
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mg/mL. Injected amounts usually equalled 5-10 mg of extract/run.  
 
3.1.3.1 HPLC analysis of Trichoderma viride ethyl acetate extract  
 
The HPLC analysis was performed on a Waters apparatus (four solvent delivery systems 
model 600 controller pump, automatic sample injector model 717, and photodiode array 
detector model 996, using RP-HPLC column (XTerra RP-18, 5 µm, 250 x 4.6 mm, Waters). 
Data acquisition and quantification were performed with Millennium 32 version 3.1 software 
(Waters). The mobile phase was gradient elution from 70:30 H2O:MeOH to 30:70 
H2O:MeOH, for 60 min; then to  MeOH, for 40 min; followed by 10 min MeOH, finally, 
return back to 70:30 H2O:MeOH in 5 min. The injecting volume of the ethyl acetate extract 
was 25 µl of 2 mg/mL (methanol). All the compounds were detected at λmax 360 nm and 300 
nm. Before each elution the column calibrated for 20 minuts.  
 
3.2 Structure elucidation 
 
Structures were elucidated mainly using 1D and 2D NMR techniques and various MS 
methods. If necessary, additional parameters such as optical rotation, UV and IR properties 
were determined. Identity of isolated compounds with compounds reported in literature was 
judged, if not stated otherwise, based on 1H and 13C NMR spectroscopic data, and specific 
optical rotation. Literature searches were done using Chapman & Hall Natural Products on 
CD-ROM (Buckingham, 2001), and Beilstein on-line databases. Structures were designated 
as new, if they could not be found in Beilstein database and Chemical Abstracts. 
 
3.2.1 NMR spectroscopy 
 
1H NMR spectra of extracts and pure compounds as a purity check were recorded at the 
Pharmaceutical Biology Institute, Bonn, on Bruker Avance 300 DPX spectrometer operating 
at 300 MHz or a Bruker Avance 500 DRX spectrometer operating at 500 MHz (with 
(CD3)2CO, or MeOH-d4, or C6D6, or CDCl3 as solvent). 1H NMR spectra of pure compounds 
and all other NMR measurements were performed at Pharmaceutical Biology Institute on 
Bruker DPX-300, or at Pharmaceutical Chemistry Institute on Bruker DRX-500 NMR 
spectrometer operating at 300, or 500 MHz (1H), and 75.5, or 125 MHz (13C), respectively. 
Spectra of pure compounds were processed using Bruker 1D WIN-NMR or 2D WIN-NMR 
software. They were calibrated using solvent signals (13C: CDCl3 77.0 ppm, CD3OD 49.0 
ppm, C6D6 128.0 ppm, (CD3)2CO 29.8 ppm) or a signal of the portion of the partly or not  
deuterated solvent (1H: CHCl3 in CDCl3:  7.26 ppm, CH3OH in CD3OD:  3.35 ppm, C6H6 in 
C6D6: 7.20, (CH3)2CO in (CD3)2CO: 2.04 ppm). Multiplicity for 13C was deduced from DEPT  
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experiments; s = C, d = CH, t = CH2, q = CH3. Structural assignments were based on spectra 
resulting from one or more of the following NMR experiments: 1H, 13C, DEPT, 1H-1H COSY, 
1H-13C direct correlation (HMQC), 1H-13C long-range correlation (HMBC), 2D NOESY and 
1H difference NOE. 
 
3.2.2 Mass spectrometry 
 
Mass spectral measurements were performed by Dr. G. Eckardt, Ms. C. Sondag and Ms. K. 
Peters (All Department of Chemistry, University of Bonn) using a Kratos MS 50 (EI), Kratos 
Concept 1H (FAB) and a Finnigan MAT 95 (EI, ESI) spectrometer.  
 
The GC-MS analysis was carried out on a Perkin-Elmer (Auto system XL) gas 
chromatograph equipped and coupled to a Perkin-Elmer Turbomass spectrometer with a 30 m 
x 0.32 mm N931-6023 Pe-1 (film thickness of 0.25 µm) capillary column. The instrument 
was set to an initial temperature of 50 °C, and maintained at this temperature for 10 min. At 
the end of this period the oven was heated at 10°/min up to 250°C, and kept there for 10 min. 
Injection port temperature was 220°C, He flow rate was 2 mL/min, and samples were injected 
in splitless mode. Mass spectral scan range was 35-650 Da.  
 
LC-ESIMS experiments were carried out on API 2000, Triple Quadrupole LC-MS/MS, 
Applied Biosystems/MDS Sciex equipped with Agilent 1100 Serie incl. DAD. The column 
was Macherey-Nagel Nucleodure 100-5 C18 HPLC column, 2mm x 125 mm. The solvents 
were (A) 2 mmol aqueous NH4Ac and (B) 2 mmol NH4Ac of MeOH, employing gradient 
elution from 9:1 H2O:MeOH to MeOH in 20 min, followed by 10 min MeOH, 0.25 mL/min, 
10 µL injecting volume of 1mg/mL of the total extract. Following are the MS parameters: 
ionization mode, positive and negative mode; scan range, 100-700 amu; scan rate, 0.5 
scan/sec; and cone voltage, 20 eV. 
 
3.2.3 UV measurements 
 
UV spectra were recorded a Perkin-Elmer Lambda 40 with a UV WinLab software, using 
1.000 cm quartz cells (Institute for Pharmaceutical Biology, University Bonn).  
 
3.2.4 IR spectroscopy 
 
IR spectra were recorded a Perkin-Elmer spectrometer, Spectrum BX Instruments with FT-IR 
Paragon 1000 PC software, at the Institute for Pharmaceutical Biology, University of Bonn. 
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3.2.5 Optical rotation 
 
Optical rotations were measured by using a Jasco DIP 140 Polarimeter (Institute for 
Pharmaceutical Biology, University of Bonn). The tested samples were dissolved in the 
proper solvent (e.g. MeOH or CHCl3). Then transferred into specific cell (10.0 cm) and using 
a Monochromatic Sodium D-line light by 589 nm at room temperature (22-23°C).  
 
3.2.6 Melting point 
 
Melting points were measured by Leitz 350 Microscope Heating Stage and are not corrected. 
 
3.2.7 X-ray analysis 
 
The single crystal X-ray analysis of 2-(1-methylethylidene) pentanedioic acid (5) was 
performed by Prof. Dr. P. G. Jones, Institute for Inorganic and Analytical Chemistry, TU 
Braunschweig. Crystals were grown from MeOH. 
 
3.3  Origin and taxonomy of fungal samples  
 
3.3.1 Fungal strains for chemical investigation  
 
All chemically investigated fungi, in this study, were obtained from fungal culture collection 
of Professor G. M. König (Pharmaceutical Biology Institute, University Bonn), and were 
isolated by former Ph. D. student Dr. Ulrich Höller and Claudia Osterhage. 
 
Acremonium sp., closely related to A. roseogriseum (S. B. Saksena) W. (Hypocreace, 
Ascomycota, M 1-11-1, 506) was isolated from the brown alga Cladostephus spongius 
(Hudson) C. Agardh, collected at the Spanish coast (Moraira, Mediterranean Sea). 
 
Alternaria sp. (Pleosporaceae, Ascomycota, M7-19, 539), isolated from red alga, Jania 
rubens L. (Corallinaceae), collect from water around Island of Morira, Mediterranean sea. 
 
Epicoccum sp. (Tuberculaiaceae, Hyphomycetes, N1-12, 353), was isolated from the brown 
alga Fucus vesiculosus L., collected at the German coast (Tönning, North Sea). 
 
Myrioconium sp. (Coelomycetes Ascomycota, Cux 3-10, 547), isolated from Fucus 
vesiculosus. L CUX-3 (Fucaceae), was collected from water around the Cuxhaven, North Sea. 
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Sporormiella sp. (Anamorph, Ascomycota, G 2-1, 493), isolated from brown alga 
Stypopodium sp.  (Stypocaulaceae).    
 
Trichoderma viride Persoon in Römer (Hypocreaceae, Ascomycota, 193E61, 54), was 
isolated from the sponge Agelas dispar J (Family Agelasidae, order Agelasida, CT193 E), 
collected by divers from the waters around the Caribbean Island of Dominica. 
 
Wardomyces anomalus Brooks & Hansford (Microascaceae, Ascomycota, OS4T3-2-1, 406), 
was isolated from the green alga Enteromorpha sp. (Ulvaceae) collected around Fehmarn 
island in the Baltic Sea. 
 
3.3.2 Isolation of endophytic fungi from egyptian algae 
 
All algal samples were stored in sterile ASW supplied with 250 mg/L benzylpenicillin and 
250 mg/L streptomycin sulphate at 4 °C for a week until examination. Algal samples were 
sliced aseptically into small pieces and placed in EtOH (70 %) or sodium hypochlorite 
solution (3.5 %), rinsed three times with sterile DW to remove the EtOH, and placed on 
isolation media. Surface sterilization time was optimised for each alga before placing cubes 
onto isolation medium. For the inoculation of algal samples medium I was used containing 
antibiotics (250 mg/L benzylpenicillin and 250 mg/L streptomycin sulphate). Samples were 
incubated at RT (Approx. 20 °C). Fungal colonies were transferred to one or more of the 
media for identification. These included media II, III. The preservation and maintenance of 
stock cultures were carried out in test tubes using medium 1V, then kept at 4 °C. 
 
Medium 1: Standard nutrient agar (SNA): KH2PO4 1 g/L, KNO3 1 g/L, MgSO4 × 7 H2O  
0.5 g/L, KCl 0.5 g/L, glucose × H2O 0.2 g/L, sucrose 0.2 g/L, agar 20 g/L. 
 
Medium II: Glucose peptone yeast extract agar (GPY): glucose × H2O 1 g/L, peptone 
from  soymeal 0.5 g/L, yeast extract 0.1 g/L, agar 15 g/L, ASW IL. 
 
Medium III: Biomalt 20 g/L, agar 20 g/L and ASW 1 L. 
 
Medium 1V: Biomalt 50 g/L, agar 20 g/L and ASW 1 L. 
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3.4 Biological testing 
 
3.4.1 Agar diffusion assays 
 
Agar diffusion assays were carried out in principle according to Schulz et al. (1995). Test 
organisms were the bacteria Bacillus megaterium de Bary (gram positive) and Escherichia 
coli (Migula) Castellani & Chambers (gram negative), the fungi Microbotryum violaceum 
(Pers.) Roussel (Ustomycetes), Mycotypha microspora Fenner (Zygomycetes), and Eurotium 
repens Corda (Ascomycetes), and the alga Chlorella fusca Shih Krauss (Chlorophyceae). 
 
Sample solutions contained 5 mg/mL extract or 1 mg/mL pure compound. Samples were 
prepared by taking 50 µL of each solution and pipetting it onto a sterile antibiotic filter disk 
(Schleicher & Schuell 2668), which was then placed onto the appropriate agar medium and 
sprayed with a suspension of the test organism. Growth media, preparation of spraying 
suspensions, and conditions of incubation were as employed by Schulz et al. (1995). The radii 
of the resultant zones of inhibition were measured from the edge of the filter disks. For 
extracts, a growth inhibition zone or complete inhibition zone ≥3 mm and /or a complete 
inhibition ≥1 mm were regarded as a positive result; growth inhibition: growth of the 
appropriate test organism was significantly inhibited compared to a negative control; 
complete inhibition: no growth at all in the appropriate zone. 
 
3.4.2 Tyrosine kinase inhibitory activity 
 
The DMSO sample solution of the appropriate extract/pure compound was diluted with H2O 
(1:1 v/v) to yield corresponding sample solutions (1 mg/mL). TK inhibitory activity was 
determined using a commercial test kit (Tyrosine Kinase Assay Kit, non-radioactively, 
Boehringer Mannheim, Cat. No. 1 534 513), modified by Dr. G. F. Matthée (Dissertation, 
1999). Assays were carried out by Christine Klemke using T cell tyrosine kinase p56lck 
(Upstate Biotechnology). Sample solutions were incubated with 1 µM TK substrate II, biotin-
labelled (Boehringer Mannheim), 1 mM ATP, 10 mM MgCl2, 1 U TK p56lck, 20 µL dilution 
buffer, and 20 µL assay buffer for 1 h at 30 °C. The resultant concentration of the 
extract/compound in the test mixture was 200 µg/mL. Dilution buffer (pH 7.0) contained 25 
mM 4-(2-hydroxyethyl)-1-piperazineethanesulphonic acid (HEPES), 10 % glycerol, and 0.1 
% ethylphenolpoly(ethylene-glycolether)n (NP-40). Assay buffer (pH 7.5) contained 250 mM 
Tris, 25 mM NaF, 2.5 mM EDTA-Na2, 4.0 mM [ethylenebis (oxyethylene-nitrilo)] tetraacetic 
acid (EGTA), 5 mM DTT, and 150 µM Na3VO4. The enzyme activity was determined as 
described in the TK  Assay  Kit,  except the measuring wavelength was 415 nm instead of 405  
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nm. In each test series 3 mM piceatannol (Boehringer Mannheim) was included as a positive 
control. Samples which reduced the enzyme activity to 60 % or less relative to a negative 
control were regarded as active. 
 
3.4.3 HIV-1 reverse transcriptase inhibitory activity 
 
The assay was performed by Mr. C. Dreikorn according to a protocol established by Dr. G. F. 
Kirsch (2000). DMSO standard solutions of the appropriate extracts/compounds were diluted 
with lysis buffer (1:10 v/v) to yield corresponding sample solutions. HIV-1 RT inhibitory 
activity was measured using 20 µL of the sample solution, 20 µL lysis buffer, and 20 µL 
reaction mixture which were then incubated for 1 h at 37 °C. The resultant concentration of 
the extract in the test mixture was 66 µg/mL. Lysis buffer (pH 7.8) contained 1 ng 
recombinant HIV-1 RT (Boehringer Mannheim), 50 mM Tris, 80 mM KCl, 2.5 mM 
dithiothreitol (DTT), 0.75 mM ethylenediamintetraacetic acid (EDTA), and 0.5 % Triton-
X100. The reaction mixture contained template/primer hybrid poly(A)*oligo(dT)15 (600A260 
nm/mL), 8 µM thymidine-5'- triphosphate (dTTP), 8 µ M digoxigenin- and biotin-labeled-2'-
deoxy-(uridine-5'- triphosphate) (dUTP), 40 µ M TrisHCl, 230 mM KCl, 24 mM MgCl2, and 
8 mM DTT (all Boehringer Mannheim). Enzyme activity was measured following the ELISA 
protocol described by Eberle & Seibl (1992) at λ = 415 nm versus λ = 490 nm using an 
ELISA reader (Rainbow, SLT Labinstruments Deutschland GmbH). As a positive control, 10 
µ M of phosphonoformic acid (Sigma) was included in each test series. Extracts which 
reduced the enzyme activity to 80 % or less relative to a negative control were regarded as 
active. 
 
3.4.4 Antioxidative activity 
 
3.4.4.1 Thiobarbituric acid reactive substances method (TBARS assay) 
 
The method used was adapted from Wallin et al. (1993) and modified by K. M. Fisch as 
follows: Assays were performed in flat bottom polystyrene 96 well microtiter plates. The final 
volume of the reaction mixture in the oxidation step of linolenic acid methyl ester was 70 
µL/well. The solution was made of 40 µL of 50 mM phosphate buffer (pH = 7.2), 10 µL of 10 
% (w/v) sodium dodecyl sulphate, 5 µL of sample in ethanol (1 mg/mL and 0.2 mg/mL), 5 µL 
linolenic acid methyl ester 70 mM in ethanol, and finally 10 µL of 0.08 % (w/v) FeSO4.7H2O 
in 0.025 M HCl. Plates were placed in a thermomixer and incubated at 50 °C and 500 rpm for 
30 min. At the end of this period 5 µL butylated hydroxytoluene (BHT) 15 mM in ethanol 
was added immediately so as to prevent further oxidation. To each well  20  µL of 50 % (w/v) 
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trichloroacetic acid and 40 µL of  0.88 % (w/v)  thiobarbituric acid,  dissolved in  0.3 % (w/v) 
NaOH, were added. The plate was then covered with a micromat and incubated at 60 °C and 
500 rpm for a further 30 min. At the end of this period the plate was maintained at room 
temperature for 4 min and the absorbances then determined at 532 nm, less the background 
absorbance at 600 nm, using a SLT Spectral Rainbow microtiter plate reader. 
 
3.4.4.2 α,α-Diphenyl-ß-picrylhydrazyl (DPPH) radical scavenging effects 
 
 Assays were performed in flat bottom polystyrene 96 well microtiter plates. The DPPH 
radical scavenging effects of the total extract and compounds were performed by using a 
modified previously established methodology (Blois et al., 1958 and Amarowicz et al., 2000).  
To 100 µL of each sample (1 mg/mL) in EtOH 25 µL DPPH (1 mM) in EtOH was added. The 
resultant mixture was briefly shaken and maintained at room temperature, in the dark for 30 
min.  At the end of this period the absorbance of the mixture was measured at 517 nm, using a 
SLT Spectral Rainbow microtiter plate reader. 
 
3.4.5 Cytotoxicity 
 
3.4.5.1 Human cancer cell lines 
 
The cytotoxicity was carried out at the Institute for Experimental Onkology in Freiburg, 
through the cooperation with Prof. Dr. Heinz-Herbert Fiebig. Ten human cancer lines were 
tested i.e. three lung carcinoma (LCL H460, LXFL 529L, and LXFA 629L), two breast cancer 
(MACL MCF7, and MAXF 401NL) two melanoma (MEXF 462NL and MEXF 486L), two 
kidney cancer (RXF 944L and RXF 486L) and a uterine cancer (UXF 1138L). The assays 
were performed as previously published (Grever et al., 992). 
 
3.4.5.2 Brine shrimp lethality bioassay  
 
Brine shrimps (Artemia salina) is a simple convenient general bioassay and also indicative for 
cytotoxicity (Meyer et al., 1982; Solis et al., 1993). The brine shrimp eggs were hatched in 
artificial seawater (ASW). 40 mg/L of the eggs supplemented with 6 mg/L dried yeast and 
oxygenated with aquarium pump for 48 hours in room temperature (22-25°C). 100 µL of the 
sample solution (1 mg/mL) transferred into sterile microtiter plate. The plate left till 
evaporated over night. Then 150 µL of the A. salina culture medium together with a few A. 
salina larvae was added, followed by 150 µL water. For each sample four replicate were 
performed. After 24 and 48 hours the plates were examined under a binocular microscope and  
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the numbers of dead (non-motile) nauplii in each well were counted aginst the negative 
control.  
 
Culture medium for A. salina: 2.4 g Tris, 25.7 g NaCl, 4.7 MgCl2 (presolved), 0.7 g KCl, 0.2 
g Na2CO3 (presolved), 6.4 g MgSO4 (presolved), 1.1 g CaCl2 (presolved), 1000 mL aqua 
bidest, adjusted to pH 7.1, stored at 4 °C or 10.0 g spezial artemia salt (Dohse aquaristik 
Bonn), 1000 mL aqua bidest. 
 
Culture: 0.3 g Artemia cysts/400mL culture medium (RT) in a 1 L beaker covered with gas 
was ventilated under oxygen for 48 h. 
 
Collecting: The adult were collected by using a brine-shrimp sieve (Dohse aquaristik Bonn). 
 
3.4.6 Recombinant yeast estrogenic assay 
 
The assay was performed by Mr. M. Nett (Pharmaceutical Biology Institute, University of 
Bonn). Details procedure and medium components of this assay have been previously 
described (Routledge and Sumpter, 1996). In brief, yeast cells transfected with the human 
estrogen recptor (ERα) gene, together with expression plasmids, were incubated in medium 
containing the extract or pure compounds, in addition to the chromogenic substrate, 
chlorophenol red-β-D-galactopyranoside (CPRG). Upon binding the active ligand, the 
estrogen-occupied receptor intertacts with transcription factors and other transcriptional 
componenta to modulate gene transcription. This causes expression of the reporter gen Lac-Z 
and the enzyme produced (galactosidase) is secreted into the medium, which causes the 
CPRG to change into red product that can be measured by absorbance at λmax 540 nm. 
 
3.5 Chemicals 
 
3.5.1 Media components: 
 
Agar (Fluka 05040) 
Biomalt (Villa Natura, Kirn) 
Malt extract (Merck 5391) 
Peptone from casein, tryptic digest (Fluka 70172) 
Peptone from meat, enzymatic digest (Fluka 70175) 
Peptone from Soya meal, papain-digested (Merck 7212) 
Yeast extract (Fluka 70161) 
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Benzylpenicillin (Fluka 13750) 
Streptomycin sulphate (Fluka 85880) 
Water used was de-ionised using a Millipore (milli-Q®) system.  
 
All other chemicals/components were research grade, and if not stated otherwise in the text, 
supplied by Merck. 
 
3.5.2 Solvents: 
 
EtOH for UV-measurements was from Merck (Uvasol®980). All other solvents were research 
grade and supplied by Merck, except n-BuOH (Roth). Water used was deionised using a 
Millipore (milli-Q®) system. Acetone, CHCl3, DCM, EtOAc, hexane, cyclohexane, MeOH 
and petroleum ether were distilled prior to use. 
Acetone-d6 (Chemotrade 97509, 99.8 % D). 
Methanol-d4 (ICB 0844-25, 99.8 % D). 
Benzene-d6 Chemotrade, 99.87 % D). 
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   4 Description of partial projects 
  
4.1 Endophytic marine fungi; isolation, selection, mass cultivation and 
biological activities 
 
Isolation of endophytic fungi 
 
One of the tasks within this project was the isolation of endophytic fungi from marine algae in 
order to investigate them for the production of new and/or biological active metabolites 
during the current study. Some of the marine fungal strains examined, were isolated from 
algae or sponges by former Ph. D. students of our research group, i.e. Dr. Ulrich Höller and 
Dr. Claudia Osterhage.  
 
From 11 egyptian algal samples, a total of 14 fungal strains were isolated (Table 3). Six of 
them were identified as belonging to the genus Aspergillus and Penicillium. Since they might 
be pathogenic they are excluded from any further studies. The remaining eight strains are not 
yet identified. Table 3 lists the algae, the collection site and number of the fungal strains 
isolated.  
 
 Table 3. Algal samples from Egypt as a source of endophytic fungi. 
 
No. Alga name Source of algal samples Identified fungi  Unidentified fungi  
1 Laurencia papilosaa Suez Canal, Ismailia Aspergillus sp. 2 
2 Gelidium sp. Port Said - - 
3 Sarconium sp. Suez Canal, Ismailia - - 
4 Jania sp. Suez Canal, Ismailia - - 
5 Ulva sp. Suez Canal, Ismailia Aspergillus sp. 1 
6 Acanthophora sp. Suez Canal, Ismailia Aspergillus sp. 1 
7 Enteromorpha sp. Suez Canal, Ismailia Penicillium sp. - 
8 Enteromorpha sp. Port Said Penicillium sp. 1 
9 Hypnea valentiae Suez Canal, Ismailia - 2 
10 Hypnea musciformis Suez Canal, Ismailia Aspergillus sp. 1 
11 Ulva sp. Suez Canal, Ismailia - - 
 
  aAll algae collected from a deepth at 0-1 meter (September 2002). 
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Selection of strains for further investigations of their secondary metabolites, 
example Trichoderma viride 
 
The selection of strains for mass cultivation was based on the biological activity of the 
extract, and/or secondary metabolites detected in 1H NMR spectra, especially from signals 
present in the δ 5-9 region. In some cases, the total extract was subjected to further analysis 
employing HPLC-DAD and/or LC-ESIMS with the aim to confirm the 1H NMR data.  
 
As an example the HPLC-DAD and LC-ESIMS investigation of the ethylacetate extract of the 
fungus Trichoderma viride shall be discussed in this chapter.  In all cases, a literature survey 
was performed to obtain information on published compounds from relevant genera, which 
revealed the ability of the selected strain might be producing variable structures. 
 
The ethylacetate extract of T. viride was analysed on reversed phase HPLC-DAD. A 
H2O/MeOH gradient from 70/30 to 0/100 H2O/MeOH on RP-18 used for this purpose. Thus, 
eleven peaks in the total extract of T. viride were detected at 360 nm (Fig. 3a), and also at 300 
nm. The latter had partially different retention times (Fig. 3b) and thus, are different 
substances. Studying the UV spectra indicated that peaks 5, 6 and 9 possess a similar 
chromophore and comparable molecular weights as detected by LC-ESIMS. UV maxima and 
Rt (min) of Trichoderma extract: 213/280 at 42.5, 212/264/366 at 43.8, 212/363 at 50.5, 
212/363 at 52.9, 212/366 at 56.3, 212/255/363 at 57.5, 213/298/369 at 76.7, 213/366 at 87.3, 
212/297/374 at 88.9, 212/362 at 91.2, 213/272/306/406 at 92.7.  
 
T. viride extract was also analysed by LC-ESIMS (positive and negative mode), and eleven 
peaks were detected. LC-MS spectra allowed to deduce the molecular weight of the 
metabolites produced by T. viride. The positive mode ESIMS analysis led to detection of 
seven peaks [m/z/ Rt (min)] 265/8.6, 251/9.1, 225/15.0, 497/16.5, 499/19.1, 497/21.1, and 
497/21.5. The negative mode ESIMS analysis led to the detection of ten peaks [m/z/ Rt 
(min)]: 263/8.6, 249/9.1, 359/13.5, 393/16.7, 495/16.5, 407/16.9, 407/18.1, 497/19.1, 495/ 
21.1, and 495/21.5. Subtraction of the peaks detected by the two modes from each other 
showed that eleven individual peaks were detected.  
 
The results obtained from HPLC-DAD analysis were in a good agreement with those obtained 
from the LC-ESIMS analysis. A similar number of peaks was detected. UV maxima of some 
detected peaks indicated that those compounds had a similar chromophore, where others 
differed, selected spectra are shown in Figure 3C.  
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Biological activity of the fungal strains 
 
All extracts were subjected to brine shrimp lethality and antibacterial, antifungal and antialgal 
assays. Few of them were tested for their antioxidant properties. The bioactivities will be 
disscussed in the individual partial projects.  
 
The combination of HPLC-DAD/MS results with those obtained from the 1H NMR spectrum 
and the biological assays, facilitated the selection of the seven fungal strains for chemical 
investigation. These fungi represented different genera. Six of them are mitosporic fungi i.e. 
Acremonium sp., Wardomyces anomalus,, Epicoccum sp., Trichoderma viride, Alternaria sp. 
and Myrioconium sp., and one is a fungus belonging to the Ascomycetes i.e. Sporormiella sp. 
(Table 4). 
 
  
Table 4. Selected fungi for chemical investigation. 
    
C. Noa Code Name 
54 193E61 Trichoderma viride 
353 N1-12 Epicoccum sp.           
406 OS4T3-2-1 Wardomyces anomalus 
493 G 2-1 Sporormiella sp.           
506 M 1-11-1 Acremonium sp. 
539 M7-19 Alternaria sp.           
547 Cux 3-10 Myrioconium sp.           
 
 aThis number refers to the fungal collection (Pharmaceutical Biology Institute, Bonn). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                    
 
Endophytic fungi 
 
 
29
 
 
A
U
0.00
0.05
0.10
0.15
0.20
Minutes
20 40 60 80 100
1
3
2 5
6
9
11
A
U
0.00
0.16
nm
2500 350 450
[M-H]+ 407 5
A
U
0.00
0.14
nm
250 350 450
[M-H]+ 495 6
A
U
0.12
nm
250 350 450
9
A
U
0.00
0.05
0.10
0.15
0.20
Minutes
20 40 60 80 100
1` 3`
7`
9`
8`
11`4`
5` 6``
A
U
0.00
0.20
nm
250 350 450
[M-H]+ 249 3`
[M-H]+ 495
a)
b)
c)
0.0
 
Figure 3. HPLC-chromatograms of the total extract of T. viride. a) UV-detection at 360 nm 
and  b) UV-detection at 300 nm. Panel (c) shows selected UV spectra (range of 200-500 nm) 
and results of ESIMS [M-H]+. HPLC with RP-18 (5 µm, 250 x 8 mm i.d, Knauer), and 
gradient elution from H2O/MeOH (70/30) to MeOH (100) in 115 min, 2 ml/min. 
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4.2 New antioxidant hydroquinone derivatives from the algicolous marine 
fungus Acremonium sp.  
 
Abstract 
 
A marine fungal isolate, identified as Acremonium sp., was mass cultivated and found to 
produce two novel hydroquinone derivatives, 7-isopropenylbicyclo[4.2.0]octa-1,3,5-triene-
2,5-diol (1) and 7-isopropenylbicyclo-[4.2.0]octa-1,3,5-triene-2,5-diol-5-β-D-gluopyranoside 
(2). Compound 1 and its glucoside 2 possess a most unusual ring system. The new natural 
products (3R*,4S*)-3,4-dihydroxy-7-methyl-3,4-dihydro-1(2H)-naphthalenone (3) and (3S*, 
4S*)-3,4-dihydroxy-7-methyl-3,4-dihydro-1(2H)-naphthalenone (4) were obtained as a 1:0.84 
mixture. 2-(1-Methylethylidene) pentanedioic acid (5) was isolated for the first time as a 
natural product and its structure proven by X-ray analysis. In addition to these compounds an 
inseparable mixture of three new isomeric compounds, pentanedioic acid 2-(1-methyl-
ethylidene)-5-methyl ester (6), pentanedioic acid 2-(1-methylethylidene)-1-methyl ester (7), 
and pentanedioic acid 2-(1-methylethenyl)-5-methyl ester (8), was also obtained. Isolated 
together with the new compounds were three known hydroquinone derivatives, 9-11. The 
structures of all compounds were determined by interpretation of their spectroscopic data (1D 
and 2D NMR, MS, UV, and IR). Each isolate was tested for its antioxidant properties, and 
compounds 1 and 9-11 were found to have significant activity.  
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Introduction 
 
Marine microorganisms, particularly marine fungi, have recently gained prominence as an 
important source of biologically active secondary metabolites (König & Wright, 1996). 
Among marine fungi, those living in association with marine algae are a particularly 
promising source of novel natural products due to the special ecological niche in which they 
exist. The association between algae and fungi appears to be highly developed since nearly 
one third of all higher marine fungi described are so-called algicolous or algae- associated 
organisms (Kohlmyeyer & Kohlmeyer, 1979). Recently, marine derived fungi have yielded 
some unique biologically active metabolites, such as ascosalipyrrolidinone and ascosalipyrone 
(Osterhage et al., 2000), microsphaeropsisin (Höller et al., 1999), and mactanamide (Lorenz 
et al.,1998), further supporting the idea that these organisms are truly valuable producers of 
potential therapeutic agents.  
 
Natural antioxidants (Yen et al., 1996) are known to be produced by Penicillium roquefortii 
(Hayashi et al., 1995), Aspergillus candidus (Yen et al., 1999, 2001), Mortierella sp. (Hirota 
et al., 1997), and Emericella falconensis (Takahashi et al., 2000) and by fungi of the genus 
Acremonium (Teshima et al., 1991). Acremonium sp. (Hypocreace, Ascomycetes), are noted 
for their secondary metabolite content, with around 132 compounds having been reported 
from fungi of this genus, including the halymecins (Chen et al., 1996), oxepinamides A-C 
(Belofsky et al., 2000), acremolactone (Sassa et al., 1998), and orbuticin (Roy et al., 1996).  
 
Materials and methods 
 
Isolation and taxonomy of the fungal strain  
 
Algal material (Cladostephus spongius, Cladostephaceae, M 1) was collected by divers from 
waters around Spain (Moraira, Mediterranean Sea). After sterilization with 70 % ethanol, 
algal samples were rinsed with sterile water and pressed onto agar plates to detect any residual 
fungal spores on the surface. Sterilized algae were then cut into pieces and placed on agar 
plates containing isolation medium: 15 g/L agar, 1 L seawater from the sample-collecting site, 
benzyl penicillin and streptomycin sulphate (250 mg/L). Fungal colonies growing out of the 
algal tissue were transferred onto medium for sporulation: 1.0 g/L glucose, 0.1 g/L yeast 
extract, 0.5 g/L peptone from meat, enzymatic digest, 15 g/L agar, 1 L artificial seawater, the 
pH was adjusted at 8, in order to enable taxonomy of the isolates.  
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Cultivation 
 
The fungus Acremonium sp. (Hypocreace, Ascomycetes, M 1-11-1, 506) was cultivated at 
room temperature for two months in 7 L (14 Fernbach flasks) of solid biomalt agar containing 
50 g biomalt, 15 g agar, and 1 L ASW. Each Fernbach flask was inoculated with 10 ml of 10-
day-old cultures (room temperature) grown in biomalt media without agar. 
 
Biological activity, see chapter 3.4. 
 
Extraction and isolation 
 
The mass cultivated fungus, mycelia and medium, was diluted with water (100 mL/L) and 
homogenized using an Ultra-turrax model T25 at 8000 min-1, the resulting mixture was 
exhaustively extracted with EtOAc (3 x 10 L) to yield 4.5 g of a highly viscous brownish 
black gum. The extract (4.3 g) was fractionated by VLC (Si gel 60, 0.063-0.200 mm, Merck) 
employing gradient elution from petroleum ether to EtOAc to MeOH, to yield 8 fractions 
(Pet.ether:EtOAc:MeOH, 1:0:0; 5:5:0; 2.5:7.5:0; 0:1:0; 0:7.5:2.5; 0:5:5; 0:2.5:7.5; 0:0:1, each 
200 mL) (47.6, 433, 1050, 1114, 99, 600, 385 and 41 mg, respectively). VLC fraction 3 (1.05 
g) was further fractionated by VLC using RP-18 material (Polyprep 60-50 C18, Machery-
Nagel 71150), and gradient elution from H2O to MeOH, to yield 15 fractions (H2O: MeOH, 
1:0; 1:0; 9:1; 8:2; 7:3; 6:4; 5:5; 4:6; 3:7; 2:8; 1:9; 0:1; 0:1; 0:1; 0:1, each in 50 mL), which 
were combined, based on 1H NMR spectral similarities, to give nine fractions (20, 42.8, 236, 
60, 10, 48, 8, 10, 2 mg, respectively). Fraction 3 appeared most promising based on several 
1H NMR resonances in the δ 6-9 region, and was further fractionated by normal phase HPLC 
(Eurospher Si, 5 µm, 250 x 8 i.d., Knauer) with cyclohexane:acetone, 8:2, in 30 min, 3 
mL/min, as eluent to yield six compounds; 1 (tR = 10 min, 14 mg or 2 mg/L), 6-8 (tR = 8 min, 
14 mg or 2 mg/L), 9 (tR = 13 min, 8 mg or 1.1 mg/L), and 10 (tR =13 min, 10 mg or 1.4 
mg/L). VLC Fraction 4 (1.1 g) was also further fractionated by VLC using normal phase 
silica and gradient elution from n-hexane to EtOAc to MeOH, to yield 15 fractions (n-
hexane:EtOAc:MeOH, 1:0:0; 1:0:0; 9:1:0; 8:2:0; 7:3:0; 6.4:0; 5:5:0; 4:6:0; 3:7:0; 2:8:0; 1:9:0; 
0:1:0; 0:5:5; 0:0:1; 0:0:1, 50 mL each), which were combined, again based on their 1H NMR 
spectral data, into 6 fractions (5.0, 85.5, 116.4, 5.1, 195.6, 3.2 mg, respectively). Of these, 
fraction 5 was purified using HPLC with RP-18 (Eurospher-100, 5 µm, 250 x 8 mm i.d., 
Knauer), and gradient elution from H2O:MeOH, 3:1 to MeOH in 25 min, 2 mL/min, to yield 
11 (tR = 11 min, 25 mg or 3.5 mg/L). From fraction 4 crystals of 5 (6 mg or 0.85 mg/L) were 
obtained  by recrystallisation from CH2Cl2:(CH3) 2CO (3:7); the mother liquor was purified by  
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RP-18 HPLC employing gradient elution from H2O:MeCN, 4:1 to MeCN in 40 min, 2 
mL/min, to yield 3 and 4 (tR =15 min, 2 mg or 0.28 mg/L) and 10 (tR = 17 min, 3 mg, 0.42 
mg/mL). VLC fraction 6 (0.6 g) was further fractionated by VLC over normal phase (230-400 
mesh ASTM, Merck), 15 fractions were collected as mentioned above (50 mL each), and 
combined into 7 pools (15, 185, 100, 35, 117, 66, 10 mg, respectively), according to 1H NMR 
spectral data. Pool 3 (0.1 g) was the most promising one and fractionated over normal phase 
HPLC (Eurospher Si, 5µ, 250 x 8 i.d., Knauer) using a gradient from CH2Cl2 to MeOH, in 25 
min, 2 mL/min, to afford 2 (tR = 17 , 20 mg, 2.8 mg/L).  
 
Acid hydrolysis of 2 
 
A solution of 2 (5 mg in 1 mL EtOH) and 10 mL of 7 % HCl:EtOH (3:7) was refluxed for 4 
hours. At the end of this period the mixture was extracted with EtOAc, and the aqueous layer 
neutralised with 7 % KOH. After evaporation of the solvent, the residue was extracted with 
C5H5N. HPLC purification of the C5H5N extract (Lichrosorb-100 NH2, 5 µ, 250 x 8 i.d., 
Knauer), using MeCN:H2O 8:2 as eluent yielded glucose (1 mg), [α]23D = +20.7° (c 0.08, 
H2O), lit. (Merck index online) [α]23D = +18.7° - +52.7° (c 10.0, H2O). 
 
GC-MS analysis of 3 and 4 
 
This analysis was carried out on a Perkin-Elmer (Auto system XL) gas chromatograph 
coupled with a Perkin-Elmer Turbomass spectrometer using a 30 m x 0.32 mm N931-6023 
Pe-1 (film thickness of 0.25 µm) capillary column. The instrument was set to an initial 
temperature of 50 °C and maintained at this temperature for 10 min. At the end of this period 
the oven was heated at 10°/min up to 250°C, and kept there for 10 min. Injection port 
temperature was 220°C, He flow rate was 2 mL/min, and samples were injected in the 
splitless mode. Mass spectral scan range was 35-650 DA. The GC of 3 and 4 showed two 
peaks. Retention times, relative intensities (%) and EIMS of the relevant peaks were as 
follows: Peak A, 21.4 min, 100, EIMS m/z (% rel int), 192 [M+] (<1), 174 (77), 159 (5), 145 
(11), 119 (32), 90 (18); Peak B, 24.2 min, 84, EIMS m/z (% rel int), 192 [M+] (<1), 174 (77), 
159 (5), 148 (46), 145 (13), 119 (100), 90 (20). 
 
GC-MS analysis of 6-8 
 
The mixture of compounds 6-8 was analysed by GC-MS in an identical manner to the 
analysis performed with 3 and 4. Retention times, relative intensities and EIMS of the 
relevant peaks were: Peak A (19.4 min, 92), EIMS m/z (% rel int), 186 (1), 168 (50), 140 (100 
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), 81 (90), 67 (100); Peak B (19.8 min, 72); EIMS m/z [M]+ (% rel int), 186 [M+] (3), 168 
(10), 140 (33), 81 (40), 67 (100) Peak C (20.2 min, 100) EIMS m/z (% rel int), 186 [M+] (2), 
168 (77), 140 (100), 81 (60), 67 (100). 
 
X-ray structure analysis of compound 5 
 
2-(1-Methylethylidene)-pentanedioic acid (5) was recrystallised from MeOH to yield 
transparent prismatic crystals. A crystal 0.34 x 0.15 x 0.11 mm3 was selected for 
crystallographic measurement. It has, molecular formaula = C9H12O4, molecular mass = 
172.18 amu, crystal system = triclinic, space group P(11-1), unit cell dimensions a = 5.0439 
Å, b = 7.2708 Å, c = 12.3363(16), α = 89.527(3)°, β = 84.456(3)°, γ = 74.754(3)°, volume = 
434.37(10) Å3, Z = 2, density = 1.316 mg/m3, F(000) = 184, absorption = 0.106 µ, λ (Mo K α) 
= 0.71073 Å. The intensity data were collected at 133 K to q(max) 30° on a Bruker SMART 
1000 CCD diffractometer. A total of 5047 reflections were recorded, of which 2495 [R(int) = 
0.0282] were unique. The structure was solved by direct methods and refined by full matrix 
least-squares methods on F2 using the SHELXL97 program (Sheldrick`s program). Acidic 
hydrogens were refined freely, methyls as rigid groups, methylene hydrogens with a riding 
model. Final R indices: R1 [I > 2σ(I)] = 0.042, wR2 (all reflections) = 0.124; goodness of fit 
1.047 (these data have been deposited at the Cambridge crystallographic data center).The 
molecule is shown in Fig. 5. Its dimensions may be regarded as normal. The molecular 
conformation is illustrated by the torsion angles C2-C3-C4-C5 177.3(1), C3-C4-C5-O3 
177.6(1)° (antiperiplanar) and C1-C2-C3-C4 85.0(1), C6-C2-C3-C4 93.2(1)° (orthogonal). 
The molecules are connected by hydrogen bonds of the "carboxylic acid dimer" type [O3-
H03….O4' and O1-H01...O2'] across inversion centres to form chains of molecules parallel to 
[11-1] (Fig. 6). 
 
Results and discussion 
 
The fungus Acremonium sp. closely related to A. roseogriseum (S. B. Saksena) W. Gams 
based on morphological characteristics was isolated from tissues of the brown alga 
Cladostephus spongius (Hudson) C. Agardh. The fungus was cultivated on a solid biomalt 
medium with added artificial sea salt. Successive fractionation of the EtOAc extract by 
vacuum liquid chromatography (VLC) over silica followed by normal (NP), and reversed 
phase (RP-18) HPLC yielded compounds 1-11. In the current partial project, the isolation and 
structure elucidation of two novel hydroquinone derivatives (1 and 2), two new 
dihydronaphthalenones (3 and 4), four new acyclic carboxylic acid derivatives (5-8), and 
three known fungal metabolites (9-11) are reported (Tanaka et al., 1999).  
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The molecular formula of 1 was deduced by accurate mass measurement to be C11H12O2. In 
the 13C NMR spectrum of 1, eleven resonances, attributable to 1 x CH3, 2 x CH2, 3 x CH, and 
5 x C groups (Table 5), were evident. It was also clear from these data that since four of the 
six degrees of unsaturation within 1 were due to multiple bonds (4 x C═C), the molecule was 
bicyclic. The 1H and 13C NMR data enabled all but two hydrogen atoms of 1 to be accounted 
for, thus, it was evident that the remaining two must be present in OH groups, a deduction 
supported by IR (νmax 3314 cm-1), and 1H NMR (δ 7.64 brs, CD3OD exchangeable) data. Also 
evident from the 1H and 13C NMR data of 1 were resonances consistent with the presence of a 
tetrasubstituted aromatic ring [δ 6.51 (d, J = 8.8, H-2); 6.54 (d, J = 8.8, H-3)], a deduction 
supported by the maximum at 286 nm in the UV spectrum of 1, an allylic methyl, an 
exomethylene, a benzylic methylene, and an allylic benzylic methine group. Accounting for 
all 1H and 13C NMR resonances associated with C-H one-bond interactions and from cross 
peaks seen in the 1H-13C 2D NMR shift-correlated (HMQC) spectrum of 1, it was possible to 
deduce the planar structure of 1 by interpretation of its 1H-1H COSY and HMBC (Figure 4) 
spectra. From the 1H-1H COSY spectrum of 1, it was evident that H2-7 coupled to H-8, and 
that H3-11 had an allylic coupling to H2-10. Cross peaks in the HMBC spectrum of 1 between 
H2-10 and C-8, C-9 and C-11, between H2-7 and C-2, C-5 and C-6, and between H-8 and C-3, 
C-4, C-5 and C-6 enabled Fragment 1 to be developed. The similarity in the 13C NMR 
chemical shifts of the resonances associated with C-1 and C-4 (δ 145.9 s, 145.8 s), and C-2 
and C-3 (116.0 d, 115.9 d) showed the aromatic ring of 1 to be pseudo-symmetrically 
substituted, as shown in 1. The absolute stereochemistry at C-8 was not determined. For 1, a 
new hydroquinone derivative, the trivial name acremonin A is proposed.  
 
 
1 R = H
2 R = ß-D-glucopyranose
1
2
4
5
7
9
10
11
3 8
OH
O
R
6
Fragment 1
 
 
The positive FABMS and NMR data of 2 showed it to have the molecular formula C17H22O7. 
Comparison of the 1H and 13C NMR data of 2 with those of 1, and with the 13C NMR data of 
arbutin (Table 5), revealed  it  to be a glucopyranose  derivative of 1.  The  chemical  shift and  
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coupling constant [4.81 d (J = 7.7 Hz)], attributable to the anomeric proton of the glucose 
showed it to be β-linked to the rest of the molecule. Acid hydrolysis of 2 yielded free glucose, 
to which the D-configuration was assigned on the basis of its optical rotation (see 
experimental section). The point of attachment of the sugar to the aglycone was concluded to 
be at C-4 based on the deshielded nature of the resonances associated with C-3, C-4, C-5, and 
that of H-3, relative to the equivalent resonances found in 1. This conclusion was supported 
by cross peaks in the NOESY spectrum of 2 between H-1' and H-8, and one of the 
exomethylene protons. For 2 the trivial name acremonin A glucoside is proposed. 
1 1
78
1 023
6
1 1
7
8
1 0
2
3
5
1 , 4
9
 
 
Figure 4. HMBC NMR spectrum of acremonin A (1), 1H [C3D6O, 300 MHz] and 13C NMR 
[C3D6O, 75.5 MHz].  
 
                                                    
 
 
 
 
 
Table 5. 1H [(CD3)2CO, 300 MHz] and 13C NMR [(CD3)2CO, 75.5 MHz] spectral data for compounds 1 and 2,a and 13C NMR data for arbutin 
 
  1  Arbutinb  2  
P. δ 13C       δ 1H     HMBC δ 13C δ 13C     δ 1H     HMBC 
1 145.9 (s)c,*   153.7 (s) 146.6 (s)*   
2 116.0 (d) 6.51 (1H, d, 8.8d) C-1, C-4, C-6 119.3 (d) 116.1 (d) 6.57 (1H, d, 8.8) C-1, C-4, C-6 
3 115.9 (d) 6.54 (1H, d, 8.8) C-1, C-4, C-5, C-8 116.6 (d) 117.8 (d) 6.74 (1H, d, 8.8) C-1, C-4, C-5, C-8 
4 145.8 (s)*   152.4 (s) 147.9 (s)*   
5 132.3 (s)   116.6 (d) 134.4 (s)   
6 128.8 (s)   119.3 (d) 128.9 (s)   
7   34.7 (t) 3.26 (1H, dd, 13.2, 5.5) 
2.70 (1H, dd, 13.2, 2.6) 
C-1, C-2, C-5, C-6, C-8, C-9    34.5 (t) 3.28 (1H, dd, 13.2, 5.5) 
2.77 (1H, dd, 13.2, 2.6) 
C-1, C-2, C-5, C-6, C-8, C-9 
8  48.9 (d) 3.94 (1H, brd, 5.5) C-3, C-5, C-6, C-7, C-9, 
 C-10, C-11 
  49.1 (d) 4.06 (1H, dd, 2.6, 5.5) C-5, C-6, C-7, C-9, C-10, 
 C-11 
9 146.4 (s)    146.4 (s)   
10 110.4 (t) 4.76 (1H, d, 0.7) 
4.86 (1H, d, 0.7) 
C-8, C-9, C-11 
C-8, C-9, C-11 
  111.6 (t) 4.78 (1H, d, 1.5) 
4.92 (1H, d, 1.5) 
C-8, C-9, C-11 
11  20.3 (q) 1.76 (3H, s) C-8, C-9, C-10   19.7 (q) 1.74 (3H, s) C-8, C-9, C-10 
OH-1  7.64 (1H, brs)    8.10 (1H, s)  
OH-4  7.64 (1H, brs)      
1´    103.6 (d) 102.7(d) 4.81 (1H, d, 7.7) C-3´ 
2´      74.9 (d)  74.9 (d) 3.39 (1H, m) C-3´, C-4´ 
3´      77.9 (d)  77.8 (d) 3.39 (1H, m) C-2´, C-4´ 
4´      71.4 (d)  71.3 (d) 3.45 (1H, m) C-2´, C-3´ 
5´      78.0 (d)  77.9 (d) 3.36 (1H, m) C-2´, C-3´, C-4´ 
6´       62.6 (t)   62.8 (t) 3.70 (1H, m), 3.81 (1H, m) C-5´, C-4´ 
 
aAll assignments are based on 1D and 2D NMR measurements (HMBC, HMQC, COSY). bData obtained by measuring an authentic sample. cImplied multiplicities as determined by DEPT (C = 
s, CH = d, CH2 = t, CH3 = q).  dJ in Hz. * Assignments may be interchanged. 
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The stereoisomers 3 and 4 (3/4), which proved to be 
inseparable by HPLC, analysed for C11H12O3 by 
accurate mass measurement. The 13C NMR 
spectrum of the mixture contained 11 carbon 
resonances for each compound that were 
attributable in each case to 1 x CH3, 1 x CH2, 5 x 
CH, and 4 x C groups (Table 6). It was also evident 
from these data that four of the six degrees of 
unsaturation within the molecules were due to 
multiple bonds, 3 x C═C, and 1 x C═O; the 
molecules are thus bicyclic. As the 13C NMR and 
1H NMR spectral data accounted for all but two of 
the hydrogen atoms within 3 and 4, it was evident that the remaining two (in each compound) 
must be present as parts of OH groups. In the 1H NMR spectrum of 3/4 the presence of three 
aromatic protons that were meta (δ 7.68), ortho and meta (δ 7.43, 7.45), and ortho coupled (δ 
7.55, 7.60), respectively, revealed the presence of a 1, 3, 4 substituted aromatic ring in each 
molecule. The UV data of 3/4 (λmax 251 and 296 nm) supported the presence of this group and 
showed it to be further conjugated with the keto-function (δ 196.4 s and 196.2 s). HMBC 
correlations between the resonance of H3-11 and those of C-1, C-2, C-3, and C-6, showed the 
methyl group to reside at C-2, leaving the keto-function to be bonded to either C-5 or C-6. 
Further HMBC correlation, this time between the resonance for H-4 and those for C-2, C-3, 
C-5, C-6, and C-10, and the resonance for H-1 and those of C-2, C-3, C-7, and C-11, clearly 
revealed C-6 to bond with C-7, and C-5 to bond with C-10. From the 1H-1H COSY spectrum 
of 3/4 it was evident that H-10 coupled with H-9, which further coupled with H2-8, leaving C-
8 to bond directly with the keto-function, and in so doing complete the planar structure of 3/4. 
The 1H-1H coupling constant associated with the resonances for H-9 in 3/4 show H-9 in 4 to 
have an axial orientation, as must H-10. In 3, the coupling constants associated with the 
resonance for H-9 are 2.9, 3.4, and 6.5 Hz, and show this proton to have no diaxial coupling 
interactions, it must thus be equatorial. Accordingly, JH-9, H-10 in 3 is noticeably smaller, 2.9 
Hz, indicating it now to have and axial-equatorial interaction with H-9. The two new natural 
products 3 and 4 are best named systematically as (3R*,4S*) 3,4-dihydroxy-7-methyl-3,4-
dihydro-1(2H)-naphthalenone and (3S*,4S*) 3,4-dihydroxy-7-methyl-3,4-dihydro-1(2H)-
naphthalenone, respectively. 
 
O
R4
R2
R3
R1
Numbers in brackets are those used for 
the systematic naming of 3 and 4.
(8a)(7)
(6)
(4a)
(2)
(1)1
3
2
5
6
7
8
9
10
4
11
(4)
3 R1 = R3 = H; R2 = R4 = OH
4 R2 = R3 = H; R1 = R4 = OH
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Table 6. 1H [(CD3)2CO, 300 MHz] and 13C NMR [(CD3)2CO, 75.5 MHz] spectral data for 
compounds 3 and 4a 
 
 3  4  3 and 4 
 δ 13C    δ 1H δ 13C    δ 1H HMBC 
1 135.2 (d)b 7.68 (1H, brs) 135.4 (d) 7.68 (1H, brs) C-2, C-3, C-7, C-11 
2 142.2 (s)  142.7 (s)   
3 126.6 (d) 7.43 (1H, dd, 7.7, 1.5c) 126.7 (d) 7.45 (1H, d, 7.7, 1.5)  
4 129.4 (d) 7.55 (1H, d, 7.7) 128.9 (d) 7.60 (1H, d, 7.7) C-6, C-2, C-3, 
C-5, C-10 
5 138.0 (s)  138.1 (s)   
6 132.2 (s)  132.2 (s)   
7 196.4 (s)  196.2 (s)   
8   44.3 (t) 2.79 (1H, dd, 16.7, 3.4)
2.86 (1H, dd, 16.7, 6.5)
  44.9 (t) 2.60 (1H, dd, 16.7, 9.3) 
2.95 (1H, dd, 16.7, 4.1) 
C-6, C-7, C-9, C-10 
9   70.7 (d) 4.35 (1H, ddd, 2.9, 3.4, 
6.5) 
  72.4 (d) 4.05 (1H, ddd, 9.3, 7.0,  
4.1) 
C-7, C-8 
10   70.5 (d) 4.92 (1H, d, 2.9)   73.4 (d) 4.68 (1H, d, 7.0) C-4, C-8 
11   20.9 (q) 2.38 (3H, s)   21.0 (q) 2.38 (3H, s) C-1, C-2, C-3, C-6 
 
   aAll assignments are based on 1D and  2D  measurements (HMBC, HMQC, and COSY).  
  bImplied multiplicities as determined by DEPT (C = s, CH = d, CH2 = t, CH3 = q). cJ in Hz. 
 
FABMS and NMR analysis of 5 showed it to have 
the molecular formula C8H12O4. Its 13C NMR 
spectrum contained 8 carbon resonances 
attributable to 4 x C, 2 x CH2, 2 x CH3 groups 
(Table 7). It was also evident from these data that 
the three degrees of unsaturation within 5 were due 
to a C═C double bond, and two carbonyl groups as 
parts of either ester or carboxyl functions, one of 
which was α, β-unsaturated; the molecule was 
acyclic. The 1H and 13C NMR data enable all but two of the hydrogen atoms within 5 to be 
assigned to directly bonded C atoms. The two remaining hydrogens were therefore present as 
parts of two carboxylic functions, a deduction that was supported by the δ 10.80 (2H) 1H 
NMR resonance, and the IR data (2922 cm-1), of 5. With all 1H and 13C NMR resonances 
assigned in the HMQC spectrum of 5, it was possible to deduce the structure of 5 by 
interpretation  of  its  1H-1H  COSY  and  HMBC  spectra. Compound  5 was crystalline X-ray  
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diffraction studies were undertaken, the results of which are shown in Figure 5 and 6, and in 
the experimental section. As such, 5 is not a new chemical entity since it is known 
synthetically (Fleury et al., 1963; Puterbaugh et al., 1962). The current report is, however, the 
first of it from a natural source, and with complete spectroscopic and X-ray data. 
 
 
 
Table 7. 1H [(CD3)2CO, 300 MHz] and 13C NMR [(CD3)2CO, 75.5 MHz] spectral data for 
compound 5a 
 
Position δ 13C  δ 1H HMBC 
1 170.0 (s)b   
2 126.2 (s)   
 3   26.1 (t)  2.40 (2H, m)  C-2, C-4, C-5 
4   33.6 (t)  2.60 (2H, m) C-1, C-2, C-3, C-5, C-6 
5 174.2 (s)   
6 145.2 (s)   
7   22.2 (q)  1.86 (3H, s)  C-1, C-2, C-3, C-6 
8   23.1 (q)  1.86 (3H, s) C-1, C-2, C-3, C-6 
2 OH  10.80 (2H, brs)  
 
aAll assignments are based on 1D and 2D measurements (HMBC, HMQC, COSY).  
 bImplied multiplicities were determined by DEPT (C = s, CH = d, CH2 = t, CH3 = q). 
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Figure 5. Structure of compound 5 in the crystal. Ellipsoids represent 50% probability levels. 
 
 
 
 
 
Figure 6. Packing diagram of compound 5, showing the chains of molecules associated by 
hydrogen bonds (dashed). Only those hydrogen atoms involved in hydrogen bonding are 
shown. Radii are arbitrary. 
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Compounds 6-8 are structural isomers that 
proved to be inseparable by HPLC. GC-MS 
analysis and accurate mass measurement of the 
mixture 6/8 showed the three compounds 
present to have the identical molecular formula 
C9H14O4. A comparison of the MS and NMR 
spectral data of 6 and 7 with those of 5 (Tables 
7 and 8), indicated 6 and 7 to be monomethoxyl 
derivatives of 5. In each case the position of the 
methoxyl group was established from HMBC 
data. For 6, an HMBC correlation between the 
resonance for H3-9 and that of C-5, clearly made the C-9 methyl group part of a methyl ester 
function and revealed the molecule to be pentanedioic acid, 2-(1-methylethylidene)-5-methyl 
ester. In the case of 7, the diagnostic HMBC correlation was between H3-9 and C-1,and 
showed the molecule to be pentanedioic acid, 2-(1-methyl- ethylidene)-1-methyl ester. 
 
Even though the molecular formula of 8 
(C9H14O4) was identical to those of 6 and 7 the 
NMR data were notably different (Table 8). As 
for 6 and 7, the 13C NMR spectrum contained 
nine carbon resonances attributable to 1 x CH3, 
1 x OCH3, 3 x CH2, 1 x CH, and 3 x C, groups. 
It was also evident from these data that one of 
the three degrees of unsaturation within 8 was 
present as an exomethylene group, in contrast to 
the endo-carbon-carbon double bond found in 6 and 7, and that the two carbonyl functions 
present in 5-7 were also to be found in 8. Interpretation of the HMQC, 1H-1H COSY and 
HMBC spectral data of 8 enabled its planar structure to be deduced. Thus, cross peaks in the 
1H-1H COSY spectrum of 8 showed H3-7 to long-range couple with H2-8 and H-2, H-2 also 
coupled with H2-3, which further coupled with H2-4, clearly characterizing the C-8 to C-4 part 
of the molecule. The HMBC spectral data of 8, showed correlations between the resonances 
for H2-8 and those for C-1, C-2, C-6, and C-7; between that for H-2 and those for C-1, C-3, C-
6, C-7, and C-8; and between those for H2-3 and C-2, C-4, C-5 and C-6, and between that for 
H3-9 and that for C-5. These data revealed C-1 to bond with C-2, C-4 with C-5, and the 
methoxyl group to be part of the methyl ester function at C-5. Accordingly, 8 is most 
appropriately named pentanedioic acid, 2-(1-methylethenyl)-5-methyl ester.  
O
R2
6  R1 = OH, R2 = OCH3
7  R1 = OCH3, R2 = OH
R1O
1
2
3
4
5
6
7
8
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6
7
8
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2 O
O
OHO
5
8
9
 
 
 
  
     Table 8. 1H (C6D6, 500 MHz) and 13C NMR (C6D6, 125.5 MHz) spectral data for compounds 6-8a 
 
 6   7   8  
Position δ 13C δ 1H HMBC δ 13C δ 1H HMBC δ 13C δ 1H HMBC 
1 174.2 (s)b    168.7 (s)   179.0 (s)   
2 125.3 (s)    125.3 (s)     52.1 (d) 3.08 (1H, dd, 7.6) C-1, C-3, C-4, C-7, 
C-9 
3   25.6 (t) 2.70 (2H, t, 7.9c) C-1, C-2,  
C-4, C-6 
   25.3 (t)  2.65 (2H, t, 7.9) C-1, C-2, 
C-4, C-6 
  25.2 (t) 2.18 (1H, m) 
1.90 (1H, m) 
C-2, C-4, C-6 
C-2, C-4, C-6 
4   33.6 (t) 2.41 (2H, t, 7.9) C-3, C-5    33.5 (t) 2.40 (2H, t, 7.9) C-3, C-5   31.6 (t) 2.15 (2H, m) C-2, C-3, C-5 
5 172.8 (s)    179.2 (s)     172.9 (s)   
6 150.2 (s)    145.4 (s)   141.6 (s)   
7   23.1 (q) 1.97 (3H, s) C-2, C-6    23.1 (q) 1.94 (3H,  s) C-2, C-6   20.0 (q) 1.56  (3H, s) C-1, C-2,  C-6, C-8 
8   22.8 (q) 1.51 (3H, s) C-2, C-6    21.8 (q) 1.49 (3H,  s) C-2, C-6 115.0 (t) 4.88 (1H, s) 
4.83 (1H, s) 
C-1, C-2, C-6, C-7 
C-1, C-2, C-6, C-7 
9  51.1 (q) 3.36 (3H, s) C-5    50.7 (q) 3.42 (3H,  s) C-1   51.0 (q) 3.37 (3H, s) C-5 
OH  8.53 (1H, brs)   8.53 (1H, brs)   8.53 (1H, brs)  
 
        aAll assignments are based on 1D and 2D NMR measurements (HMBC, HMQC, COSY).  
        bImplied multiplicities as determined by DEPT (C = s, CH = d, CH2 = t, CH3 = q). cJ in Hz. 
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2-(1-Hydroxy-1-methyl)-2,3-dihydrobenzofuran-5-ol, (9), 2-dimethyl-chroman-3,6-diol (10), 
and 2-(3-dihydroxy-3-methylbutyl)-benzene-1,4-diol (11) were published from Acremonium 
murorum as inhibitor of the magnesium-dependent sphingomyelinase enzyme. Thus, they 
have anti-inflamatory activity with  IC50  >200, >200, 7.5 µg/mL, respectively (Tanaka et al., 
1999). Compound  11 showed potent activity as comparing with compounds 9 and 10. It was 
evident that compound 11 has more free hydroxyl groups which might be required for the 
enzyme inhibiton. 
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The most unusual bicyclo[4.2.0]octa-1,3,5-triene ring system found in 1 and 2, can be 
generated synthetically by the action of UV light (254 nm) on a butane solution of 3-methyl-
1,2-dihydronaphthalene (3-MDHN) (Figure 7) (Duguid et al., 1991); the mode of cyclization 
used in this Acremonium sp., is, however, not known. 
 
 
UV (254 nm)
Butane
3-MDHN                          BOT  
 
Figure 7. Photolytic generation of bicyclo[4.2.0]octa-1,3,5-triene (BOT) containing 
compounds from 3-methyl-1,2-dihydronaphthalene (3-MDHN). 
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Compounds 1, 2, 5, 9, and 10 were tested in ELISA based assays for their HIV-1 reverse 
transcriptase and tyrosine kinase p56lck inhibitory activities, and found to be inactive. The 
antioxidative properties of all compounds were assessed using DPPH radical, and TBARS 
assays. The results of these assays are shown in Tables 9 and 10, and Figure 8. Compounds 1, 
2, and 9-11 have significant DPPH radical scavenging effects (85.5, 17.5, 85.8, 72.9, 90.2 %, 
respectively, at 25.0 µg/mL), with 1, 9, 10, and 11 being also able to inhibit peroxidation of 
linolenic acid (35.5, 15.9, 9.2, and 16.6 %, respectively, at 37.0 µg/mL) (Figure 8). The 
results of the assays were not totally surprising since it is well known that the phenolic 
compounds have antioxidant properties (Aoyama et al., 1982), the activity being dependent 
on the number and the location of the hydroxyl groups. 
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       Figure 8. DPPHc radical scavenging activity of compounds 1, 2, 9 and 10 
          aRemaining concentration of DPPH radical. bBHT = Butylated hydroxytoluene. 
          cDPPH = α,α -Diphenyl-β-picrylhydrazy1. 
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Table 9. Antioxidative effects (TBARS Assay)a of the EtOAc extract of Acremonium sp.  
and compounds 1-11 
 
 % Inhibitiona 
Item Tested 7.4 37.0 
EtOAc Extract -27.2 -55.7 
1 13.9 35.5 
2 -10.6 -10.6 
3 and 4 -22.5 -18.5 
5 -9.0 -18.1 
6-8 -8.6 -16.3 
9 -11.8 15.9 
10 -9.8 9.2 
11 2.0 16.6 
BHTc 36.2 43.9 
Arbutin -27.6 -25.2 
 
aTBARS = Thiobarbituric acid method. b% Inhibition = 100-(A sampled - A sample blank) x 100 / (A control - A blank). 
cBHT = Butylated hydroxytoluene. dA = Absorbance of test blank and control solutions are  measured at both 532 and 600 
nm. eConcentrations in µg/mL 
 
 
Table 10. DPPHa radical scavenging effects of the EtOAc extract of Acremonium sp. 
 and  compounds 1-11 
 
 % Scavengingb 
Item Tested 5c 25 50 100 500 
EtOAc Extract ntd nt 2.0 4.8 29.3 
1 26.0 85.5 90.0 90.0 90.1 
2 5.6 17.5 27.7 43.0 79.9 
3 and 4 nt nt -1.6 2.8 12.1 
5 nt nt -0.5 3.8 15.3 
6-8 nt nt 3.4 10.3 35.1 
9 35.3 85.8 89.1 90.2 90.4 
10 25.7 72.9 85.1 89.1 89.9 
11 nt 90.2 90.7 89.9 82.9 
BHTe 6.0 24.2 41.1 63.8 89.8 
Arbutin 1.9 18.3 23.5 52.6 78.6 
 
aDPPH = α, α,-Diphenyl-β-picrylhydrazyl. bScavenging % = 100-(A samplef x 100 / A controlf). cConcentrations in µg/mL.  
dnt = not tested.  eBHT = Butylated hydroxytoluene.  fAbsorbance of sample and control measured at 517 nm. 
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Acremonin A (1), 7-isopropenyl-bicyclo[4.2.0]octa-1,3,5-triene-2,5-diol was isolated as 
yellowish brown viscous oil (14.0 mg). [α]23D = + 93.0° (c 1.4, [CH3]2CO); UV λmax (MeOH) 
(log ε) 204.9 (4.4), 286 (3.6) nm; IR (film) νmax 3314, 2931, 1495, 1453, 1239 cm-1; 1H and 
13C NMR data (Table 5); EIMS m/z (% rel int) 176 [M+] (100), 147 (33), 115 (23), 91 (20); 
HREIMS m/z 176.0837, calcd for C11H12O2 176.0837. 
 
Acremonin A glucoside (2), 7-isopropenyl-bicyclo[4.2.0]octa-1, 3, 5-triene-2, 5-diol, 5-ß-D-
glucopyranoside was obtained as amorphous powder (20.0 mg). [α]23D = +4.3° (c 2.0, 
[CH3]2CO); UV λmax (MeOH) (log ε) 204.9 (4.3), 280 (3.2) nm; IR (film) νmax 3330, 2921, 
1490, 1448, 1242 cm-1; 1H and 13C NMR data see (Table 5); FABMS, m/z 361 [M+Na]+. 
 
(3R*,4S*)-3, 4-Dihydroxy-7-methyl-3, 4-dihydro-1(2H)-naphthalenone (3) and (3S*,4S*)-3, 
4-dihydroxy-7-methyl-3, 4-dihydro-1(2H)-naphthalenone (4) were obtained as amorphous 
white powdered mixture (2.0 mg). UV λmax (MeOH) (log ε) 251 (3.6), 296 (2.9) nm; 1H and 
13C NMR data (Table 6); EIMS m/z (% rel int) 192 [M+] (10), 174 (30), 148 (50), 119 (100); 
HREIMS m/z 192.0799, calcd for C11H12O3 192.0786. 
 
2-(1-Methylethylidene)-pentanedioic acid (5) was obtained as transparent crystalline solid (6 
mg). M.p. 131-132°; [α]23D = +4.4° (c 0.8, [CH3]2CO); UV λmax (MeOH) (log ε) 221 (3.8) 
nm; IR (film) νmax 2922, 2604, 1688, 1655, 1615, 1411 cm-1; 1H and 13C NMR data (Table 7). 
FABMS m/z 173 [M+H]+. 
 
Pentanedioic acid, 2-(1-methylethylidene)-5-methyl ester (6), pentanedioic acid, 2-(1-
methylethylidene)-1-methyl ester (7), and pentanedioic acid, 2-(1-methylethenyl)-5-methyl 
ester (8) was obtained as brownish viscous oil (14 mg). [α]23D = -28.4° (c 0.4, MeOH), based 
on 8 being approximately one third of the mixture; UV λmax (MeOH) (log ε) 220 (3.6) nm, 
based on 6 and 7 being approximately two thirds of the mixture; IR (film) νmax 2922, 2359, 
1735, 1720, 1436, 1216 cm-1; 1H and 13C NMR data (Table 8); EIMS data, see GC-MS 
Analysis of Compounds 6-8; HREIMS m/z 186.0891 (all three compounds have the identical 
exact mass), calcd for C9H14O4 186.0892. 
 
2-(1-Hydroxy-1-methyl)-2,3-dihydrobenzofuran-5-ol (9) was obtained as transparent crystals 
(8 mg). [α]23D = +13.0° (c 0.25, [CH3]2CO), lit. (Tanaka, et al., 1999) [α]23D = +49.8° (c 1.0, 
MeOH); 1H NMR (300 MHz, [CD3]2CO) δ 6.65 (1H, dd, J = 0.7, 2.2 Hz, H-1), 6.49 (1H, dd, 
J = 2.2, 8.8 Hz, H-3), 6.46 (1H, d, J = 8.8 Hz, H-4), 3.03 (1H, dd. J = 9.5, 16.1 Hz, H-7), 3.16 
(1H, dd, J = 8.8, 16.1 Hz, H-7), 4.5 (1H, dd, J = 8.8, 9.5 Hz, H-8), 1.17 (3H, s. H3-10), 1.20 
(3H, s, H3-10), 3.60 (1H, s, OH-9), 7.73 (1H, brs, OH-2); 13C NMR (75.5 MHz[CD3]2CO) δ 
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112.8 (d, C-1), 152.0 (s, C-2), 114.3 (d, C-3), 109.3 (d, C-4), 154.1 (s, C-5), 129.2 (s, C-6), 
31.6 (t, C-7), 90.0 (d, C-8), 71.4 (s, C-9), 25.5 (q, CH3, C-10), 26.1 (q, CH3, C-11); EIMS m/z 
(% rel int), 194 [M+] (50), 161 (32), 136 (100), 123 (20), 107 (20). 
 
2,2-Dimethyl-chroman-3,6-diol (10) was obtained as transparent crystalline solid (13 mg). 
M.p. 175°C; [α]23D = -41.0° (c 0.25, MeOH), lit. (Tanaka, et al., 1999) [α]23D = -20.4° (c 1.0, 
MeOH). 1H NMR (300 MHz, [CD3]2CO) δ 6.56 (1H, d, J = 1.8 Hz, H-1), 6.52 (1H, m, H-3), 
6.52 (1H, m, H-4), 2.90 (1H, dd, J = 4.6, 16.8 Hz, H-7), 2.63 (1H, dd, J = 8.4, 16.8 Hz, H-7), 
3.73 (1H, d, J = 8.4 Hz, H-8), 1.18 (3H, s, H3-10), 1.30 (3H, s, H3-10), 4.10 (1H, d, J = 4.7, 
Hz, OH-8), 7.70 (1H, s, OH-2)¸13C NMR (75.5 MHz, [CD3]2CO) δ 116.1 (d, C-1), 147.0 (s, 
C-2), 117.1 (d, C-3), 115.1 (d, C-4), 151.4 (s, C-5), 121.1 (s, C-6), 32.4 (t, C-7), 70.1 (d, C-8), 
77.1 (s, C-9), 20.1 (q, CH3) 26.1 (q, CH3); EIMS m/z (% rel int), 194 [M+] (100), 161 (35), 
136 (35), 123 (100), 71 (60). 
 
2-(3-Dihydroxy-3-methylbutyl)-benzene-1,4-diol (11) was obtained as light brown oil (25 
mg). [α]23D = +15.8° (c 0.15, MeOH); lit. (Tanaka, et al., 1999) [α]23D = +36.0° (c 0.2, 
MeOH). 1H NMR (300 MHz, [CD3]2CO), δ 6.56 (1H, m, H-2), 6.56 (1H, m, H-2), 6.49 (1H, 
dd, J = 2.9, 0.3 Hz, H-5), 2.58 (1H, dd, J = 9.9, 14.0 Hz, H-7), 2.71 (1H, dd, J = 1.9, 14.0 Hz, 
H-7), 3.55 (1H, ddd, J = 1.9, 9.9, 14.0 Hz, H-8), 1.18 (3H, s, H3-10), 1.18 (3H, s, H3-10), 4.60 
(1H, brs, OH-9), 7.65 (1H, brs, OH-4), 8.20 (1H, brs, OH-1), 4,79 (1H, brs, OH-8); 13C NMR 
(75.5 MHz, [CD3]2CO) δ 148.8 (s, C-1), 117.0 (d, C-2), 116.5 (d, C-3), 150.3 (s, C-4), 113.7 
(d, C-5), 128.0 (s, C-6), 33.6 (t, C-7), 80.4 (d, C-8), 72.0 (s, C-9), 24.6 (q, CH3-10), 24.5 (q, 
CH3-11).
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4.3 Two new xanthone derivatives from the algicolous marine fungus 
Wardomyces  anomalus 
 
Abstract 
 
A marine fungal isolate, identified as Wardomyces anomalus, was cultivated and found to 
produce two new xanthone derivatives, 2,3,6,8-tetrahydroxy-1-methylxanthone (12), and 
2,3,4,6,8-pentahydroxy-1-methylxanthone (13), in addition to the known xanthone derivative 
3,6,8-trihydroxy-1-methylxanthone (14), and the known fungal metabolite, 5-(hydroxyl- 
methyl)-2-furanocarboxylic acid (15). The structures of all compounds were determined based 
on extensive spectroscopic measurements (1D and  2D NMR, MS, UV, and IR). Compounds 
12 and 14 showed significant antioxidant activities. The total extract and 12, 14 and 15 were 
shown to be inhibitors of p56lck  tyrosine kinase.  
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Introduction 
 
Xanthone derivatives are widespread in nature, commonly occurring in a number of higher 
plant families, and fungi (Peres et al., 2000; Morel et al., 2000). Some fungal species are well 
known as sources of xanthone derivatives e.g., Penicillium raistrickii (Belofsky et al., 1998), 
Phomopsis sp. (Isaka et al., 2001), Actinoplanes sp. (Chu et al., 1997), Ascodesmis 
sphaerospora (Hein et al., 1998), and Humicola sp. (Tabata et al., 1996). Xanthones are 
known to have a variety of biological activities e.g., antimicrobial, antitubercular, antitumor, 
and antiviral (Peres et al., 2000; Morel et al., 2000).  
 
In continuation of our projects aimed at finding new natural products with biological activity 
and/or novel chemical structures from marine-derived fungi (Abdel-Lateff et al., 2002), 
Wardomyces anomalus Brooks & Hansford, isolated from the green alga Enteromorpha sp. 
collected around Fehmarn island in the Baltic Sea, was investigated. The crude extract 
showed antimicrobial effects towards Microbotryum violaceum and Eurotium repens, 
inhibition of HIV-1 reverse transcriptase (HIV-1-RT) (65.4 % at 66 µg/mL), and inhibition of 
p56lck tyrosine kinase (TK) (98 % at 200 µg/mL). Radical scavenging activity was observed 
using α,α-diphenyl-β-picrylhydrazyl (DPPH) as indicator (71.9 % at 500 µg/mL). An 
extensive computer survey indicated there to be no prior investigation of W. anomalus. On 
this basis, the fungus was further investigated in order to identify the natural products 
responsible for this activity. 
 
Materials and methods 
 
Isolation and taxonomy of the fungal strain 
 
After sterilization with 70 % ethanol, algal (Enteromorpha sp., Ulvaceae, OS4T) samples 
were rinsed with sterile water and pressed onto agar plates to detect any residual fungal spores 
on the surface of algae. Sterilized algae were then cut into pieces and placed on agar plates 
containing isolation medium: 15 g/L agar, and 1 L seawater from the sample collecting site, 
plus antibiotics benzyl penicillin and streptomycin sulfate (250 mg/L). Fungal colonies 
growing out of the algal tissue were transferred to medium for sporulation (1.0 g glucose, 0.1 
g yeast extract, 0.5 g peptone from meat, enzymatic digest, 15 g of agar, and 1 L artificial sea 
water, pH 8) in order to enable taxonomy of the isolates.  
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Cultivation 
 
The Fungus W. anomalus (Microascaceae, Ascomycetes, OS4T-3-2-1, 406), was cultivated 
on 100 mL of media, composed of  50 g biomalt, 15 g agar, and  1 L ASW.  
 
Biological activity, see chapter 3.4. 
 
Extraction and isolation  
 
Cultivated W. anomalus mycelia and medium were diluted with water (100 mL/L) and 
homogenized using an Ultra Turrax model T25 at 8000 min-1. The resulting mixture was 
exhaustively extracted with EtOAc (3 x 0.5 L) to yield 66 mg of highly viscous brownish 
black oil. The EtOAc extract was fractionated over a Bakerbond SPE column (octadecyl C-
18, 40 µm, APD, 60 Å, J. T. Baker, USA), gradient elution H2O to MeOH, and three fractions 
were collected, 20 mL of each: Fraction 1 (16.4 mg, 160.4 mg/L) was identified as 15. 
Fraction 2 (20 mg) was subjected to HPLC (Eurospher-100 C-18, 5 µm, 250 x 8 mm ID, 
Knauer), eluted with H2O:MeOH 8:2, and yielded 13 (1 mg, 10 mg/L). Fraction 3 (26.6 mg) 
was subjected to reversed (RP-18) phase HPLC, eluted with H2O:MeOH 4:6, and yielded 12 
(6 mg, 60 mg/L), and 14 (2 mg, 20 mg/L). 
 
Results and discussion 
 
Compound 12 has the molecular formula C14H10O6 as established by high resolution mass 
measurement. The 13C NMR spectrum of 12 contained 14 carbon resonances attributable to 
10 x C, 3 x CH, and 1 x CH3 groups (Table 11). It was also evident from these data that seven 
of the ten elements of unsaturation within 12 were present as C=C double bonds, and a 
carbonyl group (this deduction being supported by an IR absorption at νmax 1646 cm-1), the 
molecule was thus tricyclic. As the 13C and 1H NMR spectral data enabled all but four of the 
hydrogen atoms within 12 to be accounted for, it was evident that the remaining four must be 
present as OH groups, a deduction that was supported by IR data (νmax 3275 cm-1). UV 
maxima at 234, 258, 311, 358 nm suggested a xanthone nucleus (Morel et al., 2000). The 1H 
NMR spectral data revealed the presence of three aromatic protons, two of them (H-5 and H-
7) with a meta coupling, the third (H-4) one was a singlet, an aryl methyl group (11-CH3), and 
a hydrogen-bonded phenolic OH (8-OH). After association of all protons with directly bonded 
carbons via a 2D NMR (HMQC) spectral measurement, it was possible to deduce the 
substitution pattern of the xanthone nucleus from HMBC correlations. Thus, HMBC 
correlations were seen between H-5 and C-6, C-7, C-9 (weak), C-9a, and C-10a, between H-7 
and C-5, C-6, C-9 (weak) and C-9a, between H-4 and C-1 (weak), C-1a, C-2, C-3, C-4a, and 
C-9 (weak),  and also  between  H3-11, and C-1, C-1a, C-2, C-4a (weak), and C-9 (weak). The  
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HMBC correlations associated with H3-11 clearly showed it to reside at C-1. As the 8-OH 
proton formed a strong hydrogen bond with oxygen, it was likely that this occurred with the 
oxygen of the C-9 carbonyl group. From HMBC correlations as described previously, it was 
evident that the C-6 resonated at δ 165.1, and thus was hydroxylated. The 13C NMR chemical 
shifts of all of the A-ring carbons were then found to be most consistent with the remaining 
OH groups to be  positioned at C-2 and C-3. Further analysis of the 1H and 13C NMR spectral 
data showed resonances at δ 6.78, and δ 100.9 which supported the location of the remaining 
aromatic proton at C-4. Compound 12, for which the trivial name anomalin A is suggested, is 
a new xanthone derivative that is a structural isomer of 16, a compound from Penicillium 
raistrickii (Belofsky et al., 1998 ).  
 
The molecular formula of compound 13 was shown to be C14H10O7 based on HRMS. 
Comparison of 1H NMR and MS data with those of 12, revealed 13 to contain a phenolic 
group more than 12. This hydroxyl group replaced the aromatic proton H-4, a deduction 
supported by 1H NMR spectral data which showed the absence of the signal at 6.78 ppm, s, 
(H-4 in 12). Compound 13, for which the trivial name anomalin B is suggested, is a new 
xanthone derivative. 
 
3,6,8-Trihydroxy-1-methylxanthone (14) was identified by complet spectroscopic measuring 
of 1D and 2D NMR, MS, UV, and IR. Eventually, it comfirmed by comparison with the 
published data (Harris et al., 1976). 5-(Hydroxymethyl)-2-furanocarboxylic acid (15) was 
identified by comparison of the spectroscopic data with published values (Turner et al., 1977).   
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Table 11. 1H and 13C  NMR spectral data in acetone-d6 at 300/75.5 MHz for compounds 12-14a 
 
  12  13  14  
No. δ Cb δ Hc HMBCd δ Cf δ Hc δ Cb δ Hc 
1 125.6 (s)   111.9  144.4 (s)  
1a 112.5 (s)   118.0  113.0 (s)  
2 141.8 (s)   142.8  116.9 (d) 6.70 br s 
3 152.7 (s)     ng  158.1 (s)  
4 100.9 (d) 6.78 s C-1 (w)h, C-1a, C-2, C-3, C-4a, C-9 (w)   ng  101.5 (d) 6.71 br s 
4a 153.5 (s)     ng  160.3 (s)  
5   93.6 (d) 6.26 d (2.2) C-6, C-7, C-9 (w), C-9a, C-10a   93.9 6.31 d (2.1)   94.0 (d) 6.31 d (1.8) 
6 165.1 (s)   165.5   164.9 (s)e  
7   98.4 (d) 6.15 d (2.2) C-5, C-6, C-9 (w), C-9a   98.6 6.16 d (2.1)   98.7 (d) 6.17 d (1.8) 
8 164.8 (s)   165.6   163.6 (s)e  
9 183.5 (s)   183.0   183.0 (s)  
9a 103.8 (s)   104.9   103.8 (s)  
10a 158.0 (s)   158.4  165.5 (s)e  
11   13.9 (q) 2.76 s C-1, C-1a, C-2, C-3 (w), C-4 (w), C-4a (w), C-9 (w)  13.3 2.70 s   23.4 (q) 2.77 s 
2-OH  8.97 br s   7.75 se   
3-OH  8.97 br s   8.80 se  9.79 br se 
4-OH     9.20 se   
6-OH  8.97 br s   9.54 se  9.71 br se 
8-OH  13.58 s C-8  13.62 s  13.44  s 
 
aAll assignments are based on 1D and 2D measurements (HMBC, HMQC). bMultiplicities were determined by DEPT. cδ/ppm, J in Hz. dCorrelations were reported from proton resonances 
 to carbon resonance. eTentative assignment. fData were obtained indirectly from a HMBC spectrum. gNot observed in HMBC spectrum. hw =weak signal. 
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The antioxidative properties of all compounds, except 13, were assessed using DPPH radical 
and TBARS assays (see material and methods). The results of these assays are shown in Table 
12. Compounds 12 and 15 have significant DPPH radical scavenging effects (94.7 and 30.7 
%, respectively, at 25.0 µg/mL), and are also able to inhibit peroxidation of linolenic acid 
(17.0 and 2.6 %, respectively, at 7.4 µg/mL). ELISA based bioassays with HIV-1-RT and TK 
p56lck allowed determination of enzyme inhibitory activities. The total extract and 12, 13 and 
15 had significant TK p56lck enzyme inhibitor activity (100% enzyme inhibition at 200 
µg/mL) (Table 13). Finally, only minor antimicrobial activity was observed for 12, 14, and 15 
in agar diffusion assays. 
 
 
Table 12. Antioxidative effects (TBARS Assay)a and DPPHb radical scavenging effects of 
the total  extract and compounds 12, 14 and 15. 
 
 % of Inhibitionc % Scavenging effect of DPPHf 
Comp. No.    7.4 h   37.0   25 50 100 500 
Extract -29.2 -50.2   7.8 11.3 20.2 71.9 
12 17.0  37.0 94.7 94.8 95.2 95.4 
14 -7.4 -11.1   6.2 12.9 25.3 90.6 
15 2.6   7.4 30.7 53.4 87.7 97.0 
BHTd 42.8 48.5 73.4 83.1 89.1 87.8 
 
aTBARS = Thiobarbituric acid reactive substances.  
bDPPH = α,α -Diphenyl-β-picrylhydrazyl  
c% Inhibition = 100-(A samplee - A sample blanke) x 100 / (A control - A blank).  
dBHT = Butylated hydroxytoluene. eA = Absorbance of test blank and control solutions are measured at both 532 
and 600 nm.  
fScavenging % = 100-(A sampleg x 100 / A controlg). 
gAbsorbance of sample and control measured at 517 nm.  
hConcentration in µg/mL 
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Table 13. Activity of the extract and compounds towards HIV-1 reverse transcriptase, 
tyrosine kinase p56Ick and antimicrobial activity. 
 
Assay Extract 12 14 15 
Tyrosine kinasea,c,d 2 0 0 0 
HIV-1-RT a,b,d 35.6 82.2 82.9 98.3 
Bacteriae not active not active 1mm for B.m. not active 
Fungif 3 mmg for M.v. 
2 mm for E.r. 
1 mm for M.v. 1 mm for E.r. not active 
Chlorella fusca  1 mm not active not active not active 
 
aPercentage of enzyme activity observed relative to negative control (100% HIV-1-RT or TK p56lck). 
bReduction of enzyme activity to 80 % or less was regarded as a significant inhibition. Foscarnet (10 µM, rest 
activity of HIV-1-RT 13%) was used as a positive control. 
cReduction of enzyme activity to 40 % or less was regarded as a significant inhibition. Piceatannol (3 mM, rest 
activity of 2%) was used as a positive control. 
dSample concentration for  HIV-1-RT test 66 µg/ml, and for TK p56lck test 200 µg/mL. 
 eTested against  Escherichia coli (E. c.) and  Bacillus  megaterium (B. m).h 
 fTested against Microbotryum violaceum (M. v.), Eurotium repens  (E. r.), Mycotypha microspora (M.m.).h 
 gThe radii of the resultant zone of inhibition was measured from the edge of the filter disk.  
hThe concentration of the extract and pure compound is 250 and 50 µg/disk respectively. 
 
 
 
Anomalin A (12), 2,3,6,8-tetrahydroxy-1-methylxanthone was obtained as yellowish brown 
amorphous powder (6 mg). UV λmax (MeOH) (log ε) 234 (4.86), 258 (4.86), 311 (4.72), 358 
(4.50) nm; IR (film) 3275, 2838, 1646, 1456, 1292 cm-1, 1H and 13C NMR spectral data 
(Table 11). EIMS m/z (% rel int) 274 [M+] (100), 245 (28), 217 (7), 137 (7), 69 (5), accurate 
mass m/z 274.0465, calculated for C14H10O6 274.04774. 
 
Anomalin B (13), 2,3,4,6,8-pentahydroxy-1-methylxanthone, was obtained as yellowish 
brown amorphous powder (1 mg). UV λ max (MeOH) (log ε) 258 (4.70), 327 (4.48), 370 (sh), 
nm; IR (film) 3260, 2925, 1647, 1507, 1275 cm-1, 1H NMR spectral data (Table 11). EIMS 
m/z (% rel int)  290 [M+] (30), 248 (25), 190 (100), 161 (35), accurate mass m/z 290.0422, 
calculated for C14H10O7 290.0426. 
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3,6,8-Trihydroxy-1-methylxanthone (14) was obtained as yellowish brown amorphous 
powder (2 mg). Lit. (Harris et al., 1976), UV λ max (MeOH) (log ε) 238 (4.72), 310 (4.60) nm; 
IR (film) 3260, 2925, 1647, 1507, 1275 cm-1; 1H NMR (300 MHz, [CD3]2CO), δ 6.71 (1H, br 
s, H-4), δ 6.70 (1H, br s, H-2), 6.31 (1H, d, J = 1.8,  H-5), 6.171 (1H, d, J = 1.8,  H-7), 2.77 
(3H, s,  H3-11), 13.44 (1H, s, OH-8); 9.79 (1H, br s, OH-3), 9.71 (1H, br s, OH-6), 9.79 (1H, 
d, J = 1.8, OH-3); 13C NMR (75.5 MHz, (CD3)2CO) δ 183.0 (s, C-9), 165.5 (s, C-10a), 164.9 
(s, C-6), 163.6 (s, C-8), 160.3 (s, C-4a), 158.1 (s, C-3), 144.4 (s, C-1), 116.0 (d, C-2), 113.0 
(s, C-1a), 103.8 (s, C-1a), 101.5 (d, C-4), 98.7 (d, C-7), 94.0 (d, C-5), 23.4 (q, C-11). EIMS 
m/z (% rel int) 258 [M+] (100), 229 (10), 69 (5), accurate mass m/z 258.0524, calculated for 
C14H10O5 258.0528.  
 
5-(Hydroxymethyl)-2-furanocarboxylic acid (15) was obtained as brown oil (16.4 mg). Lit. 
(Turner, 1977), 1H NMR (300 MHz, [CD3]2CO), δ 7.12 (1H, d, J = 3.5, H-4), δ 6.44 (1H, d, J 
= 3.5, H-3), 4.52 (2H, s, H-6); 13C NMR (75.5 MHz, [CD3]2CO) δ 162.5 (s, C-1`), 160.6 (s, 
C-2), 145.9 (d, C-5), 119.5 (d, C-4), 110.2 (s, C-3), 57.8 (t, C-6). EIMS m/z 142, calculated 
for C6H6O4 142.0266. 
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4.4 A new antioxidant isobenzofuranone derivative from the algicolous 
marine fungus Epicoccum sp. 
 
Abstract 
 
The fungus Epicoccum sp., was isolated from the marine brown alga Fucus vesiculosus. After 
cultivation the fungus was investigated for its secondary metabolite content, and found to 
contain the new natural product 4,5,6-trihydroxy-7-methylphthalide (epicoccone, 17), 
together with 5-(acetoxymethyl)-2-furanocarboxylic acid (18), 2-furanocarboxylic acid (19), 
5-(hydroxymethyl)-2-furanocarboxylic acid (15), (-)-(3R,4S)-4-hydroxymellein (20), and (-)-
(3R)-5-hydroxymellein (21). The structures of all compounds were determined by 
interpretation of their spectroscopic data (1D and 2D NMR, MS, UV, optical rotation and IR). 
Each isolate was tested for its antioxidative properties, and compound 17 was found to be 
potently active. 
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Introduction 
 
Fungi of the genus Epicoccum are commonly associated with beach wrack material 
(Kohlmeyer et al., 1979). Only a few members of this genus of trestrial origin have been 
studied for their secondary metabolite content e.g. epicorazines A and B (Baute et al., 1976, 
1978), triornicin (Frederick et al., 1981), orevactaene (Shu et al., 1997), all being produced by 
E. nigrum (= E. purpurascens) and the ability of Epicoccum sp. to produce biologically active 
secondary metabolites is not yet investigated.  
 
During our investigation dealing with isolation and structure elcidation of novel bioactive 
secondary metabolites of fungi associated with algae, the obligate marine fungus Epicoccum 
sp. was isolated from the brown alga Fucus vesiculosus L., collected at the German coast 
(Tönning, North Sea). After successive fractionation of the EtOAc extract yielded a new 
potent isobenzofuranone (phthalide) derivative. Isobenzofuranone (phthalide) derivatives like 
convolvulanic acid A and B (Tsantrizos et al., 1992), and 3-butyl-7-hydroxyphthalide 
(Makino et al., 1998), were formerly isolated from fungi. This group of natural products is, 
however also known from higher plants, e.g. 3-ethyl-7-hydroxy phthalide (Kameoka et al., 
1975).  
 
Materials and methods 
 
Isolation and taxonomy of the fungal strain 
 
Algal material was collected from the North Sea coast (Tönning, Germany), and identified as 
Fucus vesiculosus L. (Fucaceae, N 1). After sterilisation with 70 % ethanol, algal samples 
were rinsed with sterile water and pressed onto agar plates to detect any residual fungal spores 
on their surface. Sterilised algae were then cut into pieces and placed on agar plates 
containing isolation medium: 15 g/L agar, 1 L seawater from the sample collecting site, 
benzyl penicillin and streptomycin sulphate (250 mg/L). Fungal colonies growing out of the 
algal tissue were transferred onto medium for sporulation: 1.0 g/L glucose, 0.1 g/L yeast 
extract, 0.5 g/L peptone from meat, enzymatic digest, 15 g/L agar, 1 L artificial sea water, the 
pH was adjusted to 8 in order to enable taxonomy of the isolates.  
  
Cultivation 
 
The fungus Epicoccum sp. (Hyphomycetes, Tuberculaiaceae, N 1-12, 353) was cultivated at 
room temperature for two months in 5 L (20 Fernbach flasks) of solid biomalt agar containing 
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50 g/L biomalt, 15 g/L agar in ASW. Each Fernbach flask was inoculated with 10 mL of a 10-
day-old culture (room temperature) grown in biomalt media without agar. 
 
Biological activity, see chapter 3.4. 
 
Extraction and isolation 
 
Mycelia and medium of the cultivated fungus were diluted with water (100 mL/L), 
homogenized using an Ika Ultra-turax model T25 at 8000 rpm for 2 min, the resulting mixture 
exhaustively extracted with EtOAc (3 x 8 L) and filtered. The filtrate was evaporated under 
reduced prssure to yield 1.7 g of a highly viscous dark redish gum. This extract was 
fractionated by VLC (2.5 x 20 cm, RP-18, 30 g) employing gradient elution from H2O to 
MeOH, to yield 6 fractions (H2O:MeOH, 1:0; 8:2; 6:4; 4:6; 2:8; 0:1, each 100 mL). 1H NMR 
identified fractions 1, 4 and 5 as promising for further fractionation. VLC fraction 1 (0.286 g) 
was fractionated on a Sep Pack column (RP-18) using gradient elution from H2O to MeOH, to 
yield 6 fractions (H2O:MeOH, 1:0; 8:2; 6:4; 4:6; 2:8; 0:1, each 20 mL). SPE fraction 1 was 
further fractionated by RP-18 HPLC (Eurospher-100, 5 µm, 250 x 8 mm, Knauer), employing 
gradient elution from H2O to H2O:MeOH (1:1) in 30 min, 2 mL/min, to yield 17 (semi-pure), 
18, and a mixture of 19 and 15 (tR = 27 min, 2.0 mg/L; tR = 12 min, 0.8 mg/L; tR = 6 min, 1 
mg/L, respectively). Compound 17 was finally purified by gradient elution with 4:1 
H2O:MeOH to 3:7 H2O:MeOH in 25 min, 2 mL/min. VLC fraction 4 and 5 were pooled, 
based on similarities of 1H NMR spectral data, and further fractionated by SPE (RP-18), 
employing gradient elution from H2O to MeOH, to yield 8 fractions (H2O:MeOH, 1:0; 
8.5:1.5; 7:3; 5.5:4.5; 4:6; 2.5:7.5; 1:9; 0:1, each 20 mL), which were combined, based on their 
1H NMR spectral data, into 4 pools. Of these, pool 4 was purified using RP-18 (Eurospher-
100, 5 µm, 250 x 8 mm, Knauer) HPLC, and gradient elution from 7:3 H2O:MeOH to 4:6 
H2O:MeOH in 30 min, 2 mL/min, to yield 20 (tR = 23 min, 0.3 mg/L) and 21 (tR = 27 min, 0.3 
mg/L). 
 
GC-MS analysis of 19 and 15 
 
TMS derivatives were made by dissolving 1 mg of the compound mixture (19 and 15) in 100 
µL of TFA. Then 0.9 mL of MSTFA (N-methyl-N-trimethylsilyl-trifluroacetamid; WGA 
GmbH  370520) was added dropwise, and the reaction mixture was left at room temperature 
for 1 hour. The GC-MS analysis was carried out on a A 30 m x 0.32 mm N931-6023 Pe-1 
(film thickness of 0.25 µm) capillary column. The instrument was set to an initial temperature 
of 50 °C, and maintained at this temperature for 10 min. At the end of this period the oven 
was heated at 10°/min up to 250°C, and kept there for 10 min. Injection port temperature was 
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220°C, He flow rate was 2 mL/min, and samples were injected in splitless mode. Mass 
spectral scan range was 35-650 Da. The chromatogram of the mixture contained two peaks, A 
and B. Retention times, relative intensities (%, B being 100 %) and EIMS data of the relevant 
peaks were; Peak A (19), 14.8 min, 30, EIMS m/z (% rel int), 184 [M++TMS] (10), 169 (40), 
125 (100); Peak B (15), 21.3 min, 100, EIMS m/z (% rel int), 286 [M++2xTMS] (<1), 271 
(90), 170 (5), 147 (100), 123 (70), 73 (80). 
 
Results and discussion 
 
In the present study the isolation and structure elucidation and biological activity of secondary 
metabolites obtained from Epicoccum sp. (Hyphomycetes, Tuberculaiaceae) cultivated on a 
solid biomalt medium with added artificial sea salt. Successive fractionation of the EtOAc 
extract by vacuum liquid chromatography (VLC) over reversed phase silica (RP-18) followed 
by reversed phase (RP-18) HPLC yielded compounds 17-21, all of which are highly 
oxygenated. 
 
Negative mode electrospray ionisation mass 
spectrometric (ESIMS) and 1H and 13C NMR analyses 
of 17 showed it to have the molecular formula 
C9H8O5. In the 13C NMR spectrum of 17 nine 
resonances attributable to one methyl group, one 
methylene group, and seven quarternary carbons 
(Table 14), were evident. It was also clear from these 
data that four of the six elements of unsaturation 
within 17 were present as multiple bonds (3 x C═C) 
and a carbonyl group, a deduction supported by the IR 
absorption at 1681 cm-1; the molecule was thus bicyclic. As the 1H and 13C NMR data enabled 
all but three of the hydrogen atoms within 17 to be accounted for, it was evident that the 
remaining three must be present as parts of OH groups, a deduction that was also supported 
by the IR data (νmax 3333 cm-1). Also evident from the 1H and 13C NMR data of 17 were 
resonances consistent with the presence of a fully substituted aromatic ring, a conclusion 
supported by the UV maximum 273 nm, an allylic methyl, and a benzylic methylene group. 
After association of all 1H and 13C NMR resonances from cross peaks seen in the 1H-13C 2D 
NMR shift-correlated (HMQC) spectrum of 17 interpretation of its HMBC spectral data led 
directly to the structure of 17. The HMBC spectrum of 17 contained cross peaks between the 
resonance of H3-8 and those of C-1, C-5, C-6, C-7 and C-7a, and between H2-3 and C-1, C-4, 
C-4a, C-5, and C-7a. These data enabled CH3-8 to be positioned at C-7 and the carbonyl 
group of the furanone at C-7a, leaving C-3 to bond with C-4a. X-ray crystallographic analysis 
O
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of 17 confirmed these deductions. The quality of the X-ray data was, however, not of 
publishable quality due to fact that the crystallisation solvent, MeOH, was disordered 
throughout the crystal. For 17, a new phthalide derivative, the trivial name epicoccone is 
proposed.  
 
Table 14. 1H [CD3OD, 300 MHz] ,13C NMR [CD3OD, 75.5 MHz] and HMBC data for 
compound 17a 
 
Position δ 13C δ 1H HMBC 
1 174.6 (s)b   
3   68.0 (t) 5.16 (2H, brs) C-1, C-4, C-4a, C-5, C-7a 
4 138.1 (s)   
4a 127.9 (s)   
5 141.5 (s)   
6 146.3 (s)   
7 118.3 (s)   
7a 113.9 (s)   
8    9.7 (q) 2.45 (3H, s) C-1, C-5, C-6, C-7, C-7a 
 
aAll assignments are based on 1D and 2D measurements (HMBC, HMQC).  
bImplied multiplicities were determined by DEPT (C = s, CH = d, CH2 = t, CH3 = q). 
 
 
Together with the new compound 17, 5-(acetoxymethyl)-2-furanocarboxylic acid (18), 2-
furanocarboxylic acid (19), and 5-(hydroxymethyl)-2-furanocarboxylic acid (15), (-)-(3R,4S)-
4-Hydroxymellein (20), and (-)-(3R)-5-Hydroxymellein (21) were also isolated from the 
EtOAc extract of Epicoccum sp. They were identified by comparison of their 1H and 13C  
NMR data and optical rotations with published values (Jadulco et al., 2001; Teleman et al., 
1996; Devys et al., 1994 and 1992). The 5-(acetoxymethyl)-2-furanocarboxylic acid (18) was 
first isolated from a culture of Cladosporium herbarum, a fungal isolated from marine 
sponge. The Sumiki’s acid (15) and 2-furanocarboxylic acid (19) are known fungal 
metabolites originally isolated from Penicillium italicum and Pyricularia grisea (Turner et al., 
1989). The remaining two compounds (20 and 21) are mellein derivative, well known fungal 
metabolites. The (-)-(3R,4S)-4-hydroxymellein (20) and (-)-(3R)-5-hydroxymellein (21) were 
isolated from Septoria nodorum Berk (Phaeosphaeria), a common wheat parasite (Devys et 
al., 1992 and 1994).  
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Figure 9. HMBC NMR spectrum of epicoccone (17), 1H [CD3OD, 300 MHz] and 13C NMR 
[CD3OD, 75.5 MHz]. 
 
 
                                                   
Epicoccum sp. 
 
 
63
 
O O
OOH
R1
R2
18 R1 = COOH, R2 = CH2OAc
19 R1 = H, R2 = COOH 
15 R1 = CH2OH, R2 = COOH
20 R1 = OH, R2 = H
21 R1 = H, R2 = OH
R2
R1 1
2
3
45
6
7
8
2
34
5
 
 
The antioxidative properties of all compounds were assessed using DPPH radical scavenging 
and the TBARS assays. The results of these assays are shown in Tables 15 and 16, and reveal 
the EtOAc extract, 17 and 21 to have significant DPPH radical scavenging effects (16.8, 95.2, 
and 22.4 %, respectively, at 25.0 µg/mL), with 17, 20 and 21 also being able to inhibit 
peroxidation of linolenic acid (62.1, 18.4, and 30.4 %, respectively, at 37.0 µg/mL) in the 
TBARS assay. In both of the aforementioned assays, 17 still has significant effects at levels 
between 1-5 µg/mL. The observed antioxidative activities correlate with the number of 
phenolic hydroxyl groups of the relevant structures. Thus compound 17, containing three 
hydroxyl groups showed the most prominent activity, followed by compound 21 with a 
hydroquinone moiety. Compound 20 with only one phenol group is the least active 
metabolite. 
 
Table 15. Antioxidative effects (TBARS assay)a of the EtOAc extract of Epicoccum sp. and 
compounds 17-21. 
 
 % Inhibitionb 
Item tested 3.7e 7.4 37.0 
EtOAc Extract -0.1 -2.1 0.1 
17 21.3 31.7 62.1 
18 4.6 -0.4 2.3 
19 and 15 9.1 7.4 14.4 
20 9.5 10.7 18.4 
21 14.1 15.2 30.4 
BHTc 54.2 63.8 73.9 
 
aTBARS = Thiobarbituric acid method. b% Inhibition = 100-(Ad sample-A sample blank) x 100/(A control - A 
blank). cBHT = Butylated hydroxytoluene. dA = Absorbance measured at 532 less the background Absorbande at 
600 nm. eConcentration in µg/mL. 
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Table 16. DPPHa radical scavenging effects of the EtOAc extract of Epicoccum sp. and 
compounds 17-21 
 
 % Scavengingb 
Item tested 1.0c 2.5 5.0 10.0 25.0 50.0 100.0 
EtOAc Extract 1.8 0.7 2.5 5.5 16.8 28.5 43.4 
17 10.9 28.2 46.2 83.7 95.2 94.9 94.7 
18  ntd  nt  nt  nt   5.9 10.6 22.2 
19 and 15  nt  nt  nt  nt   1.8  1.7   3.1 
20  nt  nt  nt  nt   5.7  9.6 15.9 
21  nt  nt  nt  nt 22.4 28.4 35.8 
BHTe -0.7 1.7 3.3 8.2 18.6 36.1 56.8 
 
aDPPH = α,α-Diphenyl-β-picrylhydrazyl. bScavenging % = 100-(A samplef x 100/A controlf). cConcentrations in 
µg/mL. dnt = not tested. eBHT = Butylated hydroxytoluene. fAbsorbance of sample and control measured at 517 
nm. 
 
Epicoccone (17), 4,5,6-trihydroxy-7-methylphthalide was obtained as white transparent 
crystalline solid (10.0 mg). M. p.: 249-250 °C; UV λmax  MeOH (log ε) 217 nm (4.1), 273 nm 
(3.6); IR (film) νmax 3333, 2359, 1681, 1608, 1520, 1471,1273 cm-1; 1H and 13C NMR data 
(Table 14); ESIMS m/z 195 [M-H]. 
 
5-(Acetoxymethyl)-2-furanocarboxylic acid (18) was obtained as amorphous powder (4.0 
mg). UV λmax  MeOH (log ε) 217 nm (4.6), 247 nm (3.7); IR (film) νmax 3252, 1737, 1700, 
1573, 1530, 1364, 1231 cm-1; Lit (Jadulco et al., 2001), 1H  NMR (300 MHz, CD3OD) δ 7.00 
(1H, d, J =  2.2 Hz, H-3), 6.55 (1H, d, J = 2.2, H-4), 5.10 (2H, s, H2-6), 2.11 (3H, s, H3-8); 13C 
NMR (75.5 MHz CD3OD) δ 152.6 (s, C-2), 116.2 (d, C-3), 112.9 (d, C-4), 152.56 (s, C-5), 
59.2 (t, C-6), 172.2 (s, C-7), 20.6 (q, C-8); EIMS m/z (% rel int), 184 [M+] (23), 142 (100), 
125 (45), 97 (30), 79 (66); HREIMS m/z 184.0370 (calculated for C8H8O5 184.0369).  
 
2-Furanocarboxylic acid (19), and 5-(hydroxymethyl)-2-furanocarboxylic acid (15) were 
obtained as an oily mixture (5.0 mg). IR (film) νmax 3251, 1568, 1532, 1482, 1390, 1366, 
1213 cm-1; Lit (Jadulco et al., 2001), 1H and 13C NMR data for 15 was mentioned in chapter 
4.3. For 19, Lit (Teleman et al., 1996), 1H NMR (300 MHz, CD3OD) δ 7.39 (1H, br m, H-5), 
6.80 (1H, br m, H-3), 6.35 (1H, br m, H-4); 13C NMR (75 MHz, CD3OD) δ 157.1 (s, C-1`), 
146.3 (s, C-2), 146.0 (d, C-5); 116.9 (d, C-4), 110.8 (d, C-3); EIMS (see GC-MS analysis). 
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(-)-(3R,4S)-4-Hydroxymellein (20) was obtained as amorphous solid (1.5 mg). [α]23D = -26.3° 
(c 0.05, CHCl3), lit. (Devys et al., 1992). 1H NMR (300 MHz, CDCl3) δ 4.60 (2H, brs, H-3 
and 4), 6.99 (1H, d, J = 7.7, H-5), 7.53 (1H, dd, J = 7.7, 6.6 Hz, H-6), 7.02 (1H, d, J = 6.6 Hz, 
H-7); EIMS m/z (% rel int), 194 [M+] (50), 150 (95), 121 (100), 94 (18), 65 (23). HREIMS 
m/z 194.0578 (calculated for C10H10O4 194.0578). 
 
 (-)-(3R)-5-Hydroxymellein (21) was obtained as amorphous powder (1.5 mg). [α]23D = -19.8° 
(c 0.05, CH2Cl2), lit. (Devys, et al., 1994). [α]23D = -72 (c 1650 mg %). 1H NMR (300 MHz, 
DMSO) δ 4.70 (1H, m, H-3), 3.07 (1H, dd, J = 17.2, 2.9 H-4), 2.65 (1H, m, H-4), 10.36 (1H, 
s, OH-5), 6.72 (1H, d, J = 9.15, H-6), 7.06(1H, d, J = 9.15, H-7); EIMS m/z (% rel int), 194 
[M+] (50), 176 (35), 165 (20), 149 (50), 121 (20), 111 (4), 97 (50), 121 (20), 83 (70), 69(7), 
57 (100). HREIMS m/z 194.0578 (calculated for C10H10O4 194.0576). 
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4.5 Novel sorbicillinoid derivatives from the marine fungus Trichoderma 
viride associated with the Caribbean sponge Agelas dispar 
 
Abstract 
 
The fungus Trichoderma viride  isolated from the Caribbean sponge Agelas dispar, collected on 
Dominica, was mass cultivated and found to produce four novel sorbicillinoid polyketide 
derivatives, trichodermanone A-D (22-25) and the new natural product 6-(4-hydroxy-1-
pentenyl)-4-methoxy-3-methyl-2H-pyran-2-one (trichopyranone, 26). In addition to these 
compounds two known hexaketide derivatives, epoxysorbicillinol (27), vertinolide (28) and 
three known dodecaketides trichodimerol (29), bislongiquinolide (trichotetronine, 30), and 
bisvertinol (31), were isolated. Finally, a known fungal metabolite, 2-furancarboxylic acid (19) 
was obtained. The structures of all compounds were determined by interpretation of their 
spectroscopic data (1D and 2D NMR, MS, UV and IR). Total extract and compounds 27-30 
have DPPH radical savenging effects (12.5, 43.8, 15.5, 37.2, and 23.8 % respectively at 230 
µmol/L), with 27-29 being also able to inhibit peroxidation of linolenic acid (17.8, 5.2 and 19.9, 
respectively at 164 µmol/L). Compound 27 showed moderate HIV-1 reverse transcriptase 
inhibitory activity (63.8 % at 200 µg/mL). All compounds and the total extract except 19 were 
tested for their estrogenic, antitumor and antimicrobial effects and no significant activities were 
observed. 
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Introduction  
 
The fungal genus Trichoderma (Persoon 1821) is known for its ubiquitous occurrence (Andrade 
et al., 1992). The taxonomical classification of these fungi, however is difficult. In the last 
decade considerable interest has been shown in the use of Trichoderma sp. as biological control 
(Cooney et al., 1999). Trichoderma sp. are noted for their secondary metabolite content, to date 
around 500 compounds have been reported from fungi belonging to this genus, including 
koniginin G (Culter et al., 1999), trichocaranes A-D (Macías et al., 2000), pentenocins A and B 
(Matsumoto et al., 1999). 
  
Vertinoid (sorbicillinoid) polyketides are a growing and diverse class of structurally novel 
natural products, and are endowed with a broad range of biological activities. They are 
hexaketide-derived metabolites. Included within this class are more than fourteen compounds 
with a C14 skeleton, and also dimers with C28 (Sperry et al., 1998). For instance, sorbicillin was 
the first member belonging to the simple vertinoids (C14), and is considered as the hypothetical 
biosynthetic precursor of epoxysorbicillinol, a yellow pigment obtained from Trichoderma 
longibrachiatum (Sperry et al., 1998). The bisorbicillinoids are the dimeric form of sorbicillin-
derived compounds such as bisorbibutenolide, trichodimerol, bisorbicillinolide and bisvertinol. 
This class of metabolites is restricted to a few genera including Trichoderma, Verticillium, 
Acremonium, and Penicillium (Abe et al., 1999; Andrade et al.,1996; Trifonov et al., 1982, 
1983, and 1986). The unusual and complex molecular architecture of these compounds 
motivated researchers to study their biological activities. Some of them exhibit antioxidant 
properties e.g. bisorbicillinol, bisorbibutenolide and bisorbicillinolide (Abe et al., 2000). The 
oxidized form of bisvertinol represents the first inhibitor of β-6-glucan biosynthesis, thus, it is 
considered as a potential antifungal agent (Nicolaou et al., 2000). Trichodimerol, originally 
isolated from Trichoderma sp., showed significant inhibitory activity against lipopolysaccharide 
induced production of tumor necrosis factor alpha (TNF-α) in human monocytes and thus, 
represents a new lead for the treatment of septic shock (Abe et al., 1998 and 1999; Nicolaou et 
al., 2000). 
 
On this basis, we continued our projects aimed at finding new natural products with biological 
activity and/or novel chemical structures from marine-derived fungi (Abdel-Lateff et al., 2002 
and 2003a and b). The current secondary metabolite investigation was undertaken with the 
marine fungus Trichoderma viride (Hypocreaceae, Ascomycota), isolated from the Caribbean 
sponge Agelas dispar J. (order Agelasida, family Agelasidae), collected from waters around the 
Island of  Dominica.  The fungus was cultivated on a solid glucose biomalt medium with added  
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artificial sea salt. Successive fractionation of the EtOAc extract by vacuum liquid 
chromatography (VLC) over normal phase silica followed by reversed phase (RP-18) HPLC 
yielded four novel sorbicillinoid polyketide derivatives trichodermanone A-D (22-25) and a 
new pyrone derivative (Trichopyranone, 26). In addition to these compounds two known 
hexaketide derivatives epoxysorbicillinol (27) (Sperry et al., 1998), vertinolide (28) (Trifonov et 
al., 1982), and three known dodecaketides trichodimerol (29) (Andrade et al., 1992; Abe et al., 
1998) bislongiquinolide (Trichotetronine, 30) (Sperry et al., 1998), and bisvertinol (31) 
(Trifonov et al., 1986), were isolated. Finally, a known fungal metabolite, 2-furancarboxylic 
acid (19) (Corey et al., 1958), was also obtained.  
 
Materials and methods 
 
Isolation and taxonomy of the fungal strain 
 
The sponge Agelas dispa J. was collected using Scuba in 1993 from the waters around the 
Caribbean Island of Dominica. The sponge was identified by Dr. R. Desqueroux-Faundez, 
Musee d’Historie Naturelle, Geneve. The fungus was isolated by inoculating small pieces of its 
inner tissue on cellulose (10 g/L), yeast extract (1 g/L), benzylpenicillin (250 mg/L), 
streptomycin sulphate (250 mg/L), agar (15 g/L), and ASW (800 mL/L).  
 
Cultivation 
 
The fungus Trichoderma viride (Hypocreaceae, Ascomycota, 193E61, 54), was cultivated at 
room temperature for two months in 5 L (20 Fern Bach flasks) of solid glucose biomalt agar 
containing biomalt (50 g/L, Villa Natura Gesundheitsprodukte GmbH, Germany), glucose (10 
g/L, J. T. Baker), agar (15 g/L, Fluka Chemie AG) in ASW. 
 
Biological activity, see chapter 3. 4. 
 
Extraction and isolation  
 
Mycelia and medium were diluted with water (100 mL/L), homogenized using an Ika Ultra-
turax T25 at 8000 rpm for 2 min and the resulting mixture exhaustively was extracted with 
EtOAc (3 x 8 L) and filtered. The filtrate was evaporated under reduced pressure to yield 5 g 
of a highly viscous yellowish brown gum. The extract was fractionated by Vaccum Liquid 
Chromatography (VLC) (2.5 x 20 cm, Si gel 60, 120 g, Merck 7739), employing gradient 
elution from petroleum ether to acetone, to yield 5 fractions (petroleum ether:acetone, 1:0;7.5: 
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2.5; 5:5; 2.5:7.5; 0:1, each 200 mL). According to the differences in composition detected by 
1H NMR spectral data, it was evident that fractions 2 (0.53 g) and 3 (1.2 g) were promising 
for further fractionation. VLC fraction 3 was fractionated on normal phase silica for TLC (5-
40 µm, Merck 7739) by VLC using gradient elution from petroleum ether to EtOAc, to yield 
11 fractions (petroleum ether:EtOAc, 1:0; 9:1; 8:2; 7:3; 6:4; 5:5; 4:6; 3:7; 2:8; 1:9; 0:1, each 
100 mL). Fractions 3.4-3.7 appeared very promising for further fractionation based on several 
low field 1H NMR resonances in the δ 6-8 region. Fraction 3.4 was purified by RP-18 HPLC 
(Eurospher-100, 5 µm, 250 x 8 mm ID, Knauer), employing gradient elution from 9:1 
H2O:MeOH to MeOH in 45 min, 2 mL/min, to yield 19, 27, 28, semi-pure 29, (tR = 14 min, 1 
mg; tR = 29 min, 6 mg; tR = 32 min, 4 mg; tR = 41 min, 4 mg, respectively). Compound 30 was 
purified by gradient elution from 1:1 H2O:MeOH to MeOH in 45 min, 2 mL/min (tR = 29 min, 
4 mg). Fraction 3.5 was purified by RP-18 HPLC (Eurospher-100, 5 µm, 250 x 8 mm ID, 
Knauer), employing gradient elution from 6:4 H2O:MeOH to MeOH in 60 min, 2 mL/min, to 
yield additive amount of 30 (tR = 39 min, 30 mg). Fraction 3.6 was purified by RP-18 HPLC 
(Eurospher-100, 5 µm, 250 x 8 mm ID, Knauer), employing gradient elution from 6:4 
H2O:MeOH to MeOH in 60 min, 2 mL/min, to yield five peaks (3.6.3, 3.6.4, 3.6.5, 3.6.6, 
3.6.7), (tR = 15 min, 2.5 mg; tR = 25 min, 20 mg; tR = 26 min, 18 mg; tR = 29 min, 16 mg; tR = 
35 min, 3 mg, respectively). The first peak 3.6.3 was identified as 26. HPLC peak 3.6.4 was 
purified using RP-HPLC (XTerra RP-18, 5 µm, 250 x 4.6 mm, Waters), employing gradient 
elution from 65:35 H2O:MeOH to MeOH, in 35 min, 1 mL/min, to yield 25 (tR = 21 min, 10 
mg), and 22 (tR = 25 min, 2 mg). HPLC peak 3.6.5 purified using RP-18 HPLC employing 
gradient elution from 65:35 H2O:MeOH to 2:8 H2O:MeOH, in 35 min, 1 mL/min, to yield 
compound 24 (tR = 22 min, 4 mg), and 25 (tR = 21 min, 1 mg). HPLC peak 3.6.6 was purified 
using RP-18 HPLC employing gradient elution from 7:3 H2O:MeOH to 3:7 H2O:MeOH in 30 
min, 1 mL/min, yielded 23 (tR = 23.5 min, 4 mg). Fraction 3.7 was purified by RP-18 HPLC 
(Eurospher-100, 5 µm, 250 x 8 mm ID, Knauer), employing gradient elution from 55:45 
H2O:MeOH to MeOH in 60 min, 2 mL/min, to yield additive amount of 25 (tR = 23 min, 10 
mg). VLC fraction 2 (0.56 g) was fractionated by normal phase VLC using gradient elution 
from petroleum ether to EtOAc to yield 5 fractions (petroleum ether:EtOAc, 1:0; 7.5:2.5; 5:5; 
2.5:7.5; 0:1, each 200 mL). Fractions 2.3-2.5 appeared very interesting for further 
fractionation based on several low field 1H NMR resonances in the δ 6-8 region. Fraction 2.3 
was purified by RP-18 HPLC (Eurospher-100, 5 µm, 250 x 8 mm ID, Knauer), employing 
gradient elution from 5:5 H2O:MeOH to MeOH in 45 min, 2 mL/min, to yield 29 (tR = 43 
min, 10 mg). Fraction 2.4 was purified by RP-18 HPLC (Eurospher-100, 5 µm, 250 x 8 mm 
ID, Knauer), employing gradient elution from 7:3 H2O:MeOH to MeOH in 50 min, 2 
mL/min, to yield 23, 24, and semi-pure 31 (tR = 29 min, 2 mg; tR = 32 min, 2 mg; tR = 44 min, 
5 mg, respectively).  Compound  31 was  finally purified by gradient elution from 25:75 H2O:  
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MeOH to MeOH in 30 min, 2 mL/min (tR = 14 min, 2 mg). Fraction 2.5 was purified by RP-
18 HPLC (Eurospher-100, 5 µm, 250 x 8 mm ID, Knauer), using gradient elution from 6:4 
H2O:MeOH to MeOH in 50 min, 2 mL/min, to yield 28 and 30 (tR = 22.5 min, 2 mg; 36 min, 
5 mg, respectively). 
 
Results and discussion 
 
Negative and positive mode 
electrospray ionization mass 
spectrometry (ESIMS), EIMS 
and 1H and 13C NMR analysis 
of compound 22 showed it to 
have the molecular formula 
C19H20O7. Its 13C NMR 
spectra (1H decoupled and 
DEPT) showed that seven of 
the ten elements of 
unsaturation, as indicated by 
the molecular formula of 22, could be attributed to four carbon-carbon double bonds and three 
carbonyl groups (Table 17); the molecule is thus tricyclic. The 1H and 13C NMR spectral data 
established the presence of three sp3-hyberdized methine groups, five sp2-hyberdized methine 
groups, an allylic methyl group, two methyl groups attached to quaternary carbons and eight 
quaternary carbons (Table 17 and 18). These data also showed that all but three of the 
hydrogen atoms were bonded directly to carbons, indicating the remaining three to be present 
as part of hydroxyl functions, a deduction supported by IR data (νmax 3384 cm-1). All 1H and 
13C NMR resonances were assigned using C-H one-bond couplings (HMQC), and from cross 
peaks seen in the long-range 1H-13C NMR shift-correlated 2D NMR measurement (HMBC) of 
22. It was possible to deduce the planar structure of 22 by interpretation of its 1H-1H COSY 
and 1H-13C HMBC spectra. From the 1H-1H COSY NMR spectrum of 22, 1H-1H spin 
couplings between H3-17 and H-16 and H-15, and correlations between H-13 and H-14 and 
H-15 were observed. Diagnostic long-range 1H-13C HMBC correlations between the 
resonance of H3–17 to those of C-15 and C-16, between the resonance of H-13 to C-1, C-12 
and C-15, and also correlations between H-14 and C-12 and C-16 were evident. These 
couplings established the C-C bonds from C-1 to C-17, and the presence of a sorbyl side 
chain (Fragment 1, Figure 10). HMBC long-range correlations observed between the 
resonances of H-6 to those of C-1, C-2, C-4, and C-5, correlations between H3-19 and C-4, C-
5 and C-6, also between H3-18 and C-2, and C-4, enabled ring A to be established as shown in  
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Figure 10. HMBC correlations between H-6 and C-12, and between H-13 and C-1, gave 
further proof for the sorbyl side chain to be attached to C-1, a deduction also supported by 
NOESY correlation between H-6 and H-13. The 1H-1H COSY spectrum of 22 showed 1H-1H 
spin couplings between H-8 and H-7, which further couples with H-6. Long-range C-H 
correlations, this time observed between the resonances of H-8 to C-2, C-3, C-4 and C-6, 
between H-7 and both C-1 and C-3, and also correlations observed between H-6 and both C-7 
and C-8, indicated C-8 to bond directly to both C-3 and C-7, which irectly bonded to C-6, and 
thus, ring B within 22, is completed (Figure 10).  From  13C  NMR spectral data, it was clear 
that C-7 (δ 80.9, d) has to be attached to oxygen, and that the carbonyl group C-11 (δ 161.0, s) 
is part of lactone, a deduction supported by IR data (νmax 1729 cm -1). C-9 has to be attached 
to C-8 because of 1H-1H COSY correlations observed between H-8 and H-9, and HMBC 
correlations observed between H-9 and C-8. A HMBC couplings between H-9 and C-10 and 
C-11 enabled the C-C bonds from C-9 to C-11. From these data, ring C was established. 
Remaining to be incorporated into the planar structure were three hydroxyl functions, which 
were attached to C-5 (δ 74.5, s), C-10 (δ 151.7, s), and C-12 (δ 170.9, s) as deduced on the 
basis of 13C NMR chemical shifts. 1H-1H NMR coupling constants for H-8 (10.6, 2.9 Hz) and 
H-7 (10.6, 3.7 Hz) indicated both to be pseudo-axial and either to have a dihedral angle of 
180° or alternatively close to 0°. Diagnostic NOESY correlations between H-8 and H-7 
indicated the cis junction between ring B and C. Thus, the relative stereochemistry at C-7 and 
C-8 has to be 3S*, 7S*, respectively. As the proton located at C-6 has a 1H-1H coupling 
constant of 3.7 Hz it had to be in an equatorial orientation and consequently, the CH3-18 has 
an equatorial orientation. As NOE observed between H-6 and H-13 is only possible if H-6 is 
equatorial and α positioned which also defines CH3-18 as being α. Own data do not allow to 
correlate the relative stereochemistry between H-6/CH3-18 on one side and that of H-7 and H-
8 on the other side. The stereochemistry of C-5 could not be solved yet. Diagnostic NOESY 
correlations between H-15 and H3–17, and between H-15 and H-13, and between H-16 and H-
14, together with typical 1H-1H NMR coupling constants for H-13 (δ 6.55, d, J = 15.0), H-14 
(δ 7.29, dd, J = 15.0, 11.0), H-15 (δ 6.44, dd, J = 15.0, 11.0) and H-16 (δ 6.26, dq, J = 15.0, 
7.0) established double bonds ∆13,14 and ∆15,16 to have the E geometry (Table 17). Thus the 
relative stereochemistry of the side chain in compound 22 is best described as being 1Z, 13E, 
15E. For 22, a new sorbicillinoid derivative, the trivial name trichodermanone A is proposed. 
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Figure 10.  Fragments  obtained  from1H-1H  COSY and HMBC         
spectra of 22  
 
Compound 23 was deduced to have the molecular formula C21H28O8 by interpretation of the 
NMR and EIMS data, also taking into account the accurate mass of the fragment ion at m/z 
376.1519 [M-CH4O]+. Its 13C NMR spectrum (1H decoupled and DEPT) showed that five of the 
eight elements of unsaturation, could be attributed to three carbon-carbon double bonds and two 
carbonyl groups (Table 17); the molecule is thus tricyclic. The 1H and 13C NMR spectra showed 
the presence of two sp3-hyberdized methine groups, four sp2-hyberdized methine groups, three 
methylene groups (two of them attached to oxygen), an allylic methyl group, two methyl groups 
attached to quaternary carbons, one of which attached to oxygen, a methoxyl group, and eight 
quaternary carbons (Tables 17 and 18). The 1H and 13C NMR data enabled all but four 
hydrogen atoms of 23 to be accounted for; thus it was evident that the remaining four are 
present as hydroxyl  functions, a deduction supported by IR data (νmax 3315 cm-1). From 
extensive comparison of 1H, 
13C, 1H-1H COSY, and HMBC 
NMR spectral data of 23 with 
those of 22, it was evident that 
the two compounds were in a 
good    agreement   concerning  
the sorbyl unit, and rings A and 
B. The differences between the 
two compounds are evident 
from the NMR spectral data of  
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ring C. After assignment of all protons to their directly bonded carbons via a one-bond 1H-13C 
NMR shift correlated 2D NMR measurement (HMQC), it was possible to deduce from the 1H-
1H COSY spectrum of 23, a 1H-1H spin system from H-8 to H2-9, this meant C-8 has to be 
bonded directly to C-9. The downfield 13C NMR chemical shifts of C-10 (δ 110.6, s) and C-11 
(δ 69.8, t) indicated C-10 to be attached to two oxygen atoms and C-11 attached to one oxygen 
atom. Long-range correlations observed between H-11 (δ 3.71, d, J = 11.0) and both C-7 and C-
8 showed C-11 to be attached directly to C-7. C-9 has to be linked to C-10, because of HMBC 
correlations observed between H2-9 and C-10. The methoxyl group (C-21) resided at C-10 
based on the diagnostic long-range correlation observed between H3-21 and C-10. HMBC 
correlations between H-20 (δ 3.81, d, J = 11.0) and C-9 and also between H-20 (δ 3.81, br d, J = 
11.0) and C-10, led to the linkage between C-10 and C-20. The connection between C-10 and 
C-11 via an ether bridge and therefore, the completion of ring C followed by deduction. 
Remaining to be assigned were four hydroxyl groups. 13C NMR chemical shifts of C-5 (δ 74.8, 
s), C-7 (δ 92.7, s), C-12 (δ 167.8, s), and C-20 (δ 62.8, t), indicated each carbon to bear a 
hydroxyl function. As the 12-OH proton formed a strong hydrogen bond with oxygen, it was 
likely that this occurred with the oxygen of the C-2 carbonyl group. The spin-spin coupling 
between H-8 (2.57, dd, J = 10.6, 7.7) and H-9 (1.82, dd, J = 13.5, 10.6) indicated the two 
protons had axial-axial interaction. The 2D NOESY and selective gradient NOE spectra were 
useful for the relative stereochemistry of 23. The mutual NOE enhancements observed upon 
irradiation of the H-11 signal at δ 4.35 and of H-8 at δ 2.57 indicated the two protons had axial 
orientation, and that they are present on the same side of the molecule. Irradiation of CH3-21 at 
δ 2.94 gave enhancement of Hax-11 (δ 4.35), therefore, CH3-21 was also axial orientation, and 
had α-orientation. As the chair conformation of ring C is established based on the NOESY and 
selective NOE correlations between Hax-11, Hax-8, and CH3-21, the junction of the ring B and C 
had to be trans and thus, the hydroxyl group at C-7 was β. A molecular modeling calculation of 
23 was done indicating the distance between Heq-11 and the CH3-19 was more than 4.06 Å. 
This result was consistent with the absence of NOESY correlation between CH3-19 and Heq-11. 
Irradiation of H-6 at δ 3.39 gave enhancement of H-11 (δ 3.71) but no effect was observed to 
Hax-11, and indicated H-6 and H-11 (δ 3.71) had equatorial orientation. These results were 
validated by a 2D NOESY measurement. Irradiation of CH3-18 caused enhancement of Heq-9 (δ 
2.72) and also Hax-8 and indicated the CH3-18 to have an equatorial orientation. The relative 
stereochemistry of 23 has to be 3S*, 6S*, 7R*, 8R*, 10S*, 1Z, 13E, 15E, however the centers C-
6 and C-3 cannot be related in a relative sense to C-7 and C-8. The configuration at C-5 stays 
undetermined. For 23, a new sorbicillinoid derivative, the trivial name trichodermanone B, is 
proposed.
 
 
                                              
 
  
Table 17. 1H, HMBC and NOESY NMR a spectral data for compounds 22 and 23 
 
 22  23 
Position δ1H  HMBCb NOESY δ 1H HMBC NOESY 
6 3.74 (1Heq, d, 3.7) d C-1, C-2, C-4, C-5, C-7, 
C-8, C-12 
H-13, H3-19 3.39 (1H, s) d C-1, C-2, C-4, C-5, C-7,  
C-8, C-12 
H-13, H3-19, Heq-9 
7 5.57 (1H, dd, 10.6, 3.7) C-1, C-3 H-6, H-8    
8 3.58 (1H, dd, 10.6, 2.9) C-2, C-3, C-4, C-6, C-9 H-9, H-7, H3-18 2.57 (1Hax, dd, 10.6, 7.7) C-2, C-3, C-4, C-9, C-11 Heq-9, Hax-11, H3-18 
9 5.75 (1H, d, 2.9) C-7, C-8, C-10, C-11 H-8, H3-18 1.82 (1Hax, d, 13.5,10.6) 
2.72 (1Heq, d, 13.5, 7.7) 
C-3, C-7, C-8, C-10 
C-3, C-7, C-8, C-10 
Hax-8, H3-18 
 
11    3.71 (1Heq, d, 11.0) 
4.35 (1Hax, br d, 11.0) 
C-7, C-8 
 
Heq-6, Hax-11 
Hax-8, Heq-11,CH3-21 
13 6.55 (1H, d, 15.0) C-1, C-12, C-15 H-6, H-15 6.56 (1H, d, 15.0) C-12, C-14, C-15 Heq-6, H-15 
14 7.29 (1H, dd, 15.0, 11.0) C-12, C-16 H-16 7.22 (1H, dd, 15.0, 11.0) C-12, C-13, C-16 H-16 
15  6.44 (1H, dd, 15.0, 11.0) C-16, C-17 H-13, H3-17 6.40 (1H, dd, 15.0, 11.0) C-16, C-17 H-13, H3-17 
16 6.26 (1H, dq, 15.0, 7.0) C-15, C-17 H-14, H3-17 6.18 (1H, dq 15.0, 7.0) C-14, C-15, C-17 H-14 
17 1.88 (3H, d, 7.0) C-15, C-16 H-15, H-16 1.88 (3H, d, 7.0) C-15, C-16 H-15 
18 1.19 (3H, s) C-2, C-3, C-4, C-8 H-8, H-9 1.13 (3H, s) C-2, C-3, C-4, C-8 Hax-8, Heq-9, H2-20 
19 1.25 (3H, s) C-4, C-5, C-6 H-6 1.17 (3H, s) C-4, C-5, C-6 Heq-6 
20    3.81 (1Hα, d, 11.0) 
3.50 (1Hβ, br d, 11.0) 
C-9, C-10 Heq-11, H3-21  
 
21    2.94 (3H, s) C-10 Hα-20, Hβ-20, Hax-11 
OH-5 nC   5.15 (1H, br s) C-5, C-6  
OH-7 nC   4.61 (1H, br s)   
OH-10 nC      
OH-12 nC   14.20 (1H, br s)   
OH-20 nC   4.70 (1H, br s)   
 
aAll 2D NMR spectra  were measured at 500 MHz, except HMBC was measured at 300 MHz using (CD3)2CO. bLong-range correlation from proton to carbon. CThe signal was not observed. dJ 
in Hz.   
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Table 18. 13C NMR [(CD3)2CO, 75.5 MHz], spectral data for compounds 22-25 
 
Position      22        23    24       25 
1 107.8 (s) a 112.3 (s) 111.5 (s) 111.6 (s) 
2 198.8 (s) 199.0 (s) 200.2 (s) 200.0 (s) 
3   64.7 (s) 64.2 (s) 64.6 (s)   67.4 (s) 
4 202.3 (s) 210.9 (s) 210.9 (s)  211.1(s) 
5   74.5 (s) 74.8 (s) 74.8 (s)   74.8 (s) 
6   47.6 (d) 49.1 (d) 49.2 (d)   49.5 (d) 
7   80.9 (d) 92.7 (s) 90.3 (s)   90.3 (s) 
8   53.0 (d) 50.2 (d) 49.8 (d)   50.0 (d) 
9 109.6 (d) 38.1 (t) 41.0 (t)   40.3 (t) 
10 151.7 (s) 110.6 (s) 111.0 (s) 107.5 (s) 
11 161.0 (s) 69.8 (t) 68.5 (t)   68.3 (t) 
12 170.9 (s) 167.8 (s) 169.0 (s) 168.9 (s) 
13 120.2 (d) 120.4 (d) 120.1 (d) 120.1 (d) 
14 143.4 (d) 141.2 (d) 142.2 (d) 142.1 (d) 
15 132.6 (d) 132.1 (d) 132.1 (d) 132.0 (d) 
16 140.1 (d) 138.7 (d) 139.7 (d) 139.3 (d) 
17   19.2 (q) 18.8 (q) 18.8 (q)   18.8 (q) 
18   10.6 (q) 10.9 (q) 11.0 (q)   11.0 (q) 
19   23.9 (q) 27.1 (q) 26.8 (q)   27.0 (q) 
20  62.8 (t) 62.2 (t)    64.5 (t) 
21  48.8 (q) 48.9 (q)  
 
aImplied multiplicities as determined by DEPT (C = s, CH = d, CH2 = t, CH3 = q). 
 
 
Compound 24 analyzed for C21H28O8 by ESIMS and EIMS. The molecular formula was 
confirmed by HREIMS measurement. The 1D and 2D NMR spectral data of 3 were similar to 
some extent to those of 23. It was clear from these data that compound 24 is a stereo-isomer of 
23 (see Table 17 and 19). Careful examination of 13C NMR spectral data of 24 and 23 indicated 
the differences between the two data sets arise from the chemical shift of C-7, which is at δ 
90.3, s for 24, and  at δ 92.7, s, for  23. Thus, the configuration of C-7 changed from R* in 23 to 
S* in 24 based on the deshielded nature of the resonance associated with C-7 in 23 (Dekebo et 
al., 2002). 1H-1H NMR coupling constants for H-8 (δ 2.56, dd, J = 9.9, 7.3 Hz) and H-9 (δ 2.17, 
dd, J = 13.7, 9.9 Hz) indicated the orientation of the two protons had to be axial-axial 
orientation. 2D NOESY NMR and selective gradient NOE spectra demonstrated all correlations 
in 24 were in a good agreement with those observed in 23. The relative stereochemistry of the 
rest of 24 is as described in 23. The configuration at C-5 stays undetermined. For 24, a new 
sorbicillinoid derivative, the trivial name trichodermanone C is proposed. 
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Compound 25 has the molecular formula C20H25O8 as deduced by HREIMS measurement. 
Comparison of the mass spectral data of 25 with those of 24 revealed 25, to have a methyl 
group less than 24. From 13C NMR spectral data of 25, the absence of the C-21 methyl group 
was evident. 2D NOESY and selective gradient NOE measurements indicated compound 25 to 
have the same relative stereochemistry as described in 24 except at C-10. Irradiation of Hax-11 
at δ 4.3 caused enhancement of H2-20. Thus, the configuration at C-10 changed from S* in 24 to 
R* in 25. For 25, a new sorbicillinoid derivative, the trivial name trichodermanone D is 
proposed.
  
 
  
 
                                  
  
Table 19. 1H, HMBC and NOESY NMRa spectral data for compounds 24 and 25 
 
 24  25 
Position δ1H HMBC NOESY δ1H HMBC NOESY 
6 3.51(1Heq, s)d  C-1, C-2, C-4, C-5, C-7,  
C-8, C-12 
H-13, H3-19 3.39 (1H, s)d C-1, C-2, C-4, C-5, C-7,  
C-8, C-12 
H-13, H3-19, Hax-11, 
Heq-11 
8 2.56 (1Hax, dd, 9.9, 7.3) C-3, C-9, C-11, C-18 Heq-9, H2-11, H3-18 2.74 (1Hax, dd, 9.9, 7.0) C-1, C-3 Hax-11,Heq-11, H3-8, 
Hax-9 
9 1.69 (1Heq, dd, 13.9, 7.3) 
2.17 (1Hax, dd, 13.9, 9.9) 
C-3, C-8, C-10, C-20 
C-3, C-8, C-10 
H3-18, Hα-20  
Hax-9, Hax-8 
1.76 (1Hax, dd, 13.9, 7.0) 
2.12 (1Heq, dd, 13.9, 7.0) 
 
C-2, C-3, C-4, C-6, C-9 
Heq-9, Hax-8, H3-18 
Hax-8, Hax-9, H3-18 
11 3.91 (2H, br m) C-6, C-7 Hax-8, H3-21 3.78 (1Heq, d, 11.7) 
4.30 (1Hax, d, 11.7) 
 
C-7, C-8, C-10, C-11 
Heq-6, Hax-11 
Hax-8, Heq-11, H-20 
13 6.44 (1H, d, 15.0) C-12, C-15, C-16 H-15, H-6 6.47 (1H, d, 15.0)  H-15, H-6 
14 7.25 (1H, dd, 15.0, 11.0) C-12, C-15, C-16 H-16 7.26 (1H, dd, 15.0, 11.0) C-1, C-12, C-15 H-16 
15  6.39 (1H, dd, 15.0, 11.0) C-16 H-13, H3-17 6.42 (1H, dd, 15.0, 11.0) C-12, C-16 H-13, H3-17  
16 6.23 (1H, dq, 15.0, 7.0) C-14, C-15, C-17 H-14 6.26 (1H, dq, 15.0, 7.0) C-16, C-17 H-14 
17 1.86 (3H, d, 7.0) C-13, C-15, C-16 H-15 1.87 (1H, d, 7.0) C-15, C-17 H-15 
18 1.08 (3H, s) C-2, C-3, C-4, C-8 Hax-8, Hax-9  1.11 (3H, s) C-13, C-15, C-16 Hax-8, Hax-9, Heq-9 
19 1.14 (3H, s) C-4, C-5, C-6 Heq-6, H2-11 1.16 (3H, s) C-2, C-3, C-4, C-8 Heq-6, Hax-9 
20 3.01 (1Ha, d, 11.0) 
3.85 (1Hb, d, 11.0) 
C-10 Hax-9 
H3-21, Hα-20 
3.26 (1Hα, d, 11.0) 
3.32 (1Hβ, d, 11.0) 
 
C-10 
Hax-11 
 
21 3.20 (3H, s)  H2-11, Hβ-20    
OH-5 5.70 (1H, br s)   5.45 (1H, br s)b   
OH-7 4.06 (1H, br s)   5.15 (1H, br s)b   
OH-10       
OH-12 14.00 (1H, br s)   14.00 (1H, br s)   
OH-20 3.55 (1H, m) b   4.65 (1H, br s)b   
 
aAll 2D NMR were measured in 500 MHz, except HMBC was measure in 300 MHz using (CD3)2CO. bLong-range correlation from proton to carbon. CThe signal was not observed. dJ in Hz 
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The structure elucidation of compound 26 
commenced when the molecular formula of 
C12H16O4 was established by positive mode 
electrospray ionisation mass spectrometric 
(ESIMS), EIMS and NMR spectral data. 
Finally, the HREIMS measurement 
validated these data. In the 13C NMR 
spectrum of 26, 12 resonances attributable to 
two methyl groups, a methylene group, three 
sp2-hyberdized methine groups, an aliphatic 
sp3-hyberdized methine group, a methoxyl group and four quaternary carbons, were evident 
(Table 20). It was clear from these data that four of five degrees of unsaturation within 26 were 
due to multiple bonds, three carbon-carbon double bonds and a carbonyl group, thus, the 
molecule had to be monocyclic. The 1H and 13C NMR spectral data enabled all but one 
hydrogen atom of 26 to be accounted for; thus, it was evident that the remaining proton must be 
present in hydroxyl function, a deduction supported by IR data (γmax 3384 cm-1). Also evident 
from the 1H and 13C NMR data of 26 were resonances consistent with the presence of a 
trisubstituted pyran-2-one ring, a deduction supported by a maximum absorption at 278 nm in 
the UV spectrum. After association of all 1H and 13C NMR resonances, associated with C-H 
one-bond interactions, from cross peaks seen in the 1H-13C 2D NMR shift-correlated (HMQC) 
spectrum of 26, it was possible to deduce the planar structure of 26 by interpretation of its 1H-
1H COSY and 1H-13C HMBC spectra. From the 1H-1H COSY spectrum of 26, a 1H-1H spin 
system from H3-10 to H-6 was evident. Diagnostic cross peaks in the HMBC spectrum were 
observed between H3-10 and both C-9 and C-8, between H2-8 and C-7; the combination of these 
spectral data (COSY and HMBC) enabled the side chain to be elucidated. Because of 
characteristic long-range correlations observed between H-4 and C-2, C-3, C-5 and C-6, the 
side chain has to be attached to the pyranone ring through the bond between C-5 and C-6. 
Characteristic long-range correlation this time observed between H3-12 and C-3, led to conclude 
on the methoxyl group to be attached to C-3. Diagnostic long-range 1H-13C HMBC correlations 
observed from the resonance of H3-11 to those of C-1, C-2, C-3 and C-4, enabled to be position 
the methyl group at C-2. Remaining to be incorporated into the planar structure is the hydroxyl 
group. On the basis of 13C NMR chemical shift of C-9 (δ 68.2, d), the hydroxyl function was 
resided at C-9. The absolute configuration at C-9 was not determined. For 26, a new pyranone 
derivative, the trivial name trichopyranone is proposed. 
 
 
 
 
OH
O
O
26
2
3
4
5
7
8
9
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11
12
6O
The numbers in brackets are 
used for systematic naming
(1)
(4)
(3)
(2)
(5)(1)
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(5)
(6)
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Table 20. 1H [(CD3)2CO, 300 MHz] and 13C NMR [(CD3)2CO, 75.5 MHz], spectral data for 
compound 26a 
 
Position    δ 13Cb δ 1Hc HMBC 
1 165.1 (s)   
2 103.3 (s)   
3 168.6 (s)   
4   96.9 (d) 6.44 (1H, s) C-2, C-3, C-5, C-6 
5 158.7 (s)   
6 126.1 (d) 6.20 (1H, d, 15.7)  
7 137.0 (d) 6.65 (1H, dd, 15.7, 7.7)  
8   44.5 (t) 2.35 (2H, dd, 7.7, 2.9)  
9   68.2 (d) 3.91 (1H, dq, 5.9, 2.9)  
10   25.2 (q) 1.16 (3H, d, 5.9) C-8, C-9 
11   10.8 (q) 1.84 (3H, s) C-1, C-2, C-3, C-4  
12   57.8 (q) 3.95 (3H, s) C-3 
OH-9  3.98 (1H, m)d  
 
aAll assignments are based on 1D and 2D measurements (HMBC, HMQC, COSY). bImplied multiplicities  
were determined by DEPT (C = s, CH = d, CH2 = t, CH3 = q). cJ in Hz. dTentative assignment. 
 
 
All known compounds were identified by comparison of their spectroscopic data and optical 
rotations with published values. Epoxysorbicillinol (27) was first isolated as a yellow pigment 
from sponge-derived fungus Trichoderma longibrachiatum (Sperry et al., 1998). Vertinolide 
(28) was obtained from laboratory contaminant fungus Verticillium intertextum and its structure 
was established by X-ray analysis (Trifonov et al., 1982). Trichodimerol (29) was firstly 
isolated form Trichoderma logibrachiatum (Andrade et al., 1992). Trichodimerol had DPPH 
radical scavenging effects (ED50 53.7 µM) comparing with reference substance BHT and α-
tocopherol (ED50 27.0 and 22.0 µM, repectively). Finally, compound 29 showed significant 
inhibitory activity against lipopolysaccharide induced production of tumor necrosis factor alpha 
(TNF-α) in human monocytes (Nicolaou et al., 2000). Bislongiquinolide (trichotetronine) (30) 
was isolated from Trichoderma longibrachiatum as amorphous yellow powder and its structure 
clearly composed from two sorbyl units and a tetronic acid moiety (Sperry et al., 1998). 
Bisvertinol (31) a bisorbicillinoide derivative, was first obtained from Verticillium intertextum 
as a yellow amorphous powder (Trifonov et al., 1986). 2-Furancarboxylic acid (19) was 
discussed previously (Chapter 4.4). 
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The total extract and all compounds except 19, were tested in ELISA based assays for their 
HIV-1 reverse transcriptase inhibitory activity, and found to be inactive except 27, which 
showed moderate activity (63.8 % at 200 µg/mL). The antimicrobial activities were measured 
using agar diffusion assays and no significant activity was found. All compounds and total 
extract were tested for their estrogenic effect and no activity was observed. The antioxidative 
properties of the total extract and all compounds except 31 and 19 were assessed using DPPH 
radical and TBARS assays. The results of these assays are shown in Tables 21 and 22, and  are 
in a good agreement with the published data (Abe et al., 1998a and b). The antioxidant activity 
of the known compound 27 is published for the first time. The total extract and all compounds 
except 19, were tested for cytotoxicity against ten human cancer cell lines, and no significant 
activity was observed, except weak activity of the total extract. 
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Table 21. DPPHa radical scavenging effects of the EtOAc extract of Trichoderma viride and 
compounds 22-30 
 %Scavengingb 
Item Tested 6c 12 23 46 115 230 
EtOAc Extract -2.3 -0.8 -0.6 3.2 7.3 12.5 
 22 -0.9 0.1 8.5 11.0 11.2 8.6 
 23 -1.1 -0.8 0.0 -1.3 1.0 1.3 
 24 -0.8 -3.0 0.7 1.6 3.1 3.4 
 25 -0.6 0.1 -1.4 0.8 2.1 4.7 
 26 -0.9 1.0 -0.9 -0.8 1.0 3.7 
27 1.8 3.5 8.6 20.3 30.2 43.8 
28 -1.5 -2.0 1.9 7.4 10.1 15.5 
29 -0.1 2.6 4.8 13.3 23.0 37.2 
30 0.4 1.3 4.0 9.1 16.7 23.8 
BHTd 1.0 4.2 4.0 9.2 17.3 32.8 
Vit E 10.9 19.4 38.2 94.0 94.3 94.0 
 
aDPPH = α,α-Diphenyl-β-picrylhydrazyl. bScavenging % = 100-(A samplee x 100/A controle). cConcentrations 
in µmol/L. dBHT = Butylated hydroxytoluene. fAbsorbance of sample and control measured at 517 nm. 
 
 
Table 22. Antioxidative effects (TBARS Assay)a of the EtOAc extract of Trichoderma sp. 
 and compounds 22-30 
 % Inhibitionb 
Item Tested 8f 16 33 82 164 
EtOAc Extract      6.4 5.0 1.5 -4.4 -5.3 
22 2.4 1.4 -3.0 -10.1 -7.2 
23 0.7 4.6 7.6 6.8 6.0 
24 7.1 9.4 6.3 3.8 5.5 
25 6.2 6.4 6.0 4.7 6.2 
26 1.9 1.2 3.2 2.2 1.6 
27 14.4 11.9 11.7 13.7 17.8 
28 3.2 4.6 4.3 3.6 5.2 
29 9.1 11.4 9.7 12.1 19.9 
30 6.8 3.3 0.9 -2.8 -0.1 
BHTc 20.3 34.5 50.8 63.9 69.2 
Vit. E 12.7 30.9 67.4 70.0 73.6 
 
aTBARS = Thiobarbituric acid method. b% Inhibition = 100-(A sampled - A sample blank) x 100 / (A control – A 
blank). cBHT = Butylated hydroxytoluene. dA = Absorbance of test blank and control solutions are measured at both 
532 and 600 nm.  fConcentrations in µmol/L 
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Trichodermanone A (22) was isolated as yellowish viscous oil (2 mg); [α]22D = + 51.5° (c 
0.08, MeOH); UV λmax (MeOH) (log ε) 360 (4.3), 250 (4.2), 204 (4.1) nm; IR (film) νmax 
3384, 2923, 2359, 1729, 1599, 1404 cm-1; 1H and 13C NMR data (Table 17 and 18); ESIMS: 
positive ion m/z 361 [M+H]+ and m/z 378 [M+H2O]+; negative ion m/z 359 [M-H]+; EIMS m/z 
(% rel int), 361 [M+H]+ (10), 289 (10), 279 (25), 235 (10), 207 (10), 193 (20), 179 (20), 167 
(40), 137 (30), 125 (37), 111 (50), 97 (65), 83 (55), 69 (50); calcd for C19H20O7  m/z 360.1209.  
 
Trichodermanone B (23) was isolated as yellowish viscous oil (4 mg); [α]22D = + 203° (c 
0.24, MeOH); UV λmax (MeOH) (log ε) 360 (4.6), 248 (4.2), 203 (4.2)  nm; IR (film) νmax 
3315, 2920, 2851, 1732, 1630, 1602, 1565, 1455, 1381 cm-1; 1H and 13C NMR data (Table 17 
and 18); EIMS m/z (% rel int), 408 [M+] (10), 376 (100), 101 (80), 95 (40), 59 (90); HREIMS 
m/z 376.1519 [M-CH4O]+ calcd for   C20H24O7  m/z 376.1522. 
 
Trichodermanone C (24) was isolated as yellowish viscous oil (6 mg); [α]22D = + 251.5° (c 
0.2, MeOH); UV λmax (MeOH) (log ε) 358 (4.7), 248 (4.2), 202 (4.4.) nm; IR (film) νmax 
3393, 2938, 1733, 1630, 1600, 1561, 1383 cm-1; 1H and 13C NMR data (Table 18 and 19); 
ESIMS: negative ion m/z 407 [M-H]+; positive ion m/z 426 [M+H2O]+; EIMS m/z (% rel int), 
408 [M+] (10), 376 (60), 111 (30), 95 (100); HREIMS m/z 408.1780 calcd for C21H28O8  m/z 
408.1783. 
 
Trichodermanone D (25) was isolated as yellowish viscous oil (21 mg); [α]22D = + 265.7° (c 
0.5, MeOH); UV λmax (MeOH) (log ε) 360 (4.3), 248 (3.8) nm; IR (film) νmax 3330, 2937, 
1731, 1627, 1597, 1556, 1380 cm-1; 1H and 13C NMR data (Table 18 and 19); EIMS m/z (% 
rel int), 394 [M+] (20), 376 (100), 305 (22), 287 (20), 101 (37), 95 (65), 59 (37); HREIMS m/z 
394.1625, calcd for C20H25O8 m/z 394.1628. 
 
Trichopyranone, 6-(4-hydroxy-1-pentenyl)-4-methoxy-3-methyl-2H-pyran-2-one (26) was 
isolated as yellowish viscous oil (2.5 mg); [α]22D = - 10.3° (c 0.1, MeOH); UV λmax (MeOH) 
(log ε) 334 (3.5), 278 (3.5), 227 (4.0) nm; IR (film) νmax 3384, 2930, 2360, 1676, 1549, 1458, 
1258, 1144 cm-1; 1H and 13C NMR data (Table 20); ESIMS: positive ion m/z 225 [M+H]+, 
EIMS m/z (% rel int), 224 [M+] (25), 180 (100), 152 (25), 139 (20), 125 (30), 111 (60), 83 
(45), 71 (55), 57 (65); HREIMS m/z 224.1046 calcd for C12H16O4  m/z 224.1049. 
 
Epoxysorbicillinol (27) was isolated as yellowish brown viscous oil (6 mg); [α]22D = + 85.5° 
(c 0.2, MeOH); Lit. (Sperry et al., 1998) [α]D = + 75° (c 0.15, MeOH); UV λmax (MeOH) (log 
ε) 288 (4.3) nm; IR (film) νmax 3354, 2934, 1625, 1585, 1381, 1215, 1015 cm-1; 1H NMR (300 
MHz, [CD3]2CO) δ 7.25 (1H, dd, J = 15.0, 9.9 Hz, H-9), 6.37 (1H, d, J = 15.0 Hz, H-8), 6.32-
6.28 (2H, m, H-11, H-10), 3.71 (1H, s, H-6), 1.88 (1H, d, J = 5.5 Hz, H3-12), 1.67 (3H, s, H3-
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13), 1.55 (3H, s, H3-14); 13C NMR (75.5 MHz, [CD3]2CO) δ 192.5 (s, C-7), 186.4 (s, C-4), 
172.5 (s, C-2), 145.5 (d, C-9), 142.9 (d, C-11), 131.2 (d, C-10), 124.7 (d, C-8), 107.2 (s, C-3), 
70.4 (s, C-5), 63.1 (s, C-1), 61.9 (d, C-6), 26.3 (q, C-14), 18.9 (q, C-12), 7.9 (q, C-13); EIMS 
m/z (% rel int), 264 [M+] (12), 249 (20), 221 (20), 127 (22), 95 (100), calcd for C14H16O5  m/z 
264.0998. 
 
Vertinolide (28) was isolated as yellowish brown viscous oil (6 mg); [α]22D = -11.1°  (c 0.1, 
CHCl3); UV λmax (MeOH) (log ε) 262 (4.0), 230 (sh), nm; IR (film) νmax 3404, 2928, 2360, 
1694, 1632, 1597, 1230, 1173 cm-1; 1H NMR (300 MHz, [CD3]2CO); δ 7.17 (1H, dd, J = 
15.0, 9.9 Hz, H-9), 6.30-6.24 (2H, d, J = 15.0 Hz, H-10 and H-11), 6.09 (1H, d, J = 15.0 Hz, 
H-8), 2.57 (2H, m, H-6), 2.44 (2H, m, H-5), 1.89 (3H, d, J = 5.4 Hz, H3-12), 1.68 (3H, s, H3-
14); 1.48 (3H, s, H3-13), 13C NMR (75.5 MHz, [CD3]2CO) δ 198.9 (s, C-7), 176.5 (s, C-3), 
173.6 (s, C-1), 143.3 (d, C-9), 140.7 (d, C-11), 131.2 (d, C-10), 128.4 (d, C-8), 96.6 (s, C-2), 
82.3 (s, C-4), 34.7 (t, C-6), 31.6 (t, C-5), 23.5 (q, C-14), 18.7 (q, C-12), 6.3 (q, C-13); EIMS 
m/z (% rel int), 250 [M+] (10), 237 (14), 108 (25), 99 (44), 95 (100), calcd for C14H18O4  m/z 
250.1205. 
 
Trichodimerol (29) was isolated as yellow amorphous powder (10 mg); [α]23D = -480° (c 0.1, 
MeOH), Lit (Nicolaou et al., 2000) (film) νmax 3431, 2924, 1737, 1613, 1553, 1263 cm-1; 1H 
NMR (300 MHz, [CD3]2CO); δ 7.27 (2H, dd, J = 15.0, 11.0 Hz, H-9, H-9`), 6.50–6.40 (4H, 
m, H-10, H-10`, H-11, H-11`), 6.25 (2H, d, J = 15.0 Hz, H-8, H-8`), 3.12 (2H, s, H-1, H-1`), 
1.88 (6H, d, J = 7.0 Hz, H3-12, H3-12`), 1.40 (6H, s, H3-14, H3-14`), 1.32 (6H, s, H3-13, H3-
13`); 13C NMR (75.5 MHz, [CD3]2CO) δ 200.2 (s, C-5, C-5`), 177.5 (s, C-7, C-7`), 144.7 (d, 
C-9, C-9`), 140.1 (d, C-11, C-11`), 133.3 (d, C-10, C-10`), 121.3 (d, C-8, C-8`), 105.9 (s, C-3, 
C-3`), 103.5 (s, C-6, C-6`), 81.1 (s, C-2, C-2`), 60.9 (s, C-4, C-4`), 56.1 (d, C-1, C-1`), 21.3 
(q, C-13, C-13`), 19.2 (q, C-12, C-12`), 18.9 (q, C-14, C-14`) ; ESIMS: positive ion m/z 497 
[M+H]+, negative ion m/z 495 [M-H]+, calcd for C28H32O8  m/z 496.2097. 
 
Bislongiquinolide (trichotetronine) (30) was isolated as amorphous yellow powder (39 mg); 
[α]23D = +137° (c 0.1, MeOH), Lit. (Sperry et al., 1998) [α]23D = +134° (c 0.07, MeOH); UV 
λmax (MeOH) (log ε) 370 (4.9), 292 (4.9), 263 (4.8) nm; IR (film) νmax 3417, 2932, 1730, 
1707, 1658, 1621, 1585, 1561, 1375, 1312, 1230, 1063 cm-1; 1H NMR  (300 MHz, 
[CD3]2CO); δ 7.30 (2H, dd, J = 15.0, 11.0 Hz, H-11, H-17), 6.57-6.20 (6H, m, H-10, H-12, H-
13, H-16, H-18, H-19), 3.37 (1H, m, H-4), 3.30 (1H, br d, J = 7.0 Hz, H-8), 3.21 (1H, d, J = 
7.0 Hz, H-7), 1.89 (6H, d, J = 6.5 Hz, H3-14, H3-20), 1.49 (3H, s, H3-25), 1.42 (3H, s, H3-26), 
1.17 (3H, s, H3-28), 0.99 (3H, s, H3-27); 13C NMR (75.5 MHz, [CD3]2CO); δ 210.1 (s, C-6), 
202.3 (s, C-15), 197.5 (s, C-2), 178.8 (s, C-22), 176.6 (s, C-24), 169.9 (s, C-9), 147.8 (d, C-
17), 145.1 (d, C-19), 143.9 (d, C-11), 140.8 (d, C-13), 132.3 (d, C-18), 131.5 (d, C-12), 128.4 
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(d, C-16), 119.5 (d, C-10), 110.0 (s, C-3), 97.9 (s, C-23 ), 84.4 (s, C-21), 75.8 (s, C-5), 63.5 (s, 
C-1), 53.5 (d, C-7), 43.9 (d, C-8), 43.4 (d, C-4), 23.2 (q, C-26), 24.1 (q, C-27), 19.1 (q, C-20), 
19.0 (q, C-14), 11.3 (q, C-28), 6.5 (q, C-25); EIMS m/z (% rel int), 496 [M+] (10), 453 (10), 
361 (60), 247 (20), 95 (100), calcd for C28H32O8  m/z 496.2097. 
 
Bisvertinol (31) was isolated amorphous yellow powder (2 mg); [α]23D = -690° (c 0.1, 
MeOH), [α]23D = -940° (c 0.1, CHCl3), Lit. (Trifonov et al., 1986) [α]20D = -1467° (c 0.05, 
CHCl3); UV λmax (MeOH) (log ε) 363 (4.7), 299 (4.6), 274 (sh), 240 (sh) nm; IR (film) νmax 
3375, 2921, 2852, 1726, 1613, 1556, 1457 cm-1; 1H NMR (300 MHz, [CD3]2CO); δ 7.22 (2H, 
dd, J = 15.0, 11.0 Hz, H-12, H-21 ), 6.60 (2H, d, J = 15.0 Hz, H-11, H-20), 6.40-6.10 (4H, m, 
H-23, H-22, H-14, H-13), 3.72 (1H, s, H-9a),  2.77 (1H, d, J = 15.0 Hz, H-3), 2.55 (1H, d,  J = 
15.0 Hz, H-3), 1.89 (6H, m, H3-24, H3-15), 1.44 (3H, s, H3-25), 1.41 (3H, s, H3-18), 1.30 (3H, 
s, H3-17), 1.17 (3H, s, H3-16); 13C NMR (75.5 MHz, [CD3]2CO), δ 194.3 (s, C-10), 193.0 (s, 
C-19), 180.3 (s, C-1), 170.5 (s, C-8), 167.5 (s, C-6), 143.0 (d, C-12, C-21), 140.8 (d, C-13, C-
22), 137.6 (d, C-14), 137.2 (d, C-23), 122.1 (d, C-11, C-20), 111.0 (s, C-7), 107.0 (s, C-9), 
105.1 (s, C-2), 102.6 (s, C-4a), 79.8 (s, C-5a), 74.0 (s, C-4), 59.8 (s, C-9b), 54.9 (d, C-9a), 
37.2 (t, C-3), 26.6 (q, C-25), 23.1 (q, C-16), 21.8 (q, C-17), 20.0-19.8 (q, C-24, C-15), 8.0 (q, 
C-18); ESIMS: positive ion m/z 499 [M+H]+, negative ion m/z 497 [M-H]+, calcd for 
C28H34O8  m/z 498.2254. 
 
2-Furancarboxylic acid (19) was isolated as amorphous powder (1mg) and identified by 
comparison of the 1H NMR data with those previously published (Chapter 4.4). 
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4.6 Secondary metabolites from marine fungi  
 
4.6.1 Alternaria sp. 
 
Fungi of genus Alternaria occur wide spread as a parasite on cultivated plants; they were also 
found on numerous kinds of organic material under damp conditions, and were also isolated 
from marine sources (Freeman, 1965). The genus of Alternaria is known as a source of 
secondary metabolites; to date more than 161 compounds have been reported from fungi 
belonging to this genus, e.g. djalonenol, dibenzo-α-pyrone-djalonensone (Onocha et al., 1995) 
and zinniol (Gamboa-Angulo et al., 2000). In the preliminary screening for antimicrobial 
activity using agar diffusion assays, the extract of the mitosporic fungus Alternaria sp. 
(Pleosporaceae, Ascomycota, M 7-19, 539), isolated from the red alga, Jania rubens L. 
(Corallinaceae, M 7), collected from water around the Island of Morira, Mediterranean sea, 
showed prominent antimicrobial activity (biomalt medium, inhibition zone against Mycotypha 
microspora 0.4 cm, Eurotium repens 0.5 cm, Microbotryum violaceum 0.5 cm at 250 
µg/disc). On this basis and with regard to the low field of 1H NMR signals of the total extract. 
Alternaria sp. was selected for chemical investigation.  
 
Mycelia and 10 L of solid biomalt medium were diluted with water (100 mL/L), homogenized 
using the Ultra-turax T25 at 8000 rpm-1. The resulting mixture exhaustively extracted with 
EtOAc (3 x 8 L) and filtered. The filtrate was evaporated under reduced pressure to yield 2.0 
g of a highly viscous dark reddish gum. The EtOAc extract was fractionated by VLC (2.5 x 
20 cm, Si gel 60, 0.063-0.200 mm, 40 g, Merck) normal-phase silica (gradient pet.ether-
EtOAc) to give 10 fractions (pet.ether:EtOAc, 1:0; 8:2; 7:3; 6:4; 5:5; 4:6; 3:7; 2:8; 1:9; 0:1, 
each 100 mL). According to 1H NMR spectral data, fractions 2 and 3, were interesting for 
further fractionation. VLC fraction 2 was subjected for NP (Eurospher Si, 5 µm, 250 x 8 ID, 
Knauer) HPLC using 85:15 pet.ether:acetone, to yield 32 (tR = 13 min, 0.25 mg/L, 2.5 mg). 
VLC fraction 3 was subjected for precipitation trials, by dissolving the fraction in acetone and 
preciptates by CH2Cl2, left on the bench few minuts. Turbidity was appeared followed by 
precipitation of 33 (0.3 mg/L, 3 mg). The remaining fractions appeared not interesting based 
on 1H NMR spectral data.  
 
The dibenzopyrone derivatives (alternariol 32 and alternariol monomethyl ether 33) were 
formally isolated from the mycelium of A. tenuis and recorded as the first dibenzo-α-pyrone 
derivatives (Freeman et al, 1965).  
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Alternariol, 3,7,9-trihydroxy-1-methyl-6H-benzo[c]chromen-6-one (32), was isolated as white 
amorphous powder (3 mg). 1H NMR (300 MHz, [CD3]2CO); δ 7.34 (1H, d, J = 1.0,  H-8), 
6.78 (1H, d, J = 1.5 Hz, H-2), 6.68 (1H, d, J = 
1.5 Hz, H-4), 6.43 (1H, d, J = 1.0 Hz, H-10), 
2.74 (3H, s, CH3-11); 13C NMR (75.5 MHz, 
[CD3]2CO) δ 166.3 (s, C-9), 166.2 (s, C-6), 
166.0 (s, C-7), 159.4 (s, C-3), 154.2 (s, C-4a), 
139.7 (s, C-1), 139.6 (s, C-10a), 118.5 (d, C-
2), 110.8 (s, C-10b), 105.3 (d, C-4), 102.8 (d, 
C-8), 102.0 (d, C-10), 99.3 (s, C-6a), 25.8 (q, 
CH3-11); EIMS m/z (% rel int) 258.1 [M] + 
(100), 69 (20), calcd 258.0528 for C14H10O5. 
 
Alternariol monomethyl ether, 3,7-dihydroxy-9-methoxy-1-methyl-6-H-benzo[c]chromen-6-
one (33), was isolated as white amorphous powder (2.5 mg). 1H NMR (300 MHz, [CD3]2CO); 
δ 7.34 (1H, d, J = 2.2,  H-8), 6.83 (1H, d, J = 2.6 Hz, H-2), 6.83 (1H, d, J = 2.6 Hz, H-4), 6.65 
(1H, d, J = 2.2 Hz, H-10), 4.01 (3H, s, OCH3), 2.98 (3H, s, CH3-11); 13C NMR (75.5 MHz, 
[CD3]2CO) δ 167.5 (d, C-9), 166.1 (s, C-6), 165.9 (s, C-7), 159.5 (s, C-3), 154.1 (s, C-4a), 
139.6 (s, C-1), 139.1 (s, C-10a), 118.5 (d, C-2), 110.5 (s, C-10b), 104.5 (d, C-4), 102.7 (d, C-
8), 99.9 (s, C-6a), 104.5 (d, C-10), 56.2 (q, C-12, OCH3), 25.6 (q, C-11); EIMS m/z (% rel int) 
272.1 [M] + (100), 69 (30), calcd 272.0685 for C15H12O5.              
 
 
4.6.2 Sporormiella sp.  
 
Sporormiella species are well known as coprophilous fungi, mainly found in dung and also 
isolated from marine sources (Osterhage dissertation, 2001). The genus Sporormiella is noted 
for its ability to produce bioactive secondary metabolites, e.g. similins A and B isolated from 
S. similes (Weber et al., 1992), australifungin reported from S. australis (Mandala et al., 
1995), terezines A-D isolated from S. teretispora (Wang et al., 1995) and sporovexins A-C 
from S. vexans (JS 306) (Soman et al., 1999). In the preliminary screening for antimicrobial 
activity using agar diffusion assay, the extract of the fungus Sporormiella sp. isolated from 
the brown alga Stypopodium sp. (Stypocaulaceae) showed prominent antimicrobial activity 
(biomalt medium, inhibition zone against Microbotryum violaceum 0.4 cm at 250 µg/disc).  
The fungus Sporormiella (Ascomycetes, G 2-1, 493) was cultivated at room temperature for 
two months in 5 L (20 Erlenmayer flasks) of liquid biomalt containing 50 g biomalt and 1 L 
distilled water. Each Fernbach flask was inoculated with 10 ml of 10-day-old cultures (room 
temperature) grown under the same medium. The mycelia and media were extracted by 
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EtOAc (3 x 10L). The total extract (0.75 g, brown viscous oil) was fractionated by Vaccum 
Liquid Chromatography (2.5 x 20 cm, Polyprep 60-50 C18, 30 g, Macherey-Nagel 71150; 
reversed-phase), employing gradient elution from H2O to MeOH, to yield 4 fractions 
(H2O:MeOH, 7.5:2.5; 5:5; 2.5:7.5; 0:1; each 200 mL) (177.6, 249.8, 110.0, 28.5 mg, 
respectively,). After 1H NMR spectral data analysis, resulted in fraction 1 was interesting for 
further fractionation. VLC fraction 1 was fractionated by using reversed phase VLC, 
employing gradient elution from H2O to MeOH, to yield 9 fractions (H2O:MeOH, 9:1; 8:2; 
7:3; 6:4; 5:5; 4:6; 3:7; 3:7; 2:8, each 100 mL) ( 37.0, 66.8, 8.4, 6.3, 7.4, 6.6, 3.6, 6.4 mg, 
respectively). VLC Fractions 14 (6.3 mg) identified as 2-furancarboxylic acid (19) (Chapter 
4.4). VLC Fractions 15 and 16 (13 mg) were pooled 
together, and purified by isocratic RP-18 HPLC 
using  90:10 H2O: MeOH, in 35 min, 2 mL/min, to 
yield p-hydroxyphenylethanol (34) (tR = 16.5 min, 
0.6 mg/L, 3 mg), which, has been previously 
repoted from various fungi (Turner and Aldridge, 
1983). 
 
p-Hydroxyphenylethanol (34) was isolated as 
colourless oil (3 mg); 1H NMR (300 MHz, CD3OD) δ 7.00 (2H, d, J = 8.6 Hz, H-4, H-8), 6.70 
(2H, t, J = 8.6 Hz, H-5, H-7), 3.65 (2H, t, J = 7.2 Hz, H2-1), 2.68 (2H, t, J = 7.2 Hz, H2-2); 13C 
NMR (75.5 MHz, CD3OD) δ 157.2 (s, C-6), 131.0 (s, C-3), 130.9 (d, C-4, C-8), 116.1 (d, C-5, 
C-7), 64.6 (t, C-1), 39.4 (t, C-2); ESIMS: negative ion m/z 137.0 [M-H]+, calcd for C8H10O2  
m/z 138.0681. 
 
 4.6.3 Myrioconium sp. 
 
In the preliminary screening for antimicrobial activity using agar diffusion assay, the ethyl 
acetate extract of a mitosporic fungus Myrioconium sp. isolated from Fucus vesiculosus.L 
CUX-3 (Fucaceae), collected by divers around Cuxhaven, North Sea, showed prominent 
antimicrobial activity (biomalt medium, inhibition zone against Eurotium repens 1.2 cm, 
Microbotryum violaceum total inhibition zone at 250 µg/disc). A literature survey was carried 
out and indicated that there is no publication on secondary metabolites from this genus. The 
1H NMR spectrum of the total extract showed signals in the δ 6-9 region. On this basis 
Myrioconium sp. was selected for chemical investigation. The fungus Myrioconium sp. 
(Mitosporic, Cux 3-10, 547) was cultivated at room temperature for two months in 10 L (20 
Erlenmayer flasks) of liquid biomalt containing 50 g biomalt and 1 L distilled water. Each 
Fernbach flask was inoculated with 10 ml of 10 day-old cultures (room temperature) grown in 
biomalt media without agar. 
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The mycelia and medium were extracted with EtOAc (3 x 15 L). The total extract (2.95 g, 
brown viscous oil) was fractionated by VLC (2.5 x 20 cm, Si gel 60, 0.063-0.200 mm, 40 g, 
Merck), employing gradient elution from pet.ether/EtOAc/MeOH, to yield 8 fractions 
(pet.ether:EtOAc:MeOH, 7.5:2.5:0; 5:5:0; 2.5: 7.5:0; 0:1:0; 0:7.5:2.5; 0:5:5; 0:2.5:7.5; 0:0:1; 
each 100 mL) (0.8, 6.0, 1525.0, 75.8, 58.8, 27.4, 136.8, 
and 94.5 mg, respectively). 1H NMR spectral data 
analysis, showed fraction 4 to be interesting for further 
fractionation. NP-HPLC with cyclohexane:EtOAc, 8:2, 2 
mL/min, in 30 mints to yield p-hydroxybenzaldehyde 
(35) (tR = 9 min, 0.1 mg/L, 1 mg). This compound is 
known since longe time ago and well known as 
microorganisms metabolites (Ayer et al., 1993).  
 
p-Hydroxybenzaldehyde (35) was isolated as amorphous white powder (1 mg). 1H NMR (300 
MHz, CDCl3) δ 9.91 (1H, s, H-1), 7.84 (2H, d, J = 8.3 Hz, H-3, H-7), 6.96 (2H, d, J = 8.3 Hz, 
H-4, H-6); 13C NMR (75.5 MHz, CDCl3) δ 190.8 (s, C-1), 160.9 (s, C-5), 132.4 (d, C-3, C-7), 
129.8 (s, C-2), 115.9 (d, C-4, C-6); EIMS m/z (% rel int) 122.0 [M] + (80), 121.0 [M-H] + 
(100), 93 [M-CO] + (45), 65 (30), calcd 122.0368 C7H6O2. 
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5 Summary 
 
The objective of this thesis was the investigation of the secondary metabolites produced by 
selected fungal strains isolated from the marine environment, and the assessment of their 
biological activity. Predominantly the antioxidant potential of the isolated compounds was 
assessed. In addition the isolation of endophytic fungi from Egyptian marine algae was 
performed.  
 
Extracts of seven fungal strains, including six algal-derived and one sponge-derived fungus, 
were investigated chemically. This investigation resulted in the isolation and structure 
elucidation of 34 pure compounds representing different structural sub-classes within the 
polyketides i.e. hydroquinones, naphthalenones, xanthones, isobenzofuranones, pyrones, 
furanones and vertinoide/sorbicillinoid derivatives. Sixteen compounds (1-8, 12, 13, 17, and 
22-26) proved to be new natural products.  
 
The structurally unusual hydroquinone derivative acremonin A (1) and acremonin A 
glucoside (2) were isolated from Acremonium sp. and proved to be a new structural type of 
natural products. Compound 1 has significant antioxidant activity. Additionally, two 
naphthalenone stereoisomers (3 and 4) were obtained from this fungus. Compound 5 was 
isolated for the first time as a natural product and its structure was proven by x-ray analysis. 
In addition to these compounds an inseparable mixture of three new isomeric compounds (6-
8) was analysed. Two new xanthone derivatives (12 and 13) were isolated from the rare 
fungal strain Wardomyces anomalus. These compounds showed an interesting new 
oxygenation pattern. Compound 12 has significant DPPH radical scavenging effects, and is 
also able to inhibit peroxidation of linolenic acid. Significant TK p56lck enzyme inhibitor 
activity is also observed for 12. From Epicoccum sp., a new isobenzofuranone derivative (17) 
was isolated. Epicoccone (17) has potent antioxidant activity.The sponge-derived fungus 
Trichoderma viride contained four unprecedented and most structurally unusual sorbicillinoid 
derivatives (22-25), together with a new pyrone derivative (26).  
 
To date reports concerning antioxidant metabolites from marine fungi are very rare. This 
study demonstrates that marine fungi are an excellent source for the discovery of novel 
antioxidant derivatives. Besides the prominent biological activity the diversity of structures 
obtained during this project is a further motivation for the investigation of marine-derived 
fungi.  
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6 Discussion and future aspects 
 
The main objective of this study was the investigation of some marine-derived fungi aiming at 
finding new natural products with biological activity and/or novel chemical structures. Both, 
sponge- and algae-derived fungi are a prolific source of highly diverse secondary metabolites 
(Koenig & Wright, 1996; Pietra, 1997; Biabani, 1998; Faulkner 2001). The current project 
mainly deals with strains, isolated by Dr. Höller (Dissertation, 1999) and Dr. Osterhage 
(Dissertation, 2001). As aforementioned the selection of the fungal species for further 
investigation was predominantly based on the bioactivity of the total extract and/or the 
presence of several low field 1H NMR resonances (δ 5-8 region) in the NMR spectrum of the 
extract. On this basis, seven fungal strains of different genera were selected for large-scale 
cultivation. Six of them were mitosporic fungi i.e. Acremonium sp., Wardomyces anomalus, 
Epicoccum sp., Trichoderma viride, Alternaria sp., and Myrioconium sp., and one was a 
fungus belonging to the Ascomycetes i.e. Sporormiella sp. From their extracts, 34 secondary 
metabolites were obtained. Sixteen compounds, (1-8, 12, 13, 17, and 22-26) were obtained as 
new natural products. In addition to these compounds, 18 known secondary metabolites were 
isolated.  
 
The experimental work throughout this thesis revealed that most of the isolated metabolites 
possess antioxidant effects. This activity can be attributed to the presence of phenolic 
moieties. Especially, acremonin A (1), 2-(1-hydroxy-1-methyl)-2,3-dihydrobenzofuran-5-ol 
(9), 2,2-dimethyl-chroman-3,6-diol (10), 2-(3-dihydroxy-3-methylbutyl)-benzene-1,4-diol 
(11), anomalin A (12) and epicoccone (17) had potent antioxidant activities.  
 
The compounds isolated in this study all belong to the polyketides and can be classified 
according to their structural features into seven sub-classes: hydroquinones, naphthalenones, 
xanthones, isobenzofuranones, pyrones, furanones and vertinoide/sorbicillinoid derivatives. 
This diversity of structures highlights the biosynthetic capability of marine derived fungi. 
Thus, a discussion of hypothetical biosynthetic pathways for the metabolites obtained seems 
worthwhile. 
 
Hydroquinone derivatives 
 
Five structurally related compounds (1, 2, and 9-11) were obtained from the extract of the alga-
derived fungus Acremonium sp. Two of them, 7-isopropenyl bicyclo[4.2.0] octa-1,3,5-triene-
2,5-diol (1), and 7-isopropenylbicyclo[4.2.0]octa-1,3,5-triene-2,5-diol-5-ß-D-glucopyranoside 
(2) possess a most unusual ring system, observed for the first time in natural products. 
Biosynthetically, 1, 2 and 9-11 are probably related (Fig. 11). All of these compounds possess 
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an aromatic moiety, possibly of polyketide origin, substituted with a hemiterpene unit. Different 
cyclization reactions would then yield the three types shown.  
 
 
 
O
O
OH
OH
OH HO
HO
Common precursor
11  type
1, 2  type
9  type
10  type
 
 
 
Figure 11. Proposed biosynthetic pathway for compounds 1, 2 and 9-11. 
 
 
 
 
Naphthalenone 
 
Two new natural products (3R*,4S*)-3,4-dihydroxy-7-methyl-3,4-dihydro-1(2H) naphthalene- 
one (3), and  (3S*,4S*)-3,4-dihydroxy-7-methyl-3,4-dihydro-1(2H)-naphthalenone (4) were 
obtained as a 1:0.84 inseparable mixture from Acremonium sp. This class of natural products 
was previously reported from both higher plants and fungi (Talapatra et al., 1988). For 
instance, 4,8-dihydroxy- tetralone was first isolated from a fungus of the genus Scytalidium 
(Findlay & Kwan, 1973). The naphthalenone skeletone possibly originates from one acetate 
and four malonate units condensed head to tail through aldol condensation followed by 
cyclization, aromatization and hydroxylation. Methylation could occur after cyclization as 
drawn in Figure 12, or the methyl group might originate from a methylmalonyl-CoA unit.  
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O
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Hydroxylation
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4  Malonyl-CoA
+
Claisen condensation
Cyclization and aromatization
Reduction
 
 
Figure 12. Proposed biosynthetic pathway for naphthalenone derivatives 3 and 4. 
 
 
 
Xanthone derivatives 
 
Three xanthone derivatives (12-14) were isolated from the fungus Wardomyces anomalus, 
two of them (12 and 13) proved to be new natural products. The third one (14) was previously 
isolated from the lichen Lecanora reuteri (Harris et al., 1976). Experiments with labelled 
precursors indicated that the xanthone nucleus is usually produced through the acetate 
pathway (Hill et al., 1982). In Figure 13 the proposed biosynthetic pathway for compounds 
12-14 is shown. This illustrates again the unusual hydroxylation pattern of 12 and 13. 
 
 
Discussion 
                        
 
93
 
Enz
O
HO
OH
OH
O
HO
OH
OHO
O
OOH
HO OH
12                                                                                     13
14
Hydroxylation
Acetyl-CoA
6 x Malonyl-CoA
+
OH
O
OOH
HO OH
OH
OH
OO
O OO
O
O
2 x Aldol condensation
Aromatization
HO
2 x Hydroxylation
 
 
Figure 13. Proposed biosynthetic pathway for compounds 12-14 
 
 
 
Isobenzofuranone derivative 
 
Epicoccone (17) is an unique isobenzofuranone derivative and may originate from the 
condensation of one acetate and three malonate units (Figure 14). Aldol condensation 
followed by aromatization might be the key steps in this biosynthesis. The presence of the 
phenolic group activates the ortho positions so as to allow two further hydroxyl groups to be 
positioned. Methylation leads to the intermediate (17a). Oxidation of methyl group, followed 
by lactonization may give a isobenzofuranone (17) (Dewick, 2002). 
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Figure 14. Proposed biosynthetic pathway for compound 17 
 
 
Mellein derivatives 
 
Pentaketides of the mellein-type are well known as fungal metabolites, often with prominent 
biological, e.g. antimicrobial, activity. The mellein derivative (-)-(3R,4S)-4-hydroxymellein 
(20) and (-)-(3R)-5-hydroxymellein (21) obtained in this study were first isolated from 
Septoria nordorum (Devys et al., 1992), Lasidioplodia theobromae (Aldrige et al., 1971) and 
Sporormia affinis (McGahren & Mitcher, 1986). A hypothetical biosynthetic pathway shown 
in Figure 15. 
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Figure 15. Proposed biosynthetic pathway for compounds 20 and 21 
 
 
 
Vertinoide derivatives 
 
The pathway of vertinoid biosynthesis is shown in Figure 16. It is an extension of the 
suggestion of Trifonov et al. (1986). Their illustration based on the sorbicillinoid derivative, 
bisvertinol (31), which may be produced from two sorbicillin units (Figure 17). Experimental 
evidence came from Abe et al. (2000) who showed that sorbicillinol, which originated from 
sorbicillin, is the precursor for trichodimerol (29) and bisvertinol (31). Bisloniquinolide (30) 
was produced by reaction of the intermediate (28A) with sorbicillinol (Sperry et al., 1998). The 
intermediate 28A, was a precursor for vertinolide (28), might orignate from sorbicillinol in a 
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similar way as penicillic acid from orsellinic acid. Our suggestion for 28 is thus based on 
analogies to the biosynthesis of penicillic acid from orsellinic acid (Figure 17). Penicillic acid 
was reported as a fungal metabolite from Penicillium cyclopium, and biosynthetically produced 
via the ring fission of orsellinic acid as in Figure 17 (Dewick, 2002). It is possible that 
compounds 22-25 were produced through a Diels-Alder cycloaddition of A to B followed by 
oxidation and decarboxylation to yield 22, or by cyclization to give compounds 23-25 (Figure 
18). 
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Figure 16.  Summary of  the proposed biosynthetic relationship between 
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Figure 17.  Proposed biosynthetic pathway for penicillic acid.
 
 
 
 
 
 
 
 
 
 
 
    Figure 18. Proposed biosynthetic pathway of compounds 22-25. 
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Dibenzopyrone derivatives  
 
Thomas (1961) studied the chemical degradation of labeled alternariol (32) derived from 
sodium [1-14C] acetate and demonstrated the biosynthesis to involve a head to tail 
condensation of one acetate and six malonate units. This indicated that the two compounds 
(32-33) originated from the polyketide pathway through the condensation of the acetyl-CoA 
and malonyl-CoA as shown in Figure 19. 
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Figure 19. Proposed biosynthetic pathway of alternariol (32) and alternariol monomethyl 
ether (33). 
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The next step of the current project would be the investigation of the biosynthetic pathways 
based on the hypothesis illustrated, using labelled (13C or 2H or 18O) precursors. The most 
interesting compounds would be the trichodermanones A-D (22-25), as well as the other 
polyketide compounds (26-31) produced by Trichoderma viride since they represent most 
unusual novel structures. Once the biosynthetic pathway is established, molecular biologic 
experiments might be worthwhile for the isolation and identification of the genclusters 
responsible for the polyketide production.  
 
Secondary metabolites isolated during this study represented different structural classes of 
natural product. This indicates that marine-derived fungi have a wide range of biosynthetic 
capabilities for the production of novel structures. Within this study the polyketides produced 
by Trichoderma viride possess the most unusual structural skeletons and these compounds 
might have still undiscovered biological activities. Thus, the application of OSMAC (One 
Strain-Many Compounds) concept may be worthy in this case (Bode et al., 2000, 2002). 
OSMAC is carried out by using different media and/or different cultivation parameters such 
as UV-light irradiation, pH, temperature, and oxygen. This could yield further new 
metabolites. 
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HO
HO
OH
Acremonin A (1) 7-isopropenylbicyclo[4.2.0]octa-1,3,5-triene-2, 5-diol, R = H 
Acremonin A glucoside (2) 7-isopropenylbicyclo-[4.2.0]octa-1,3,5-triene-2, 
5-diol-5- ß-D-gluopyranoside, R = ß-D-glucopyranose
OH
O
R
O
OH
OH
OH
O
OHHO
O
R2
(3R*,4S*)-3,4-dihydroxy-7-methyl-3,4-dihydro-1(2H)-naphthalenone (3) 
R1 = R3 = H; R2 = R4 = OH
(3S*,4S*)-3,4-dihydroxy-7-methyl-3,4-dihydro-1(2H)-naphthalenone (4)
R2 = R3 = H; R1 = R4 = OH
R2
O
R1
O
O
O
OHO
R3
R1
R4
Pentanedioic acid 2-(1- methylethenyl)- 
5-methyl ester (8)
2-(1-Methylethylidene)pentanedioic acid (5) 
R1 = OH, R2 = OH 
pentanedioic acid 2-(1-methylethylidene)-5-methyl ester (6)
R1 = OH, R2 = OCH3 
pentanedioic acid 2-(1-methylethylidene)-1-methyl ester (7)
R1 = OCH3, R2 = OH
2-(1-Hydroxy-1-methyl)-2,3-dihydrobenzofuran-5-ol (9)
2, 2-Dimethyl-chroman-3, 6-diol (10)
O
O O
H
R3
R1
R2 OH
Anomalin A (12) 2,3,6,8-tetrahydroxy-1-ethylxanthone 
R1 = R2 = OH, R3 = H 
Anomalin B (13) 2,3,4,6,8-pentahydroxy-1- methylxanthone 
R1 = R2 = R3 = OH
3,6,8-Trihydroxy-1-methylxanthone (14) R1 = R3 = H, R2 = OH
2-(3-Dihydroxy-3-methylbutyl)-
benzene-1, 4-diol (11)
 
 
Figure 20. Metabolites 1-14 isolated during this study.
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Figure 21. Metabolites 15 and 17-26 isolated during this study.  
O
O
OH
HO
HO
O
OOH
R1R2
 R1      R2
OH      H   (-)-(3R,4S)-4-Hydroxymellein (20)                Trichodermanone A (22)
 H      OH  (-)-(3R)-5-Hydroxymellein (21)
O
OH O
O
O
OH
HO
H
H
H
OH
O
O
O
HO
O
HO
Hax
H
HO
Heq
Hax
Heq
Hax
Epicoccone, 4,5,6-trihydroxy-7-
methylphthalide (17)
O
O
O
O
HO
O
HO
HO
H
H Heq
Hax
Hax
Trichodermanone B (23)                                                     Trichodermanone C (24)
O R2R1
5-(Hydroxymethyl)-2-furanocarboxylic acid 
R1 = CH2OH, R2 =COOH(15)
5-(Acetoxymethyl)-2-furanocarboxylic acid 
R1 = COOH, R2 = CH2OAc(18)
2-Furanocarboxylic acid 
R1 = H, R2 = COOH (19)
OH
O
O
O
6-(4-Hydroxy-1-pentenyl)-4-methoxy-3-methyl-
2H-pyran-2-one (26).
O
O
O
O
HO
OH
HO
HO
Hax
Heq
H
Heq
Hax
Hax
H
Trichodermanone D (25)
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HO
OO
OH
O O
OH
HO
OO
OH
O
OH
O
O
OH
O
Epoxysorbicillinol (27)                                                              Vertinolide (28)
OOH
O
O
O
OH
OH O
O
HO
OOH
O
OH
OH
HO
H
Bisvertinol (31)
Bislongiquinolide (trichotetronine) (30)
Trichodimerol (29)
O
O
CH3
HO
O
OH
R
Alternariol, R = H (32)
Alternariol monomethyl ether, R = CH3 (33)
OH
HO
p-Hydroxyphenylethanol (34)                                        p-Hydroxybenzaldehyde (35)
H
O
HO
 
 
Figure 22. Metabolites 27-35 isolated during this study.  
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8.2 1H NMR spectra of selected compounds   
 page
 
Acremonin A (1) 112
Acremonin A glucoside (2) 112
(3R*,4S*)-3,4-Dihydroxy-7-methyl-3,4-dihydro-1(2H)-naphthalenone (3)  113
(3S*,4S*)-3,4-Dihydroxy-7-methyl-3,4-dihydro-1(2H)-naphthalenone (4) 113
2-(1-Methylethylidene)-pentanedioic acid (5) 113
Pentanedioic acid, 2-(1-methylethylidene)-5-methyl ester (6)  114
Pentanedioic acid, 2-(1-methylethylidene)-1-methyl ester (7) 114
Pentanedioic acid, 2-(1-methyl ethenyl)-5-methyl ester (8) 114
2-(1-Hydroxy-1-methyl)-2, 3-dihydrobenzofuran-5-ol (9) 114
2,2-Dimethyl-chroman-3,6-diol (10) 115
2-(3-Dihydroxy-3-methylbutyl)-benzene-1,4-diol (11) 115
Anomalin A (12) 116
Epicoccone, 4,5,6-trihydroxy-7-methylphthalide (17) 116
5-(Acetoxymethyl)-2-furanocarboxylic acid (18) 117
(-)-(3R,4S)-4-Hydroxymellein (20) 117
(-)-(3R)-5-Hydroxymellein (21) 118
Trichodermanone A (22) 118
Trichodermanone B (23) 119
Trichodermanone C (24) 119
Trichodermanone D (25) 120
Trichopyranone (26) 120
Epoxysorbicillinol (27) 121
Vertinolide (28) 121
Trichodimerol (29) 122
Bislongiquinolide (trichotetronine) (30) 122
Bisvertinol (31) 123
Alternariol monomethy ether (33) 123
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2.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0
1.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
O H
O H
Acremonin A, 7-isopropenyl-bicyclo[4.2.0]octa-1,3,5-triene-2, 5-diol (1)
300 MHz, (CD3)2CO
Acremonin A glucoside, 7-isopropenyl-bicyclo[4.2.0]octa-1,3,5-triene-2,5-diol,
5-ß-D-glucopyranoside (2)
300 MHz, (CD3)2CO
R =ß-D-glucopyranose
O
O H
R
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1.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
1.52.02.53.03.54.04.55.05.56.06.57.07.58.0
O O H
O H
2-(1-Methylethylidene)-pentanedioic acid (5)
300 MHz,(CD3)2CO
O
R3
R1
O
R2R4
(3R*,4S*)-3,4-Dihydroxy-7-methyl-3,4-dihydro-1(2H)-naphthalenone (3)
(3S*,4S*)-3,4-Dihydroxy-7-methyl-3,4-dihydro-1(2H)-naphthalenone (4)
300 MHz, (CD3)2CO
3 R1 = R3 = H; R2 = R4 = OH
4 R2 = R3 = H; R1 = R4 = OH
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1.01.52.02.53.03.54.04.55.05.5.6.06.57.07.58.0
1.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
O R1
R2
6 R1 = OH, R2 = OCH3
7 R1 = OCH3, R2 = OH
Pentanedioic acid, 2-(1-methylethylidene)-5-methyl ester (6)
Pentanedioic acid, 2-(1-methylethylidene)-1-methyl ester (7)
Pentanedioic acid, 2-(1-methyl ethenyl)-5-methyl ester (8)
300 MHz, (CD3)2CO
O
O O H
O
O
8
O
O H
HO
2-(1-Hydroxy-1-methyl)-2,3-dihydrobenzofuran-5-ol (9)
300 MHz, (CD3)2CO
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0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5.9.0
O
O HHO
2,2-Dimethyl-chroman-3,6-diol (10)
300 MHz, (CD3)2CO
HO
O H
O H
O H
2-(3-Dihydroxy-3-methylbutyl)-benzene-1,4-diol (11)
300 MHz, (CD3)2CO
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1234567891011121314
2.22.4.2.62.83.03.23.43.63.84.04.24.44.64.85.05.25.45.65.86.0
O
O O
H
HO
HO O H
Anomalin A, 2,3,6,8-tetrahydroxy-1-methylxanthone (12)
300 MHz, (CD3)2CO
O
O
HO
HO
O H
Epicoccone, 4,5,6-trihydroxy-7-methylphthalide (17)
300 MHz, CD3OD
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2.02.53.03.54.04.55.05.56.06.57.07.58.0
23456789101112
O
5-(Acetoxymethyl)-2-furanocarboxylic acid (18)
300 MHz, CD3OD
O
HO
O
O
O
OO H
(-)-(3R,4S)-4-Hydroxymellein (20)
300 MHz, (CD3)2CO
O H
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1.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.5
1.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
O
H
O
H
H
O H
O
O H
O
HO
Trichodermanone A (22)
300 MHz, (CD3)2CO
O
O H
O H
O
(-)-(3R)-5-Hydroxymellein (21)
300 MHz, (CD3)2CO
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1.52.02.53.03.54.04.55.05.56.06.57.07.58.0
1234567891011121314
H
O
OO H
HO
H
HO
O
H
H
H
H
HO
O
Trichodermanone B (23)
300 MHz, (CD3)2CO
H
O
OO
HO
H
H
H
HO
O
O
HO
Trichodermanone C (24)
300 MHz, (CD3)2CO H
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1234567891011121314
2.02.53.03.54.04.55.05.56.06.57.0
O O
O H
O
Trichopyranone, 6-(4-hydroxy-1-pentenyl)-4-methoxy-3-methyl-2H-pyran-2-one (26)
300 MHz, (CD3)2CO
H
H
O
OO
O
H O
H O
OH
H O
H
H
H
H
Trichodermanone D (25)
300 MHz, (CD3)2CO H
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1.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0
1.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0
O
O
O H
O
Vertinolide (28)
300 MHz, (CD3)2CO
O
O H
O
O H
O
Epoxysorbicillinol (27)
300 MHz, (CD3)2CO
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1.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0
OO
O H
HO
O H
HO
OO
Trichodimerol (29)
300 MHz, (CD3)2CO
O H
O
OO H
O
O
O
O H
Bislongiquinolide (30)
300 MHz, (CD3)2CO
 
 
 
Appendix: 8.2 1H NMR spectra of selected compounds 
 
 
 123
 
1.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0
2.02.53.03.54.04.55.05.56.06.57.07.58.0
HO
OO H
O
O H
O H
H
O
HO
Bisvertinol (31)
300 MHz, (CD3)2CO
O
HO O
O H
O
Alternariol monomethy ether (33)
300 MHz, (CD3)2CO
 
